
<html lang="en"     class="pb-page"  data-request-id="044649d3-3a72-4ff3-97bb-1d311ed55d9c"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;article:article:10.1021/acs.jmedchem.9b01511;issue:issue:10.1021/jmcmar.2019.62.issue-21;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Vaccine Adjuvants Derivatized from Momordica Saponins I and II" /></meta><meta name="dc.Creator" content="Pengfei  Wang" /></meta><meta name="dc.Creator" content="Xiong  Ding" /></meta><meta name="dc.Creator" content="Hyunjung  Kim" /></meta><meta name="dc.Creator" content="Đani  Škalamera" /></meta><meta name="dc.Creator" content="Suzanne M.  Michalek" /></meta><meta name="dc.Creator" content="Ping  Zhang" /></meta><meta name="dc.Description" content="We have derivatized Momordica saponins (MS) I and II through their coupling at C3 glucuronic acid site with dodecylamine. The derivatives show significantly different immunostimulant activity profi..." /></meta><meta name="Description" content="We have derivatized Momordica saponins (MS) I and II through their coupling at C3 glucuronic acid site with dodecylamine. The derivatives show significantly different immunostimulant activity profi..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="October 28, 2019" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.9b01511" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2019 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b01511" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.9b01511" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b01511" /></link>
        
    
    

<title>Vaccine Adjuvants Derivatized from Momordica Saponins I and II | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.9b01511" /></meta><meta property="og:title" content="Vaccine Adjuvants Derivatized from Momordica Saponins I and II" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01511/20191108/images/large/jm9b01511_0008.jpeg" /></meta><meta property="og:description" content="We have derivatized Momordica saponins (MS) I and II through their coupling at C3 glucuronic acid site with dodecylamine. The  derivatives show significantly different immunostimulant activity profiles from their respective natural parent saponins. In particular, adjuvant VSA-1 (5), the derivative of MS I, potentiates a significantly higher IgG2a responose than the corresponding natural product. Its IgG1 and IgG2a production is similar to that of GPI-0100, indicating a potential mixed and antigen-specific Th1/Th2 immune response, which is different from the Th2 immunity induced by the natural saponin MS I. In addition, toxicity evaluations show that adjuvant VSA-1 (5) is much less toxic than the widely used natural saponin mixture Quil A. These results prove that derivatizing Momordica saponins can be a viable way for easy access to structurally defined saponin immunostimulants with favorable adjvuant activity and low toxicity." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.9b01511"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01511">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.9b01511&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.9b01511&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.9b01511&amp;href=/doi/10.1021/acs.jmedchem.9b01511" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2019</span><span class="cit-fg-volume">, 62</span><span class="cit-fg-issue">, 21</span><span class="cit-fg-pageRange">, 9976-9982</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/62/21" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.9b01463" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.9b00283" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Vaccine Adjuvants Derivatized from <i>Momordica</i> Saponins I and II</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Pengfei Wang</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Pengfei Wang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry, University of Alabama at Birmingham, 901 14th Street South, Birmingham, Alabama 35294, United States</div></div><span class="conrtib-corresp"><strong>*</strong>Phone: (205) 996-5625. E-mail, <a href="/cdn-cgi/l/email-protection#a1d6c0cfc6d1e1d4c0c38fc4c5d4"><span class="__cf_email__" data-cfemail="7106101f1601310410135f141504">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Pengfei++Wang">Pengfei Wang</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-0285-2069" title="Orcid link">http://orcid.org/0000-0002-0285-2069</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Xiong Ding</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Xiong Ding</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry, University of Alabama at Birmingham, 901 14th Street South, Birmingham, Alabama 35294, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Xiong++Ding">Xiong Ding</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Hyunjung Kim</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hyunjung Kim</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry, University of Alabama at Birmingham, 901 14th Street South, Birmingham, Alabama 35294, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hyunjung++Kim">Hyunjung Kim</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Đani Škalamera</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Đani Škalamera</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry, University of Alabama at Birmingham, 901 14th Street South, Birmingham, Alabama 35294, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=%C4%90ani++%C5%A0kalamera">Đani Škalamera</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-7764-5750" title="Orcid link">http://orcid.org/0000-0002-7764-5750</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Suzanne M. Michalek</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Suzanne M. Michalek</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Microbiology, University of Alabama at Birmingham, 901 14th Street South, Birmingham, Alabama 35294, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Suzanne+M.++Michalek">Suzanne M. Michalek</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Ping Zhang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ping Zhang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pediatric Dentistry, University of Alabama at Birmingham, 901 14th Street South, Birmingham, Alabama 35294, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ping++Zhang">Ping Zhang</a></span></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b01511&amp;href=/doi/10.1021%2Facs.jmedchem.9b01511" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2019</span></span><span class="cit-volume">, 62</span><span class="cit-issue">, 21</span><span class="cit-pageRange">, 9976–9982</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">October 28, 2019</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>11 September 2019</li><li><span class="item_label"><b>Published</b> online</span>28 October 2019</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 14 November 2019</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.9b01511" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01511</a></div><div class="article_header-article-copyright"><strong>Copyright © 2019 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D9976%26pageCount%3D7%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DPengfei%2BWang%252C%2BXiong%2BDing%252C%2BHyunjung%2BKim%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D62%26issueNum%3D21%26contentID%3Dacs.jmedchem.9b01511%26title%3DVaccine%2BAdjuvants%2BDerivatized%2Bfrom%2BMomordica%2BSaponins%2BI%2Band%2BII%26numPages%3D7%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D9982%26publicationDate%3DNovember%2B2019">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.9b01511"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">689</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">4</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.9b01511" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Vaccine Adjuvants Derivatized from Momordica Saponins I and II&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Pengfei&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Xiong&quot;,&quot;last_name&quot;:&quot;Ding&quot;},{&quot;first_name&quot;:&quot;Hyunjung&quot;,&quot;last_name&quot;:&quot;Kim&quot;},{&quot;first_name&quot;:&quot;Đani&quot;,&quot;last_name&quot;:&quot;Škalamera&quot;},{&quot;first_name&quot;:&quot;Suzanne&quot;,&quot;last_name&quot;:&quot;M. Michalek&quot;},{&quot;first_name&quot;:&quot;Ping&quot;,&quot;last_name&quot;:&quot;Zhang&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2019&quot;,&quot;month&quot;:&quot;10&quot;,&quot;day&quot;:&quot;28&quot;,&quot;issue&quot;:&quot;21&quot;,&quot;volume&quot;:&quot;62&quot;,&quot;pages&quot;:&quot;9976-9982&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.9b01511&quot;},&quot;abstract&quot;:&quot;We have derivatized Momordica saponins (MS) I and II through their coupling at C3 glucuronic acid site with dodecylamine. The derivatives show significantly different immunostimulant activity profiles from their respective natural parent saponins. In particular, adjuvant VSA-1 (5), the derivative of MS I, potentiates a significantly higher IgG2a responose than the corresponding natural product. Its IgG1 and IgG2a production is similar to that of GPI-0100, indicating a potential mixed and antigen-specific Th1/Th2 immune response, which is different from the Th2 immunity induced by the natural saponin MS I. In addition, toxicity evaluations show that adjuvant VSA-1 (5) is much less toxic than the widely used natural saponin mixture Quil A. These results prove that derivatizing Momordica saponins can be a viable way for easy access to structurally defined saponin immunostimulants with favorable adjvuant activity and low toxicity.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01511&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01511" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01511&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01511" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01511&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01511" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b01511&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01511&amp;href=/doi/10.1021/acs.jmedchem.9b01511" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.9b01511" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.9b01511" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (904 KB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01511&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.9b01511%26sid%3Dliteratum%253Aachs%26pmid%3D31657920%26genre%3Darticle%26aulast%3DWang%26date%3D2019%26atitle%3DVaccine%2BAdjuvants%2BDerivatized%2Bfrom%2BMomordica%2BSaponins%2BI%2Band%2BII%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D62%26issue%3D21%26spage%3D9976%26epage%3D9982%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291909" title="Immunology">Immunology</a>,</li><li><a href="/action/doSearch?ConceptID=292224" title="Serum">Serum</a>,</li><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=290925" title="Carbohydrates">Carbohydrates</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/62/21" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/jmcmar.2019.62.issue-21/20191114/jmcmar.2019.62.issue-21.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01511/20191108/images/medium/jm9b01511_0008.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01511/20191108/images/large/jm9b01511_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01511&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">We have derivatized <i>Momordica</i> saponins (MS) I and II through their coupling at C3 glucuronic acid site with dodecylamine. The  derivatives show significantly different immunostimulant activity profiles from their respective natural parent saponins. In particular, adjuvant VSA-1 (<b>5</b>), the derivative of MS I, potentiates a significantly higher IgG2a responose than the corresponding natural product. Its IgG1 and IgG2a production is similar to that of GPI-0100, indicating a potential mixed and antigen-specific Th1/Th2 immune response, which is different from the Th2 immunity induced by the natural saponin MS I. In addition, toxicity evaluations show that adjuvant VSA-1 (<b>5</b>) is much less toxic than the widely used natural saponin mixture Quil A. These results prove that derivatizing <i>Momordica</i> saponins can be a viable way for easy access to structurally defined saponin immunostimulants with favorable adjvuant activity and low toxicity.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10271" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10271" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">A vaccine adjuvant is part of a vaccine formulation for boosting and/or modulating the immune responses induced by the vaccine. Modern vaccines frequently utilize refined and homogeneous antigens to minimize undesirable side effects. However, subunit antigens are often less immunogenic and require use of adjuvants/immunostimulants for a strong, long-lasting, and antigen-specific immune response.<a onclick="showRef(event, 'ref1 ref2 ref3 ref4 ref5 ref6 ref7 ref8 ref9 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3 ref4 ref5 ref6 ref7 ref8 ref9 ref10 ref11">(1−11)</a> Despite the important role of adjuvants in vaccination, only a few are approved for human vaccines.<a onclick="showRef(event, 'ref10 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref10 ref12 ref13">(10,12,13)</a> Discovery and development of new vaccine adjuvants become a prioritized endeavor in the vaccine field.<a onclick="showRef(event, 'ref3 ref14 ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref3 ref14 ref15 ref16">(3,14−16)</a></div><div class="NLM_p">FDA recently approved the combination adjuvant AS01<sub>b</sub> for human use.<a onclick="showRef(event, 'ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref17 ref18">(17,18)</a> One of its components, the natural saponin QS-21 isolated from the tree bark of <i>Quillaja saponaria</i> Molina (QS) (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), can potentiate a balanced antigen-specific Th1/Th2 response with CTL production.<a onclick="showRef(event, 'ref19 ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref19 ref20 ref21">(19−21)</a> QS-21 has shown significant advantages over a broad range of clinical and experimental adjuvants<a onclick="showRef(event, 'ref20 ref22'); return false;" href="javascript:void(0);" class="ref ref20 ref22">(20,22)</a> and has been evaluated in numerous anticancer and anti-infective vaccines in preclinical and clinical trials.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> However, QS-21 has its own limitations. For example, abundance of QS-21 in QS tree bark extracts is low.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Overexploitation of QS bark has already led to ecological destruction and supply shortage and resulted in more strict environmental regulations and increased price.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> The current natural supply of QS-21 was estimated to be only sufficient for about 6 million doses (calculated based on 100 μg/dose for human use), not sufficient for widespread clinical uses.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a>The limited supply of QS-21, along with its hydrolytical instability, dose-limiting toxicity, and laborious and inefficient purification, hinders its wider use.<a onclick="showRef(event, 'ref22 ref24'); return false;" href="javascript:void(0);" class="ref ref22 ref24">(22,24)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01511/20191108/images/medium/jm9b01511_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01511/20191108/images/large/jm9b01511_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structure of QS-21.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01511/20191108/images/large/jm9b01511_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01511&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The favorable adjuvant activity of QS-21 coincides with its unique molecular structure. It is one of the rare saponins bearing an acyl side chain that is responsible for its capability in stimulating a cell-mediated immune response. Earlier structure–activity-relationship (SAR) results indicated that elimination of the acyl side chain resulted in loss of QS-21’s Th1 and antigen-specific CTL capacity.<a onclick="showRef(event, 'ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref25 ref26">(25,26)</a> Our own research in synthesizing and evaluating QS analogs demonstrated the dramatic difference in adjuvant activity between analogs with or without a side chain.<a onclick="showRef(event, 'ref27 ref28 ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref27 ref28 ref29 ref30">(27−30)</a> We recently demonstrated that the deacylated QS-17/18 (<b>2a</b>) mainly potentiated IgG1 immunity, and incorporation of a dodecylamide side chain at the C3 glucuronic acid moiety led to new adjuvant <b>2b</b> with different adjuvant activity (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). It not only potentiates IgG1 response but also boosts IgG2a response significantly. For <b>2b</b>, the ratio of IgG2a/IgG1 is comparable to that of GPI-0100 which is a complex mixture of semisynthetic sapoinins prepared from the QS tree bark extracts.<a onclick="showRef(event, 'ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref31 ref32">(31,32)</a> GPI-0100 retains the capacity of natural QS saponins in potentiating humoral and T-cell immunity and has been used in preclinical and clinical studies.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> The similar IgG2a/IgG1 profiles between <b>2b</b> and GPI-0100 suggest that saponin <b>2b</b> might have the favorable adjuvant property of GPI-0100.<a onclick="showRef(event, 'ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref29 ref30">(29,30)</a></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01511/20191108/images/medium/jm9b01511_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01511/20191108/images/large/jm9b01511_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Synthesized QS analogs with different adjuvant activities.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01511/20191108/images/large/jm9b01511_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01511&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Herein we report a simple strategy to obtain saponin adjuvants with activity similar to that of QS analog <b>2b</b>. It involves only one-step derivatization of <i>Momordica</i> saponins (MS) I and II.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> These two saponins were isolated from widely available and inexpensive seeds of <i>Momordica cochinchinensis</i> Spreng (MC). Their structures only differ in the triterpenoid core; i.e., MS saponin I (<b>3</b>) has a gypsogenin core (R<sub>3</sub> = H), while MS II (<b>4</b>) has a quillaic acid core (R<sub>3</sub> = OH) identical to the core of QS-21 and QS-17/18 (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). The structures of saponins <b>3</b> and <b>4</b> strikingly resemble that of the deacylated QS-17/18 (<b>2a</b>); therefore, we infer that by incorporating a side chain to saponins <b>3</b> and <b>4</b>, we can obtain two new adjuvants with an immunostimulation profile similar to that of <b>2b</b>, given their structural similarity and consequently their similar hydrophile–lipophile balance (HLB) values (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). Oda and co-workers correlated HLB values to adjuvant activity in their SAR studies of soyasaponins.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a></div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01511/20191108/images/medium/jm9b01511_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01511/20191108/images/large/jm9b01511_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Structural similarity between MS and deacylated QS-17/18.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01511/20191108/images/large/jm9b01511_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01511&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The advantage of having structurally defined new saponin adjuvants from natural sources other than  QS tree bark is multifold. For example, new natural saponin sources can circumvent the “limited supply” issue of QS saponins. <i>Momordica cochinchinensis</i> Spreng is a perennial plant and grows mainly in China and Southeast Asia. It is easy to grow; the seeds (<i>Mubiezi</i>) are readily available and have been utilized in traditional Chinese medicine for more than 1000 years.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> The abundance of <b>3</b> and <b>4</b> in the MC seeds is high, and their isolation is more efficient and thus cost-effective than QS saponins. Recently, a MC seed extract was evaluated for adjuvant activity in an experimental swine vaccine against foot-and-mouth disease. The MC saponins showed synergistic effect with oil emulsion in boosting antigen-specific IgG in guinea pigs.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> However, in comparison of adjuvant activities against other adjuvants, i.e., Freund’s adjuvant, Quil A (QA), and propolis, in chickens immunized with the antigen F4 fimbriae, MS <b>3</b> and <b>4</b> showed lower capacity than Freund’s adjuvant and QA in boosting IgG response in both serum and egg yolk.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> These results are in agreement with our observations that without a fatty side chain, the deacylated QS-17/18 (<b>2a</b>) only showed modest humoral immunity.<a onclick="showRef(event, 'ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref29 ref30">(29,30)</a></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24124" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24124" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">We isolated the two natural MC saponins from MC seeds by using a known procedure.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> We then synthesized the two MS derivatives, i.e., <b>5</b> and <b>6</b>, from natural saponins <b>3</b> and <b>4</b>, respectively, by using a routine one-step amide-formation reaction (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>).<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a></div><figure id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01511/20191108/images/medium/jm9b01511_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01511/20191108/images/large/jm9b01511_0007.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Derivatizing <i>Momordica</i> Saponins</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01511/20191108/images/large/jm9b01511_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01511&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">With pure natural saponins <b>3</b> and <b>4</b> and their derivatives <b>5</b> and <b>6</b> in hand, we evaluated their ability to potentiate antibody responses to chicken egg ovalbumin (OVA). We immunized groups of BALB/c mice (female, 8–10 weeks of age, six per group) via the subcutaneous route (sc) with OVA (20 μg) alone or with GPI-0100 (100 μg) or saponins <b>3</b>–<b>6</b> (at 100 μg dose) on days 0, 14, and 28. Serum samples were collected, and mice were weighed prior to each immunization and at 2 weeks after the last immunization. The serum IgG, IgG1, and IgG2a antibody activities to OVA antigen were determined with enzyme-linked immunosorbent assay (ELISA).</div><div class="NLM_p">All groups of mice showed a serum anti-OVA IgG response at week 2, and the magnitude of the response continued to grow at weeks 4 and 6 (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). Similar to the positive control GPI-0100, VSA-1 (<b>5</b>) enhanced IgG responses to OVA antigen significantly at weeks 2, 4, and 6, compared with the group without an adjuvant. The OVA + <b>5</b> group also had significantly higher anti-OVA IgG responses than the OVA + <b>3</b> group at weeks 2 (<i>P</i> < 0.001), 4 (<i>P</i> < 0.001), and 6 (<i>P</i> < 0.01). The OVA group and the OVA + <b>3</b> group did not have significant difference in their IgG activity. The OVA + <b>4</b> group showed significant difference in IgG responses from the OVA group at weeks 2 and 4 but not at week 6. The OVA + <b>6</b> (derivative of natural MS II (<b>4</b>)) showed significantly higher anti-OVA IgG responses than the OVA group at weeks 4 and 6 but did not show significant difference from its parent compound <b>4</b> until week 6 (<i>P</i> < 0.05). Weight monitoring of mice indicated no sign of toxicity.</div><figure id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01511/20191108/images/medium/jm9b01511_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01511/20191108/images/large/jm9b01511_0004.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Serum IgG anti-OVA response in mice immunized by the sc route with OVA alone or with GPI-0100 or saponins <b>3</b>–<b>6</b>. Mice were immunized on days 0, 14, and 28. Serum samples were collected prior to each immunization and at 6 weeks after the initial immunization. Values are expressed as the mean ± SEM: *<i>P</i> < 0.05, **<i>P</i> < 0.01, and ***<i>P</i> < 0.001 compared with mice immunized with OVA alone.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01511/20191108/images/large/jm9b01511_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01511&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We then analyzed the IgG subclass distribution of different adjuvants. All adjuvants enhanced IgG1 responses significantly at weeks 2 and 4 (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>A). However, only GPI-0100, VSA-1 (<b>5</b>), and <b>6</b> showed significantly higher IgG1 titers than that of the OVA group at week 6. In IgG2a assessment (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>B), there was no significant difference among the groups at week 2, but GPI-0100 and VSA-1 (<b>5</b>) induced significantly higher IgG2a than seen in mice with OVA alone or with adjuvants <b>3</b>, <b>4</b>, or <b>6</b> at weeks 4 and 6.</div><figure id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01511/20191108/images/medium/jm9b01511_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01511/20191108/images/large/jm9b01511_0005.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Serum IgG1 (A) and IgG2a (B) anti-OVA response in mice immunized by the sc route with OVA alone or with GPI-0100 or saponins <b>3</b>–<b>6</b>. Mice were immunized on days 0, 14, and 28. Serum samples were collected prior to each immunization and at 6 weeks following the initial immunization. Values are expressed as the mean ± SEM: *<i>P</i> < 0.05, **<i>P</i> < 0.01, and ***<i>P</i> < 0.001 compared with mice immunized with OVA alone.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01511/20191108/images/large/jm9b01511_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01511&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Analysis of the anti-OVA IgG2a and IgG1 activities at week 6 revealed that OVA + <b>5</b> had a significantly higher IgG2a/IgG1 ratio than OVA alone or OVA with <b>3</b>, <b>4</b>, or <b>6</b> but no significant difference from GPI-0100 (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). The negligible IgG2a responses from the groups without an adjuvant or with adjuvant <b>3</b>, <b>4</b>, or <b>6</b> suggest that Th2-biased immune responses were selectively induced in these groups. Since GPI-0100 is known for its capability in potentiating a mixed Th1/Th2 response with CTL production, similar IgG2a/IgG1 distributions between GPI-0100 (0.194, <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, entry 2) and adjuvant <b>5</b> (0.312, <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, entry 5) groups suggest that these two adjuvants could have a similar activity profile, which warrants further evaluations.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Serum IgG1 and IgG2a Anti-OVA Activity at Week 6<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">entry</th><th class="colsep0 rowsep0" align="center">adjuvant</th><th class="colsep0 rowsep0" align="center">IgG1 (μg/mL)</th><th class="colsep0 rowsep0" align="center">IgG2a (μg/mL)</th><th class="colsep0 rowsep0" align="center">IgG2a/IgG1</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">none</td><td class="colsep0 rowsep0" align="left">113 ± 37</td><td class="colsep0 rowsep0" align="left">0.1</td><td class="colsep0 rowsep0" align="left">0.001**</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">GPI-0100</td><td class="colsep0 rowsep0" align="left">1,047 ± 292</td><td class="colsep0 rowsep0" align="left">166 ± 50</td><td class="colsep0 rowsep0" align="left">0.194 ± 0.060 (ns)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">233 ± 74</td><td class="colsep0 rowsep0" align="left">0.2</td><td class="colsep0 rowsep0" align="left"><0.001**</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">262 ± 37</td><td class="colsep0 rowsep0" align="left">0.1</td><td class="colsep0 rowsep0" align="left"><0.001**</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">713 ± 293</td><td class="colsep0 rowsep0" align="left">208 ± 81</td><td class="colsep0 rowsep0" align="left">0.312 ± 0.126</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">869 ± 334</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left"><0.001**</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Values are expressed as the mean ± SEM. Statistical significance compared with OVA + <b>5</b>: *<i>P</i> < 0.05. **<i>P</i> < 0.01. ***<i>P</i> < 0.001.</p></div></div></div><div class="NLM_p">As a comparison, we also evaluated adjuvants <b>3</b>–<b>6</b> in augmenting immune responses to rHagB antigen, a recombinant and nonfimbrial adhesion hemagglutinin B from <i>Porphyromonas gingivalis</i>.<a onclick="showRef(event, 'ref33 ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref33 ref40 ref41">(33,40,41)</a> In an experimental animal model, it was effective in inducing protective immunity against <i>P. gingivalis</i>-induced alveolar bone loss.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> By using the same procedure with rHagB antigen (at 35 μg dose), we observed the results similar to those with OVA antigen, and the IgG, IgG1 and IgG2a data are summarized in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A–C.</div><figure id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01511/20191108/images/medium/jm9b01511_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01511/20191108/images/large/jm9b01511_0006.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Serum IgG (A), IgG1 (B), and IgG2a (C) anti-rHagB response in mice immunized by the sc route with rHagB alone or with GPI-0100 or saponins <b>3</b>–<b>6</b>. Mice were immunized on days 0, 14, and 28. Serum samples were collected prior to each immunization and at 6 weeks after the initial immunization. Values are expressed as the mean ± SEM: *<i>P</i> < 0.05, **<i>P</i> < 0.01, and ***<i>P</i> < 0.001 compared with mice immunized with rHagB alone.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01511/20191108/images/large/jm9b01511_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01511&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The antigen rHagB stimulated a strong humoral immune response. Although the group without adjuvant was lower in IgG and IgG1 activities than the groups with an adjuvant at weeks 2 and 4, the difference became insignificant at week 6 (except for IgG of the group with <b>5</b>). However, the rHagB + GPI-0100 or rHagB + VSA-1 (<b>5</b>) groups showed significantly higher IgG2a activity than the group with rHagB alone at weeks 2, 4, and 6, which is consistent with our observation with the OVA antigen. The rHagB + <b>6</b> also had significantly higher IgG2a titers than the rHagB group at weeks 2 and 4 but not at week 6.</div><div class="NLM_p">These results clearly showed that by incorporating a simple and chemically stable fatty side chain to natural MS I (<b>3</b>), the new derivative (<b>5</b>) not only retains and enhances the IgG1 immunity of <b>3</b> but also modulates its adjuvant activity profile by inducing a significant IgG2a immune response. However, when the same strategy was applied to MS II (<b>4</b>), no significant increase of IgG2a was observed. Given that the only structural difference between the two MS derivatives is in the triterpenoid core, i.e., gypsogenin (R<sub>1</sub> = H) versus quillaic acid (R<sub>1</sub> = OH) (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>), it appears that the structure of the triterpenoid core instead of the hydrophile–lipophile balance of the saponin structure<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> plays an important role in affecting adjuvant activity of derivatives <b>5</b> and <b>6</b>. On the other hand, similar adjuvant activity between MS derivative <b>5</b> (with gypsogenin core) and QS derivative <b>2</b> (with quillaic acid core) suggests that the SAR is not straightforward, and the overall adjuvant activity is a result of complicated coordination of different structural moieties, i.e., the triterpene core and C3 and C28 sugar domains. Nevertheless, identification of derivative <b>5</b> demonstrates a viable way for easy access to structurally defined and potent saponin immunostimulants through simple chemical derivatization of inexpensive natural products.</div><div class="NLM_p">We then went on to evaluate acute toxicity of adjuvant VSA-1 (<b>5</b>) by using the same procedure for GPI-0100.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Thus, BALB/c mice (female, 10 weeks of age) were given an injection of an adjuvant in 0.1 mL of PBS on the neck via the subcutaneous route with the doses indicated in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>. All of the mice in the groups treated with VSA-1 (<b>5</b>) (5000 μg) or Quil-A (100 or 200 μg) died within 5 days after injection. The survival mice all had healthy looking fur and appeared to be behaving normally. None of the survival mice seemed lethargic in any way by day 7, and no lesion formation was observed on any of the mice. The data in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a> showed that the acute toxicity of VSA-1 (<b>5</b>) was similar to that of GPI-0100 but much lower than that of Quil A.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Acute Toxicity Comparison of <b>5</b>, Quil A, and GPI-0100<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">dose (μg)</th><th class="colsep0 rowsep0" align="center"><b>5</b></th><th class="colsep0 rowsep0" align="center">GPI-0100<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">Quil-A</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">controls</td><td class="colsep0 rowsep0" align="left">5/5</td><td class="colsep0 rowsep0" align="left">5/5</td><td class="colsep0 rowsep0" align="left">5/5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">5/5</td><td class="colsep0 rowsep0" align="left">5/5</td><td class="colsep0 rowsep0" align="left">0/5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">200</td><td class="colsep0 rowsep0" align="left">5/5</td><td class="colsep0 rowsep0" align="left">5/5</td><td class="colsep0 rowsep0" align="left">0/5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">500</td><td class="colsep0 rowsep0" align="left">5/5</td><td class="colsep0 rowsep0" align="left">5/5</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1000</td><td class="colsep0 rowsep0" align="left">5/5</td><td class="colsep0 rowsep0" align="left">5/5</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">2000</td><td class="colsep0 rowsep0" align="left">5/5</td><td class="colsep0 rowsep0" align="left">4/5</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5000</td><td class="colsep0 rowsep0" align="left">0/5</td><td class="colsep0 rowsep0" align="left">0/5</td><td class="colsep0 rowsep0" align="left"> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">Results are expressed as the number of surviving mice per group of 5 mice 5 days after injection.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">Literature results, female BALB/c mice of 16 weeks of age.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a></p></div></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i7">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_68138" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_68138" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">We have derivatized MS I and II by coupling them with dodecylamine at C3 glucuronic acid site. The obtained derivatives show significantly different immunostimulant activity profiles from their respective natural parent saponins. In particular, adjuvant VSA-1 (<b>5</b>), the derivative of MS I (<b>3</b>), induces an IgG2a responose significantly higher than the corresponding natural product. Its IgG1 and IgG2a productions are similar to that of GPI-0100, suggesting a potential mixed Th1/Th2 immune response against the specific antigens, different from the Th2 immunity induced by the natural saponins. Toxicity evaluations show that VSA-1 (<b>5</b>) has a toxicity profile similar to that of GPI-0100 and is much less toxic than the widely used natural saponin mixture Quil A. These results prove that derivatizing <i>Momordica</i> saponins is a viable way for easy access to structurally defined and potent saponin immunostimulants that can potentiate a mixed Th1/Th2 immune response and have low toxicity. Given the fact that Momordica saponins are readily available and easy to isolate, it will be practical for large-scale preparation of MS derivatives for potential preclinical studies and clinical applications.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77333" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77333" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Chemistry. General</h3><div class="NLM_p last">Organic solutions were concentrated by rotary evaporation at ∼12 Torr. Flash column chromatography was performed employing 230–400 mesh silica gel. Thin-layer chromatography was performed using glass plates precoated to a depth of 0.25 mm with 230–400 mesh silica gel impregnated with a fluorescent indicator (254 nm). Infrared (IR) data are presented as frequency of absorption (cm<sup>–1</sup>). Proton and carbon-13 nuclear magnetic resonance (<sup>1</sup>H NMR or <sup>13</sup>C NMR) spectra were recorded on 400, 700, and 850 MHz NMR spectrometers. Chemical shifts are expressed in parts per million (δ scale) downfield from tetramethylsilane and are referenced to residual protium in the NMR solvent (CHCl<sub>3</sub>: δ = 7.26). Data are presented as follows: chemical shift, multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet and/or multiple resonances, AB = AB quartet), coupling constant in hertz (Hz), integration. Anhydrous solvents were used without distillation. Solvents for workup and column chromatography were obtained from commercial vendors and used without further purification. The purity of the products was determined by a combination of HPLC, HRMS, and <sup>1</sup>H NMR and found to be ≥95%. All in vivo studies were performed in accordance with local IACUC guidelines.</div></div><div id="sec4_1_1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> General Procedure of Derivatizing Momordica Saponins I and II</h3><div class="NLM_p"><i>Momordica</i> saponins were isolated by using the published procedure.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> To the obtained saponin (<b>3</b>) (120 mg, 0.07 mmol) in ethanol (3.0 mL) and water (1.0 mL) were added dodecylamine (50 mg, 0.27 mmol), <i>N</i>-methylmorpholine (NMM) (91 mg, 0.90 mmol), hydroxybenzotriazole (HOBt) (83 mg, 0.54 mmol), and 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDC·HCl) (107 mg, 0.54 mmol) at room temperature.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> The reaction mixture was stirred for 1 day and then filtered. The filtrate was purified with RP HPLC by using a Prep-C18, 21.2 mm × 50 mm, 5 μm column and H<sub>2</sub>O/MeCN gradients (90–10% H<sub>2</sub>O over 9 min with a 25 mL/min flow rate). The desired product had a retention time of 7.5–9.5 min and the fraction was concentrated on a rotary evaporator at room temperature to remove MeCN, and the remaining water was then removed on a lyophilizer to provide final product <b>5</b> (93 mg, 70%) as a white solid.</div><div class="NLM_p">For <b>5</b>, <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD) (characteristic protons) δ 9.48 (s, 1H), 5.35 (d, <i>J</i> = 1.6 Hz, 1H), 5.33 (d, <i>J</i> = 8.2 Hz, 1H), 5.27 (t, <i>J</i> = 3.5 Hz, 1H), 5.04 (d, <i>J</i> = 1.5 Hz, 1H), 4.66 (d, <i>J</i> = 7.9 Hz, 1H), 4.59 (d, <i>J</i> = 7.8 Hz, 1H), 4.51–4.49 (m, 2H), 4.47 (m, 1H), 4.27 (dd, <i>J</i> = 3.0, 1.8 Hz, 1H), 4.03 (dd, <i>J</i> = 3.2, 1.8 Hz, 1H), 4.00 (dd, <i>J</i> = 11.4, 5.3 Hz, 1H), 3.15 (t, <i>J</i> = 10.9 Hz, 1H), 3.06 (dd, <i>J</i> = 9.2, 7.9 Hz, 1H), 2.82 (dd, <i>J</i> = 13.8, 3.9 Hz, 1H), 1.20 (s, 3H), 1.19 (s, 3H), 1.02 (s, 3H), 0.82 (s, 3H); <sup>13</sup>C NMR (150.9 MHz, CD<sub>3</sub>OD) δ 209.3, 176.5, 169.8, 143.6, 121.8, 104.6, 103.9, 103.7, 102.8, 102.5, 101.8, 100.0, 94.0, 87.3, 84.3, 84.1, 81.5, 77.7, 77.6, 76.6, 76.1, 76.0, 75.40, 75.38, 74.9, 74.5, 74.0, 73.6, 73.0, 72.8, 72.4, 72.2, 71.6, 71.3, 70.8, 70.7, 70.4, 70.1, 69.9, 69.6, 69.2, 69.1, 68.1, 67.4, 65.7, 65.6, 60.81, 60.77, 54.8, 46.6, 46.0, 41.8, 41.6, 39.6, 38.7, 38.0, 35.7, 33.5, 32.2, 32.1, 31.7, 31.5, 30.1, 29.54, 29.51, 29.5, 29.4, 29.2, 29.1, 28.9, 27.5, 26.5, 24.8, 24.4, 23.2, 22.7, 22.6, 22.4, 20.2, 17.0, 16.5, 16.4, 15.1, 15.0, 13.1, 9.5. HRMS (ESI-TOF) <i>m</i>/<i>z</i>: [M – H]<sup>−</sup> calcd for C<sub>88</sub>H<sub>144</sub>NO<sub>39</sub> 1838.9315; found 1838.9305.</div><div class="NLM_p last">For <b>6</b> (9.8 mg, 50%), <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD) (characteristic protons) δ 9.50 (s, 1H), 5.43 (d, <i>J</i> = 1.5 Hz, 1H), 5.33 (t, <i>J</i> = 3.6 Hz, 1H), 5.23 (d, <i>J</i> = 8.3 Hz, 1H), 5.04 (d, <i>J</i> = 1.4 Hz, 1H), 4.74 (d, <i>J</i> = 7.9 Hz, 1H), 4.56 (d, <i>J</i> = 7.8 Hz, 1H), 4.53 (s, 1H), 4.50–4.47 (m, 2H), 4.45 (d, <i>J</i> = 7.6 Hz, 1H); 4.24 (dd, <i>J</i> = 3.0, 1.9 Hz, 1H), 3.38 (t, <i>J</i> = 8.9 Hz, 1H), 3.18 (t, <i>J</i> = 10.9 Hz, 1H), 3.14 (dd, <i>J</i> = 9.3, 8.3 Hz, 1H), 2.91 (dd, <i>J</i> = 13.9, 4.3 Hz, 1H), 2.31 (t, <i>J</i> = 13.4 Hz, 1H), 1.43 (s, 3H), 1.20 (s, 3H), 1.04 (s, 3H), 0.96 (s, 3H), 0.89 (s, 3H), 0.81 (s, 3H); <sup>13</sup>C NMR (150.9 MHz, CD<sub>3</sub>OD) δ 209.5, 175.6, 169.8, 143.5, 121.5, 104.7, 103.8, 103.5, 102.8, 102.7, 101.9, 99.3, 94.0, 87.4, 84.6, 84.5, 82.1, 77.2, 76.8, 76.4, 76.0, 75.43, 75.38, 75.1, 74.2, 74.0, 73.6, 73.4, 73.0, 72.4, 72.3, 71.6, 71.52, 71.47, 70.8, 70.7, 70.5, 70.04, 69.98, 69.6, 69.2, 69.1, 68.0, 67.4, 65.7, 60.8, 60.7, 54.8, 41.5, 41.0, 39.7, 38.7, 38.0, 35.7, 35.2, 32.7, 31.9, 31.7, 30.5, 29.9, 29.6, 29.52, 29.46, 29.42, 29.21, 29.15, 28.9, 26.5, 25.9, 24.6, 23.3, 23.1, 22.4, 20.0, 17.0, 16.44, 16.36, 15.1, 13.1, 9.6. HRMS (ESI-TOF) <i>m</i>/<i>z</i>: [M – H]<sup>−</sup> calcd for C<sub>88</sub>H<sub>144</sub>NO<sub>40</sub> 1854.9265; found 1854.9240.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Antigens</h3><div class="NLM_p last">The chicken egg albumin for in vivo use (Vac-pova) was purchased from InvivoGen. Recombinant <i>Porphyromonas gingivalis</i> HagB was prepared as previously described.<a onclick="showRef(event, 'ref33 ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref33 ref40 ref41">(33,40,41)</a> Briefly, the HagB gene was cloned from <i>P. gingivalis</i> 381 into a pET vector with a lac promoter and histidine tag and expressed in <i>Escherichia coli</i> JM109 (kindly provided by Ann Progulske-Fox and Thomas Brown, University of Florida, Gainesville). Protein expression was induced following isopropyl-β-<span class="smallcaps smallerCapital">d</span>-thiogalactopyranoside (IPTG) induction. rHagB was purified from the soluble fraction of the bacterial lysates by using a His-bind resin column, according to the manufacturer’s instruction (Novagen, Madison, WI). The purity of rHagB was confirmed by silver staining and Western blot analysis using a rabbit anti-rHagB antibody. The concentration of rHagB was estimated by the bicinchoninic acid protein determination assay (Pierce, Rockford, IL), using bovine serum albumin (BSA) as the standard.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Mice and Immunization</h3><div class="NLM_p last">BALB/c mice used in this study were purchased from Frederick Cancer Research (Frederick, MD) and maintained within an environmentally controlled, pathogen-free animal facility at the University of Alabama at Birmingham (UAB). To assess the adjuvant activity of the MS saponin-based immune adjuvants, groups of female mice (8–10 weeks of age; 6 mice per group) were immunized by the subcutaneous (sc) route with OVA (20 μg) or rHagB (35 μg) alone or with antigen plus proper adjuvant such as GPI-0100 (100 μg) or a MS adjuvant (100 μg) on days 0, 14, and 28. Prior to each immunization and at 2 weeks after last immunization, mice were weighed and blood samples were collected from the lateral tail vein by using heparinized capillary pipettes. The serum was obtained after centrifugation and stored at −20 °C until assayed. All studies were performed according to National Institutes of Health guidelines, and protocols were approved by the UAB Institutional Animal Care and Use Committee.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Evaluation of Antibody Responses</h3><div class="NLM_p last">The levels of specific serum IgG and IgG subclasses against OVA or rHagB in each group were determined by an enzyme-linked immunosorbent assay (ELISA). Maxisorpmicrotiter plates (NUNC International, Roskilde, Denmark) were coated with rHagB (1 μg/mL), OVA (0.1 μg/mL) or with optimal amounts of goat anti-mouse IgG, IgG1 or IgG2a (Southern Biotechnology Associates, Inc., Birmingham, AL) in borate buffer saline (BBS; 100 mM NaCl, 50 mM boric acid, 1.2 mM Na<sub>2</sub>B<sub>4</sub>O<sub>7,</sub> pH 8.2) at 4 °C overnight. Plates were blocked with 1% bovine serum albumin (BSA) and 0.02% sodium azide in BBS for 2 h at room temperature. Serial 2-fold dilutions of serum samples were added in duplicate to the plates. To generate standard curves, serial dilutions of a mouse immunoglobulin reference serum (MP Biomedicals, Solon, OH) were added to two rows of wells in each plate that had been coated with the appropriate anti-mouse IgG or IgG subclass reagent. After incubation (overnight at 4 °C) and washing of the plates, horseradish peroxidase-conjugated goat anti-mouse IgG or IgG subclass antibody (Southern Biotechnology Associates, Inc.) was added to appropriate wells. After 4 h of incubation at room temperature, plates were washed and developed by <i>o</i>-phenylenediamine substrate with hydrogen peroxide. Color development was recorded at 490 nm. The concentrations of antibodies were determined by interpolation on standard curves generated by using the mouse immunoglobulin reference serum and constructed by a computer program based on four-parameter logistic algorithms (Softmax/Molecular Devices Corp., Menlo Park, CA).</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Statistical Analysis</h3><div class="NLM_p last">Statistical significance in antibody responses was evaluated by ordinary one-way ANOVA and the Dunnett test or Tukey multiple-comparisons test using GraphPad Prism 8.0.1. Differences were considered significant at a <i>p</i> value of <0.05.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15"><a href="/doi/suppl/10.1021/acs.jmedchem.9b01511" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_66160" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_66160" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.9b01511" class="ext-link">10.1021/acs.jmedchem.9b01511</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline"><sup>1</sup>H NMR spectra of the known compounds <b>3</b> and <b>4</b> and <sup>1</sup>H and <sup>13</sup>C NMR spectra of the new compounds <b>5</b> and <b>6</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01511/suppl_file/jm9b01511_si_001.pdf" class="ext-link">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01511/suppl_file/jm9b01511_si_001.pdf">jm9b01511_si_001.pdf (0.99 MB)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.9b01511" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_03045" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_03045" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pengfei Wang</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry, , and , University of Alabama
at Birmingham, 901 14th Street South, Birmingham, Alabama 35294, United
States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-0285-2069" title="Orcid link">http://orcid.org/0000-0002-0285-2069</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#384f59565f48784d595a165d5c4d"><span class="__cf_email__" data-cfemail="9fe8fef1f8efdfeafefdb1fafbea">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiong Ding</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry, , and , University of Alabama
at Birmingham, 901 14th Street South, Birmingham, Alabama 35294, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hyunjung Kim</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry, , and , University of Alabama
at Birmingham, 901 14th Street South, Birmingham, Alabama 35294, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Đani Škalamera</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry, , and , University of Alabama
at Birmingham, 901 14th Street South, Birmingham, Alabama 35294, United
States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-7764-5750" title="Orcid link">http://orcid.org/0000-0002-7764-5750</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Suzanne M. Michalek</span> - <span class="hlFld-Affiliation affiliation">Department of Microbiology, , and , University of Alabama
at Birmingham, 901 14th Street South, Birmingham, Alabama 35294, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ping Zhang</span> - <span class="hlFld-Affiliation affiliation">Department of
Pediatric Dentistry, , and , University of Alabama
at Birmingham, 901 14th Street South, Birmingham, Alabama 35294, United
States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare the following competing financial interest(s): P.W. is inventor on patent applications based on this work.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80515" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80515" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by NIH Grant R01 GM120159 to P.W.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">IgG</td><td class="NLM_def"><p class="first last">immunoglobulin G</p></td></tr><tr><td class="NLM_term">Th</td><td class="NLM_def"><p class="first last">T helper cells</p></td></tr><tr><td class="NLM_term">CTL</td><td class="NLM_def"><p class="first last">cytotoxic T cell</p></td></tr><tr><td class="NLM_term">rha</td><td class="NLM_def"><p class="first last">rhamnose</p></td></tr><tr><td class="NLM_term">xyl</td><td class="NLM_def"><p class="first last">xylose</p></td></tr><tr><td class="NLM_term">OVA</td><td class="NLM_def"><p class="first last">ovalbumin</p></td></tr><tr><td class="NLM_term">NMM</td><td class="NLM_def"><p class="first last"><i>N</i>-methylmorpholine</p></td></tr><tr><td class="NLM_term">HOBt</td><td class="NLM_def"><p class="first last">hydroxybenzotriazole</p></td></tr><tr><td class="NLM_term">EDC·HCl</td><td class="NLM_def"><p class="first last">1-ethyl-3-(3-dimethylaminopropyl)carbodiimide</p></td></tr><tr><td class="NLM_term">DCM</td><td class="NLM_def"><p class="first last">dichloromethane</p></td></tr><tr><td class="NLM_term">MeCN</td><td class="NLM_def"><p class="first last">acetonitrile</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">tetrahydrofuran</p></td></tr><tr><td class="NLM_term">rHagB</td><td class="NLM_def"><p class="first last">recombinant hemagglutinin B</p></td></tr><tr><td class="NLM_term">sc</td><td class="NLM_def"><p class="first last">subcutaneous</p></td></tr><tr><td class="NLM_term">ESI-TOF</td><td class="NLM_def"><p class="first last">electrospray ionization time-of-flight mass spectrometry</p></td></tr><tr><td class="NLM_term">ELISA</td><td class="NLM_def"><p class="first last">enzyme-linked immunosorbent assay</p></td></tr><tr><td class="NLM_term">IACUC</td><td class="NLM_def"><p class="first last">International Animal Care and Use Committee.</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46653" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46653" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 42 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brunner, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen-Jarolim, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pali-Scholl, I.</span></span> <span> </span><span class="NLM_article-title">The ABC of clinical and experimental adjuvants-A brief overview</span>. <i>Immunol. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>128</i></span>,  <span class="NLM_fpage">29</span>– <span class="NLM_lpage">35</span>, <span class="refDoi"> DOI: 10.1016/j.imlet.2009.10.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=10.1016%2Fj.imlet.2009.10.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=19895847" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlegtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2010&pages=29-35&author=R.+Brunnerauthor=E.+Jensen-Jarolimauthor=I.+Pali-Scholl&title=The+ABC+of+clinical+and+experimental+adjuvants-A+brief+overview&doi=10.1016%2Fj.imlet.2009.10.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The ABC of clinical and experimental adjuvants-A brief overview</span></div><div class="casAuthors">Brunner, Richard; Jensen-Jarolim, Erika; Pali-Schoell, Isabella</div><div class="citationInfo"><span class="NLM_cas:title">Immunology Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">128</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">29-35</span>CODEN:
                <span class="NLM_cas:coden">IMLED6</span>;
        ISSN:<span class="NLM_cas:issn">0165-2478</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Adjuvants are compds. that can increase and/or modulate the intrinsic immunogenicity of an antigen and elicit strong and long lasting immune responses.  During the last 80 years many adjuvants have been used in exptl. settings, but due to various shortcomings of most of them only aluminum compds. made it into regular clin. usage.  However, during the last years promising candidates have arisen that may finally adjunct or displace aluminum substances as main adjuvant.  This review summarizes information on adjuvants currently used in clin. as well as in exptl. settings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJiiZR6dRoyrVg90H21EOLACvtfcHk0lgeBVNYXLzEuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlegtr4%253D&md5=f3d75eefb3072d975ba71daf3b4bfb39</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.imlet.2009.10.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.imlet.2009.10.005%26sid%3Dliteratum%253Aachs%26aulast%3DBrunner%26aufirst%3DR.%26aulast%3DJensen-Jarolim%26aufirst%3DE.%26aulast%3DPali-Scholl%26aufirst%3DI.%26atitle%3DThe%2520ABC%2520of%2520clinical%2520and%2520experimental%2520adjuvants-A%2520brief%2520overview%26jtitle%3DImmunol.%2520Lett.%26date%3D2010%26volume%3D128%26spage%3D29%26epage%3D35%26doi%3D10.1016%2Fj.imlet.2009.10.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kensil, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mo, A. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Truneh, A.</span></span> <span> </span><span class="NLM_article-title">Current vaccine adjuvants: an overview of a diverse class</span>. <i>Front. Biosci., Landmark Ed.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">2972</span>– <span class="NLM_lpage">2988</span>, <span class="refDoi"> DOI: 10.2741/1452</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=10.2741%2F1452" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=15353330" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=1%3ACAS%3A528%3ADC%252BD2cXls1enu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=2972-2988&author=C.+R.+Kensilauthor=A.+X.+Moauthor=A.+Truneh&title=Current+vaccine+adjuvants%3A+an+overview+of+a+diverse+class&doi=10.2741%2F1452"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Current vaccine adjuvants: an overview of a diverse class</span></div><div class="casAuthors">Kensil, Charlotte Read; Mo, Annie Xiaoyan; Truneh, Alemseged</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Bioscience</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">Suppl.</span>),
    <span class="NLM_cas:pages">2972-2988</span>CODEN:
                <span class="NLM_cas:coden">FRBIF6</span>;
        ISSN:<span class="NLM_cas:issn">1093-4715</span>.
    
            (<span class="NLM_cas:orgname">Frontiers in Bioscience</span>)
        </div><div class="casAbstract">A review.  Numerous compds. are under evaluation as immunol. adjuvants for improvement of vaccine performance.  This review will briefly summarize some of the many diverse substances that are currently being utilized as vaccine adjuvants in preclin. and clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9URKBt0onobVg90H21EOLACvtfcHk0lgeBVNYXLzEuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXls1enu70%253D&md5=72b7a9d5250812a02c6ae8121c729995</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.2741%2F1452&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2741%252F1452%26sid%3Dliteratum%253Aachs%26aulast%3DKensil%26aufirst%3DC.%2BR.%26aulast%3DMo%26aufirst%3DA.%2BX.%26aulast%3DTruneh%26aufirst%3DA.%26atitle%3DCurrent%2520vaccine%2520adjuvants%253A%2520an%2520overview%2520of%2520a%2520diverse%2520class%26jtitle%3DFront.%2520Biosci.%252C%2520Landmark%2520Ed.%26date%3D2004%26volume%3D9%26spage%3D2972%26epage%3D2988%26doi%3D10.2741%2F1452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leroux-Roels, G.</span></span> <span> </span><span class="NLM_article-title">Unmet needs in modern vaccinology: Adjuvants to improve the immune response</span>. <i>Vaccine</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>28</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">C25</span>– <span class="NLM_lpage">36</span>, <span class="refDoi"> DOI: 10.1016/j.vaccine.2010.07.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=10.1016%2Fj.vaccine.2010.07.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=20713254" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2010&pages=C25-36&issue=3&author=G.+Leroux-Roels&title=Unmet+needs+in+modern+vaccinology%3A+Adjuvants+to+improve+the+immune+response&doi=10.1016%2Fj.vaccine.2010.07.021"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.vaccine.2010.07.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.vaccine.2010.07.021%26sid%3Dliteratum%253Aachs%26aulast%3DLeroux-Roels%26aufirst%3DG.%26atitle%3DUnmet%2520needs%2520in%2520modern%2520vaccinology%253A%2520Adjuvants%2520to%2520improve%2520the%2520immune%2520response%26jtitle%3DVaccine%26date%3D2010%26volume%3D28%26issue%3D3%26spage%3DC25%26epage%3D36%26doi%3D10.1016%2Fj.vaccine.2010.07.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sharp, F. A.</span>; <span class="NLM_string-name">Lavelle, E. C.</span></span> <span> </span><span class="NLM_article-title">Discovery of Vaccine Adjuvants</span>. In  <i>Development of Therapeutic Agents Handbook</i>, <span class="NLM_edition">1</span>st ed.; <span class="NLM_contrib-group"><span class="NLM_string-name">Gad, S. C.</span></span>, Ed.; <span class="NLM_publisher-name">John Wiley & Sons, Inc,</span>: <span class="NLM_publisher-loc">Hoboken, NJ</span>, <span class="NLM_year">2012</span>; pp  <span class="NLM_fpage">533</span>– <span class="NLM_lpage">546</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&pages=533-546&author=F.+A.+Sharp&author=E.+C.+Lavelleauthor=S.+C.+Gad&title=Development+of+Therapeutic+Agents+Handbook"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DSharp%26aufirst%3DF.%2BA.%26atitle%3DDiscovery%2520of%2520Vaccine%2520Adjuvants%26btitle%3DDevelopment%2520of%2520Therapeutic%2520Agents%2520Handbook%26aulast%3DGad%26aufirst%3DS.%2BC.%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26date%3D2012%26spage%3D533%26epage%3D546" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, M.</span></span> <span> </span><span class="NLM_article-title">Selection of adjuvants for enhanced vaccine potency</span>. <i>World J. Vaccines</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>01</i></span>,  <span class="NLM_fpage">33</span>– <span class="NLM_lpage">78</span>, <span class="refDoi"> DOI: 10.4236/wjv.2011.12007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=10.4236%2Fwjv.2011.12007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVOksLrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=01&publication_year=2011&pages=33-78&author=W.+Wangauthor=M.+Singh&title=Selection+of+adjuvants+for+enhanced+vaccine+potency&doi=10.4236%2Fwjv.2011.12007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Selection of adjuvants for enhanced vaccine potency</span></div><div class="casAuthors">Wang, Wei; Singh, Manmohan</div><div class="citationInfo"><span class="NLM_cas:title">World Journal of Vaccines</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">33-78</span>CODEN:
                <span class="NLM_cas:coden">WJVOAC</span>;
        ISSN:<span class="NLM_cas:issn">2160-5815</span>.
    
            (<span class="NLM_cas:orgname">Scientific Research Publishing, Inc.</span>)
        </div><div class="casAbstract">A review.  The advent of mass vaccination has saved millions of human lives and revolutionized the quality of life.  Vaccination is currently one of the most cost effective ways of managing healthcare costs in both emerging and developed countries.  Despite the long vaccine history and success, design and development of efficacious and safe vaccines has been traditionally semi-empirical.  This is mainly due to our limited understanding of vaccination mechanism and its influencing factors.  The most important factor is arguably the type and concn. of vaccine adjuvants.  Until recently, however, only one type of adjuvant-aluminum salts, had been widely used within licensed human vaccines in the US, even though a variety of novel adjuvants have been evaluated in the past few decades.  This review summarizes the key adjuvants that have been evaluated in recent years with an intention to facilitate more efficient development of vaccine products to combat human diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXdaLL9Pj7dbVg90H21EOLACvtfcHk0lhvpUnW9yXw_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVOksLrM&md5=1b95c366abd0723e5f2bef7725d369c6</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.4236%2Fwjv.2011.12007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4236%252Fwjv.2011.12007%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DW.%26aulast%3DSingh%26aufirst%3DM.%26atitle%3DSelection%2520of%2520adjuvants%2520for%2520enhanced%2520vaccine%2520potency%26jtitle%3DWorld%2520J.%2520Vaccines%26date%3D2011%26volume%3D01%26spage%3D33%26epage%3D78%26doi%3D10.4236%2Fwjv.2011.12007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weeratna, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCluskie, M. J.</span></span> <span> </span><span class="NLM_article-title">Recent Advances in Vaccine Adjuvants</span>. In  <i>Emerging Trends in Antibacterial Discovery: Answering the Call to Arms</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, A. A.</span>, <span class="NLM_string-name">Miller, P. F.</span></span>, Eds.; <span class="NLM_publisher-name">Caister Academic Press</span>: <span class="NLM_publisher-loc">Great Britain</span>, <span class="NLM_year">2011</span>; pp  <span class="NLM_fpage">303</span>– <span class="NLM_lpage">322</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&pages=303-322&author=R.+D.+Weeratnaauthor=M.+J.+McCluskieauthor=A.+A.+Miller&author=P.+F.+Miller&title=Emerging+Trends+in+Antibacterial+Discovery%3A+Answering+the+Call+to+Arms"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DWeeratna%26aufirst%3DR.%2BD.%26aulast%3DMcCluskie%26aufirst%3DM.%2BJ.%26atitle%3DRecent%2520Advances%2520in%2520Vaccine%2520Adjuvants%26btitle%3DEmerging%2520Trends%2520in%2520Antibacterial%2520Discovery%253A%2520Answering%2520the%2520Call%2520to%2520Arms%26aulast%3DMiller%26aufirst%3DA.%2BA.%26pub%3DCaister%2520Academic%2520Press%26date%3D2011%26spage%3D303%26epage%3D322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coffman, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sher, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seder, R. A.</span></span> <span> </span><span class="NLM_article-title">Vaccine adjuvants: putting innate immunity to work</span>. <i>Immunity</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">492</span>– <span class="NLM_lpage">503</span>, <span class="refDoi"> DOI: 10.1016/j.immuni.2010.10.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=10.1016%2Fj.immuni.2010.10.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=21029960" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlGmtLvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2010&pages=492-503&author=R.+L.+Coffmanauthor=A.+Sherauthor=R.+A.+Seder&title=Vaccine+adjuvants%3A+putting+innate+immunity+to+work&doi=10.1016%2Fj.immuni.2010.10.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Vaccine Adjuvants: Putting Innate Immunity to Work</span></div><div class="casAuthors">Coffman, Robert L.; Sher, Alan; Seder, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Immunity</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">492-503</span>CODEN:
                <span class="NLM_cas:coden">IUNIEH</span>;
        ISSN:<span class="NLM_cas:issn">1074-7613</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Adjuvants enhance immunity to vaccines and exptl. antigens by a variety of mechanisms.  In the past decade, many receptors and signaling pathways in the innate immune system have been defined and these innate responses strongly influence the adaptive immune response.  The focus of this review is to delineate the innate mechanisms by which adjuvants mediate their effects.  We highlight how adjuvants can be used to influence the magnitude and alter the quality of the adaptive response in order to provide max. protection against specific pathogens.  Despite the impressive success of currently approved adjuvants for generating immunity to viral and bacterial infections, there remains a need for improved adjuvants that enhance protective antibody responses, esp. in populations that respond poorly to current vaccines.  However, the larger challenge is to develop vaccines that generate strong T cell immunity with purified or recombinant vaccine antigens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOyLxJMtsIx7Vg90H21EOLACvtfcHk0lgJGKpSqSgXKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlGmtLvF&md5=26e53f025adef76f6446093b935c52b3</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.immuni.2010.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.immuni.2010.10.002%26sid%3Dliteratum%253Aachs%26aulast%3DCoffman%26aufirst%3DR.%2BL.%26aulast%3DSher%26aufirst%3DA.%26aulast%3DSeder%26aufirst%3DR.%2BA.%26atitle%3DVaccine%2520adjuvants%253A%2520putting%2520innate%2520immunity%2520to%2520work%26jtitle%3DImmunity%26date%3D2010%26volume%3D33%26spage%3D492%26epage%3D503%26doi%3D10.1016%2Fj.immuni.2010.10.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Banday, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeelani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hruby, V. J.</span></span> <span> </span><span class="NLM_article-title">Cancer vaccine adjuvants - Recent clinical progress and future perspectives</span>. <i>Immunopharmacol. Immunotoxicol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">11</span>, <span class="refDoi"> DOI: 10.3109/08923973.2014.971963</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=10.3109%2F08923973.2014.971963" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=25318595" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFaltLjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2015&pages=1-11&author=A.+H.+Bandayauthor=S.+Jeelaniauthor=V.+J.+Hruby&title=Cancer+vaccine+adjuvants+-+Recent+clinical+progress+and+future+perspectives&doi=10.3109%2F08923973.2014.971963"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer vaccine adjuvants - recent clinical progress and future perspectives</span></div><div class="casAuthors">Banday, Abid H.; Jeelani, Salika; Hruby, Victor J.</div><div class="citationInfo"><span class="NLM_cas:title">Immunopharmacology and Immunotoxicology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-11</span>CODEN:
                <span class="NLM_cas:coden">IITOEF</span>;
        ISSN:<span class="NLM_cas:issn">0892-3973</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Despite recent breakthroughs in the prognosis, prevention and treatment, cancer still remains the leading cause of death and affects millions of people worldwide.  With the US FDA approval of various preventive cancer vaccines such as Gardasil (Merck), Cervarix (Glaxosmithkline) and the therapeutic vaccine Sipulencel-T (Provenge), cancer vaccine development is gaining huge ground.  Approval of these vaccines has encouraged the concept of cancer treatment through cellular immunotherapy.  The FDA approval of the above vaccines has provided support for renewed interest and attention which the development of new therapeutic cancer vaccines deserves.  However, most of the new generation vaccines including that for cancer are poorly immunogenic sub-unit vaccines and thus essentially need adjuvants in their formulations to compensate for the immune suppression.  Adjuvants are the essential components of a potent vaccine which increases the efficacy by enhancing the antigen-specific immune response.  However, the design of a successful adjuvant is not easy because of the complexity and the difficulty in designing adjuvants that are safe, potent and economically viable.  The present communication takes a short review of the advancements in adjuvant technol., current clin. scenario of new adjuvants and application of their molecularly defined formulations to new generation cancer vaccines which are currently under development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-wsYLBnvOGLVg90H21EOLACvtfcHk0lgJGKpSqSgXKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFaltLjK&md5=582f37c3159747eaa9bc068fbc258d30</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.3109%2F08923973.2014.971963&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F08923973.2014.971963%26sid%3Dliteratum%253Aachs%26aulast%3DBanday%26aufirst%3DA.%2BH.%26aulast%3DJeelani%26aufirst%3DS.%26aulast%3DHruby%26aufirst%3DV.%2BJ.%26atitle%3DCancer%2520vaccine%2520adjuvants%2520-%2520Recent%2520clinical%2520progress%2520and%2520future%2520perspectives%26jtitle%3DImmunopharmacol.%2520Immunotoxicol.%26date%3D2015%26volume%3D37%26spage%3D1%26epage%3D11%26doi%3D10.3109%2F08923973.2014.971963" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bastola, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noh, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keum, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bashyal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seo, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.</span></span> <span> </span><span class="NLM_article-title">Vaccine adjuvants: smart components to boost the immune system</span>. <i>Arch. Pharmacal Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">1238</span>– <span class="NLM_lpage">1248</span>, <span class="refDoi"> DOI: 10.1007/s12272-017-0969-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=10.1007%2Fs12272-017-0969-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=29027637" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1KgsrnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2017&pages=1238-1248&author=R.+Bastolaauthor=G.+Nohauthor=T.+Keumauthor=S.+Bashyalauthor=J.+E.+Seoauthor=J.+Choiauthor=Y.+Ohauthor=Y.+Choauthor=S.+Lee&title=Vaccine+adjuvants%3A+smart+components+to+boost+the+immune+system&doi=10.1007%2Fs12272-017-0969-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Vaccine adjuvants: smart components to boost the immune system</span></div><div class="casAuthors">Bastola, Rakesh; Noh, Gyubin; Keum, Taekwang; Bashyal, Santosh; Seo, Jo-Eun; Choi, Jaewoong; Oh, Yeonsu; Cho, YoungSik; Lee, Sangkil</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Pharmacal Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1238-1248</span>CODEN:
                <span class="NLM_cas:coden">APHRDQ</span>;
        ISSN:<span class="NLM_cas:issn">0253-6269</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Korea</span>)
        </div><div class="casAbstract">A review.  Vaccination is an effective approach to prevent the consequences of infectious diseases.  Vaccines strengthen immunity and make individuals resistant to infections with pathogens.  Although conventional vaccines are highly immunogenic, they are assocd. with some safety issues.  Subunit vaccines are safe, but they require adjuvants to stimulate the immune system because of their weaker immunogenicity.  Adjuvants are entities incorporated into vaccines to increase the immunogenic responses of antigens.  They play a crucial role in increasing the potency and efficacy of vaccines.  Different adjuvants have different modes of action; therefore, a better understanding of their immunol. could provide guidance for the development of novel adjuvants.  Numerous studies have been conducted using different types of adjuvants to characterize their potency and safety; however, in practice, only few are used in human or animal vaccines.  This review aims to introduce the different modes of action of adjuvants and give insight into the types of adjuvants that possess the greatest potential for adjuvanticity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZCN1ub0Y1rLVg90H21EOLACvtfcHk0lgJGKpSqSgXKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1KgsrnO&md5=8c32b5d1bcecc1b81cc0094a516bb3cc</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1007%2Fs12272-017-0969-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12272-017-0969-z%26sid%3Dliteratum%253Aachs%26aulast%3DBastola%26aufirst%3DR.%26aulast%3DNoh%26aufirst%3DG.%26aulast%3DKeum%26aufirst%3DT.%26aulast%3DBashyal%26aufirst%3DS.%26aulast%3DSeo%26aufirst%3DJ.%2BE.%26aulast%3DChoi%26aufirst%3DJ.%26aulast%3DOh%26aufirst%3DY.%26aulast%3DCho%26aufirst%3DY.%26aulast%3DLee%26aufirst%3DS.%26atitle%3DVaccine%2520adjuvants%253A%2520smart%2520components%2520to%2520boost%2520the%2520immune%2520system%26jtitle%3DArch.%2520Pharmacal%2520Res.%26date%3D2017%26volume%3D40%26spage%3D1238%26epage%3D1248%26doi%3D10.1007%2Fs12272-017-0969-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di
Pasquale, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Preiss, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tavares Da Silva, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcon, N.</span></span> <span> </span><span class="NLM_article-title">Vaccine Adjuvants: From 1920 to 2015 and Beyond</span>. <i>Vaccines (Basel, Switz.)</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">320</span>– <span class="NLM_lpage">343</span>, <span class="refDoi"> DOI: 10.3390/vaccines3020320</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=10.3390%2Fvaccines3020320" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=26343190" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=1%3ACAS%3A528%3ADC%252BC1cXlsFanu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2015&pages=320-343&author=A.+Di%0APasqualeauthor=S.+Preissauthor=F.+Tavares+Da+Silvaauthor=N.+Garcon&title=Vaccine+Adjuvants%3A+From+1920+to+2015+and+Beyond&doi=10.3390%2Fvaccines3020320"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Vaccine adjuvants: from 1920 to 2015 and beyond</span></div><div class="casAuthors">Di Pasquale, Alberta; Preiss, Scott; Tavares Da Silva, Fernanda; Garcon, Nathalie</div><div class="citationInfo"><span class="NLM_cas:title">Vaccines (Basel, Switzerland)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">320-343</span>CODEN:
                <span class="NLM_cas:coden">VBSABP</span>;
        ISSN:<span class="NLM_cas:issn">2076-393X</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">The concept of stimulating the body's immune response is the basis underlying vaccination.  Vaccines act by initiating the innate immune response and activating antigen presenting cells (APCs), thereby inducing a protective adaptive immune response to a pathogen antigen.  Adjuvants are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities, and have been used in human vaccines for more than 90 years.  While early adjuvants (aluminum, oil-in-water emulsions) were used empirically, rapidly increasing knowledge on how the immune system interacts with pathogens means that there is increased understanding of the role of adjuvants and how the formulation of modern vaccines can be better tailored towards the desired clin. benefit.  Continuing safety evaluation of licensed vaccines contg. adjuvants/adjuvant systems suggests that their individual benefit-risk profile remains favorable.  Adjuvants contribute to the initiation of the innate immune response induced by antigens; exemplified by inflammatory responses at the injection site, with mostly localized and short-lived effects.  Activated effectors (such as APCs) then move to draining lymph nodes where they direct the type, magnitude and quality of the adaptive immune response.  Thus, the right match of antigens and adjuvants can potentiate downstream adaptive immune responses, enabling the development of new efficacious vaccines.  Many infectious diseases of worldwide significance are not currently preventable by vaccination.  Adjuvants are the most advanced new technol. in the search for new vaccines against challenging pathogens and for vulnerable populations that respond poorly to traditional vaccines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFyT3gxZhwCbVg90H21EOLACvtfcHk0liDCROb_u_CPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXlsFanu78%253D&md5=c3fb1dccaf51d71fbac38a3204efae0c</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.3390%2Fvaccines3020320&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fvaccines3020320%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BPasquale%26aufirst%3DA.%26aulast%3DPreiss%26aufirst%3DS.%26aulast%3DTavares%2BDa%2BSilva%26aufirst%3DF.%26aulast%3DGarcon%26aufirst%3DN.%26atitle%3DVaccine%2520Adjuvants%253A%2520From%25201920%2520to%25202015%2520and%2520Beyond%26jtitle%3DVaccines%2520%2528Basel%252C%2520Switz.%2529%26date%3D2015%26volume%3D3%26spage%3D320%26epage%3D343%26doi%3D10.3390%2Fvaccines3020320" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Temizoz, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuroda, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishii, K. J.</span></span> <span> </span><span class="NLM_article-title">Vaccine adjuvants as potential cancer immunotherapeutics</span>. <i>Int. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">329</span>– <span class="NLM_lpage">338</span>, <span class="refDoi"> DOI: 10.1093/intimm/dxw015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=10.1093%2Fintimm%2Fdxw015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=27006304" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFOru7fE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2016&pages=329-338&author=B.+Temizozauthor=E.+Kurodaauthor=K.+J.+Ishii&title=Vaccine+adjuvants+as+potential+cancer+immunotherapeutics&doi=10.1093%2Fintimm%2Fdxw015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Vaccine adjuvants as potential cancer immunotherapeutics</span></div><div class="casAuthors">Temizoz, Burcu; Kuroda, Etsushi; Ishii, Ken J.</div><div class="citationInfo"><span class="NLM_cas:title">International Immunology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">329-338</span>CODEN:
                <span class="NLM_cas:coden">INIMEN</span>;
        ISSN:<span class="NLM_cas:issn">0953-8178</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Accumulated evidence obtained from various clin. trials and animal studies suggested that cancer vaccines need better adjuvants than those that are currently licensed, which include the most commonly used alum and incomplete Freund's adjuvant, because of either a lack of potent anti-tumor immunity or the induction of undesired immunity.  Several clin. trials using immunostimulatory adjuvants, particularly agonistic as well as non-agonistic ligands for TLRs, C-type lectin receptors, retinoic acid-inducible gene I-like receptors and stimulator of interferon genes, have revealed their therapeutic potential not only as vaccine adjuvants but also as anti-tumor agents.  Recently, combinations of such immunostimulatory or immunomodulatory adjuvants have shown superior efficacy over their singular use, suggesting that seeking optimal combinations of the currently available or well-characterized adjuvants may provide a better chance for the development of novel adjuvants for cancer immunotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpP5mJ4BDhOUrVg90H21EOLACvtfcHk0liDCROb_u_CPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFOru7fE&md5=92aa03134406c55673017cb24da45eb4</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1093%2Fintimm%2Fdxw015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fintimm%252Fdxw015%26sid%3Dliteratum%253Aachs%26aulast%3DTemizoz%26aufirst%3DB.%26aulast%3DKuroda%26aufirst%3DE.%26aulast%3DIshii%26aufirst%3DK.%2BJ.%26atitle%3DVaccine%2520adjuvants%2520as%2520potential%2520cancer%2520immunotherapeutics%26jtitle%3DInt.%2520Immunol.%26date%3D2016%26volume%3D28%26spage%3D329%26epage%3D338%26doi%3D10.1093%2Fintimm%2Fdxw015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">O’Hagan, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedland, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanon, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Didierlaurent, A. M.</span></span> <span> </span><span class="NLM_article-title">Towards an evidence based approach for the development of adjuvanted vaccines</span>. <i>Curr. Opin. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">93</span>– <span class="NLM_lpage">102</span>, <span class="refDoi"> DOI: 10.1016/j.coi.2017.07.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=10.1016%2Fj.coi.2017.07.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=28755542" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1WhsbvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2017&pages=93-102&author=D.+T.+O%E2%80%99Haganauthor=L.+R.+Friedlandauthor=E.+Hanonauthor=A.+M.+Didierlaurent&title=Towards+an+evidence+based+approach+for+the+development+of+adjuvanted+vaccines&doi=10.1016%2Fj.coi.2017.07.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Towards an evidence based approach for the development of adjuvanted vaccines</span></div><div class="casAuthors">O'Hagan, Derek T.; Friedland, Leonard R.; Hanon, Emmanuel; Didierlaurent, Arnaud M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Immunology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">93-102</span>CODEN:
                <span class="NLM_cas:coden">COPIEL</span>;
        ISSN:<span class="NLM_cas:issn">0952-7915</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">In the last two decades, several vaccines formulated with a new generation of adjuvants have been licensed or approved to target diseases such as influenza, hepatitis B, cervical cancer, and malaria.  These new generation adjuvants appear to work by delivering a localized activation signal to the innate immune system, which in turn promotes antigen-specific adaptive immunity.  Advances in understanding of the innate immune system together with high-throughput discovery of synthetic immune potentiators are now expanding the portfolio of new generation adjuvants available for evaluation.  Meanwhile, omics and systems biol. are providing mol. benchmarks or signatures to assess vaccine safety and effectiveness.  This accumulating knowledge and experience raises the prospect that the future selection of the right antigen/adjuvant combination can be more evidence based and can speed up the clin. development program for new adjuvanted vaccines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcySAov5jYBrVg90H21EOLACvtfcHk0lhiKMvXz_-asw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1WhsbvM&md5=6a764a037df0e03e71e6a5fe68fc323d</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.coi.2017.07.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coi.2017.07.010%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Hagan%26aufirst%3DD.%2BT.%26aulast%3DFriedland%26aufirst%3DL.%2BR.%26aulast%3DHanon%26aufirst%3DE.%26aulast%3DDidierlaurent%26aufirst%3DA.%2BM.%26atitle%3DTowards%2520an%2520evidence%2520based%2520approach%2520for%2520the%2520development%2520of%2520adjuvanted%2520vaccines%26jtitle%3DCurr.%2520Opin.%2520Immunol.%26date%3D2017%26volume%3D47%26spage%3D93%26epage%3D102%26doi%3D10.1016%2Fj.coi.2017.07.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Garçon, N.</span>; <span class="NLM_string-name">Leroux-Roels, G.</span>; <span class="NLM_string-name">Cheng, W.-F.</span></span> <span> </span><span class="NLM_article-title">Vaccine Adjuvants</span>. In  <i>Understanding Modern Vaccines Perspectives in Vaccinology</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garçon, N.</span>, <span class="NLM_string-name">Stern, P. L.</span>, <span class="NLM_string-name">Cunningham, A. L.</span></span>, Eds.; <span class="NLM_publisher-name">Elsevier</span>: <span class="NLM_publisher-loc">Amsterdam</span>, <span class="NLM_year">2011</span>; Vol.  <span class="NLM_volume">1</span>; pp  <span class="NLM_fpage">89</span>– <span class="NLM_lpage">113</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&pages=89-113&author=N.+Gar%C3%A7on&author=G.+Leroux-Roels&author=W.-F.+Chengauthor=N.+Gar%C3%A7on&author=P.+L.+Stern&author=A.+L.+Cunningham&title=Understanding+Modern+Vaccines+Perspectives+in+Vaccinology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DGar%25C3%25A7on%26aufirst%3DN.%26atitle%3DVaccine%2520Adjuvants%26btitle%3DUnderstanding%2520Modern%2520Vaccines%2520Perspectives%2520in%2520Vaccinology%26aulast%3DGar%25C3%25A7on%26aufirst%3DN.%26pub%3DElsevier%26date%3D2011%26volume%3D1%26spage%3D89%26epage%3D113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harandi, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medaglini, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shattock, R. J.</span></span> <span> </span><span class="NLM_article-title">Working Group convened by EUROPRISE. Vaccine adjuvants: a priority for vaccine research</span>. <i>Vaccine</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">2363</span>– <span class="NLM_lpage">2366</span>, <span class="refDoi"> DOI: 10.1016/j.vaccine.2009.12.084</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=10.1016%2Fj.vaccine.2009.12.084" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=20064476" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=1%3ACAS%3A280%3ADC%252BC3c7nsF2muw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2010&pages=2363-2366&author=A.+M.+Harandiauthor=D.+Medagliniauthor=R.+J.+Shattock&title=Working+Group+convened+by+EUROPRISE.+Vaccine+adjuvants%3A+a+priority+for+vaccine+research&doi=10.1016%2Fj.vaccine.2009.12.084"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Vaccine adjuvants: a priority for vaccine research</span></div><div class="casAuthors">Harandi Ali M; Medaglini Donata; Shattock Robin J</div><div class="citationInfo"><span class="NLM_cas:title">Vaccine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2363-6</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The workshop on vaccine adjuvants was held in July of 2009 at the European Commission in Brussels, with the goal of identifying key scientific priorities as they pertain to the development of effective vaccines against life-threatening diseases especially those associated with poverty, including HIV/AIDS, malaria and tuberculosis as well as neglected infectious diseases.  On the basis of new advances in adjuvant research and related technology as well as potential challenges and roadblocks, six priorities were identified to accelerate development of improved or novel vaccine adjuvants for human use.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSivWj553HudAyMywPm6HgQfW6udTcc2eawB11cL-sZ97ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3c7nsF2muw%253D%253D&md5=e4cd9efcd73d1051ce8ab76e3ff08dc5</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.vaccine.2009.12.084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.vaccine.2009.12.084%26sid%3Dliteratum%253Aachs%26aulast%3DHarandi%26aufirst%3DA.%2BM.%26aulast%3DMedaglini%26aufirst%3DD.%26aulast%3DShattock%26aufirst%3DR.%2BJ.%26atitle%3DWorking%2520Group%2520convened%2520by%2520EUROPRISE.%2520Vaccine%2520adjuvants%253A%2520a%2520priority%2520for%2520vaccine%2520research%26jtitle%3DVaccine%26date%3D2010%26volume%3D28%26spage%3D2363%26epage%3D2366%26doi%3D10.1016%2Fj.vaccine.2009.12.084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bowen, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Svrivastava, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batra, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barsoumian, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shirwan, H.</span></span> <span> </span><span class="NLM_article-title">Current challenges for cancer vaccine adjuvant development</span>. <i>Expert Rev. Vaccines</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">207</span>– <span class="NLM_lpage">215</span>, <span class="refDoi"> DOI: 10.1080/14760584.2018.1434000</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=10.1080%2F14760584.2018.1434000" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=29372660" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVKgtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2018&pages=207-215&author=W.+S.+Bowenauthor=A.+K.+Svrivastavaauthor=L.+Batraauthor=H.+Barsoumianauthor=H.+Shirwan&title=Current+challenges+for+cancer+vaccine+adjuvant+development&doi=10.1080%2F14760584.2018.1434000"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Current challenges for cancer vaccine adjuvant development</span></div><div class="casAuthors">Bowen, William S.; Svrivastava, Abhishek K.; Batra, Lalit; Barsoumian, Hampartsoum; Shirwan, Haval</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Vaccines</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">207-215</span>CODEN:
                <span class="NLM_cas:coden">ERVXAX</span>;
        ISSN:<span class="NLM_cas:issn">1476-0584</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">: Although much progress has been made in the last decade(s) toward development of effective cancer vaccines, there are still important obstacles to therapeutic successes.  New generations of cancer vaccines will benefit from a combination adjuvant approach that targets multiple branches of the immune response.: Herein we describe how combinatorial adjuvant strategies can help overcome important obstacles to cancer vaccine development, including antigen immunogenicity and tumor immune suppression.  Tumor antigens may be both tolerogenic and may utilize active mechanisms to suppress host immunity, including downregulation of MHC mols. to evade recognition and upregulation of immune inhibitory receptors, to subvert an effective immune response.  The current cancer vaccine literature was surveyed to identify advancements in the understanding of the biol. mechanisms underlying poor antigen immunogenicity and tumor immune evasion, as well as adjuvant strategies designed to overcome them.: Poor immunogenicity of tumor antigens and tumor immune evasion mechanisms make the design of cancer vaccines challenging.  Growing understanding of the tumor microenvironment and assocd. immune responses indicate the importance of augmenting not only the effector response, but also overcoming the endogenous regulatory response and tumor evasion mechanisms.  Therefore, new vaccines will benefit from multi-adjuvanted approaches that simultaneously stimulate immunity while preventing inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruqNXpJ6DAkbVg90H21EOLACvtfcHk0lgp9x3yJcv1ZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVKgtrs%253D&md5=3910ef73b0edeb5570c8b516870b5f00</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1080%2F14760584.2018.1434000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F14760584.2018.1434000%26sid%3Dliteratum%253Aachs%26aulast%3DBowen%26aufirst%3DW.%2BS.%26aulast%3DSvrivastava%26aufirst%3DA.%2BK.%26aulast%3DBatra%26aufirst%3DL.%26aulast%3DBarsoumian%26aufirst%3DH.%26aulast%3DShirwan%26aufirst%3DH.%26atitle%3DCurrent%2520challenges%2520for%2520cancer%2520vaccine%2520adjuvant%2520development%26jtitle%3DExpert%2520Rev.%2520Vaccines%26date%3D2018%26volume%3D17%26spage%3D207%26epage%3D215%26doi%3D10.1080%2F14760584.2018.1434000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brito, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Hagan, D. T.</span></span> <span> </span><span class="NLM_article-title">Designing and building the next generation of improved vaccine adjuvants</span>. <i>J. Controlled Release</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>190</i></span>,  <span class="NLM_fpage">563</span>– <span class="NLM_lpage">579</span>, <span class="refDoi"> DOI: 10.1016/j.jconrel.2014.06.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=10.1016%2Fj.jconrel.2014.06.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=24998942" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFOjt7%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=190&publication_year=2014&pages=563-579&author=L.+A.+Britoauthor=D.+T.+O%E2%80%99Hagan&title=Designing+and+building+the+next+generation+of+improved+vaccine+adjuvants&doi=10.1016%2Fj.jconrel.2014.06.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Designing and building the next generation of improved vaccine adjuvants</span></div><div class="casAuthors">Brito, Luis A.; O'Hagan, Derek T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Controlled Release</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">190</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">563-579</span>CODEN:
                <span class="NLM_cas:coden">JCREEC</span>;
        ISSN:<span class="NLM_cas:issn">0168-3659</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Vaccine adjuvants interact with the immune system, to increase the potency of vaccine antigens.  Many of the adjuvants currently available were developed with little understanding of how they worked.  Highly pure recombinant antigens are typically very poorly immunogenic due to a lack of exogenous immune activating components such as nucleic acids, lipids, and cell membrane components.  In this review we discuss the role of adjuvants and their role as 'delivery systems' or 'immune potentiators'.  We also highlight the need for appropriate delivery of immune potentiators with several 'delivery system' adjuvants such as alum, emulsions, liposomes, and polymeric particles.  The challenges faced by vaccinologists to create the next generation of vaccines can be solved in-part by developing a greater understanding of the impact of delivery, and an appreciation of the key role of pharmaceutical sciences.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2YXLm6MLzCLVg90H21EOLACvtfcHk0lgp9x3yJcv1ZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFOjt7%252FE&md5=01052901ac692e712f9418540fceb593</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.jconrel.2014.06.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jconrel.2014.06.027%26sid%3Dliteratum%253Aachs%26aulast%3DBrito%26aufirst%3DL.%2BA.%26aulast%3DO%25E2%2580%2599Hagan%26aufirst%3DD.%2BT.%26atitle%3DDesigning%2520and%2520building%2520the%2520next%2520generation%2520of%2520improved%2520vaccine%2520adjuvants%26jtitle%3DJ.%2520Controlled%2520Release%26date%3D2014%26volume%3D190%26spage%3D563%26epage%3D579%26doi%3D10.1016%2Fj.jconrel.2014.06.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Didierlaurent, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laupeze, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Pasquale, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hergli, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collignon, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcon, N.</span></span> <span> </span><span class="NLM_article-title">Adjuvant system AS01: helping to overcome the challenges of modern vaccines</span>. <i>Expert Rev. Vaccines</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">55</span>– <span class="NLM_lpage">63</span>, <span class="refDoi"> DOI: 10.1080/14760584.2016.1213632</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=10.1080%2F14760584.2016.1213632" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=27448771" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1ygurfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&pages=55-63&author=A.+M.+Didierlaurentauthor=B.+Laupezeauthor=A.+Di+Pasqualeauthor=N.+Hergliauthor=C.+Collignonauthor=N.+Garcon&title=Adjuvant+system+AS01%3A+helping+to+overcome+the+challenges+of+modern+vaccines&doi=10.1080%2F14760584.2016.1213632"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Adjuvant system AS01: helping to overcome the challenges of modern vaccines</span></div><div class="casAuthors">Didierlaurent, Arnaud M.; Laupeze, Beatrice; Di Pasquale, Alberta; Hergli, Nadia; Collignon, Catherine; Garcon, Nathalie</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Vaccines</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">55-63</span>CODEN:
                <span class="NLM_cas:coden">ERVXAX</span>;
        ISSN:<span class="NLM_cas:issn">1476-0584</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">: Adjuvants are used to improve vaccine immunogenicity and efficacy by enhancing antigen presentation to antigen-specific immune cells with the aim to confer long-term protection against targeted pathogens.  Adjuvants have been used in vaccines for more than 90 years.  Combinations of immunostimulatory mols., such as in the Adjuvant System AS01, have opened the way to the development of new or improved vaccines.: AS01 is a liposome-based vaccine adjuvant system contg. two immunostimulants: 3-O-desacyl-4'-monophosphoryl lipid A (MPL) and the saponin QS-21.  Here we describe studies investigating the mode of action of AS01, and consider the role of AS01 in enhancing specific immune responses to the antigen for selected candidate vaccines targeting malaria and herpes zoster.  The effects of AS01 are rapid and transient, being localized to the injected muscle and draining lymph node.  AS01 is efficient at promoting CD4+ T cell-mediated immune responses and is an appropriate candidate adjuvant for inclusion in vaccines targeting viruses or intracellular pathogens.: AS01 activity to enhance adaptive responses depends on synergistic activities of QS-21 and MPL.  AS01 adjuvantation shows good prospects for use in new vaccines targeted to populations with challenging immune statuses and against diseases caused by complex pathogens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrypUW00VPSPbVg90H21EOLACvtfcHk0lgp9x3yJcv1ZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1ygurfF&md5=715022fe094be1b814d6b79ff2171bd6</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1080%2F14760584.2016.1213632&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F14760584.2016.1213632%26sid%3Dliteratum%253Aachs%26aulast%3DDidierlaurent%26aufirst%3DA.%2BM.%26aulast%3DLaupeze%26aufirst%3DB.%26aulast%3DDi%2BPasquale%26aufirst%3DA.%26aulast%3DHergli%26aufirst%3DN.%26aulast%3DCollignon%26aufirst%3DC.%26aulast%3DGarcon%26aufirst%3DN.%26atitle%3DAdjuvant%2520system%2520AS01%253A%2520helping%2520to%2520overcome%2520the%2520challenges%2520of%2520modern%2520vaccines%26jtitle%3DExpert%2520Rev.%2520Vaccines%26date%3D2017%26volume%3D16%26spage%3D55%26epage%3D63%26doi%3D10.1080%2F14760584.2016.1213632" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">James, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chahine, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sucher, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanna, C.</span></span> <span> </span><span class="NLM_article-title">Shingrix: The New Adjuvanted Recombinant Herpes Zoster Vaccine</span>. <i>Ann. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">673</span>– <span class="NLM_lpage">680</span>, <span class="refDoi"> DOI: 10.1177/1060028018758431</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=10.1177%2F1060028018758431" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=29457489" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtVyjsLrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2018&pages=673-680&author=S.+F.+Jamesauthor=E.+B.+Chahineauthor=A.+J.+Sucherauthor=C.+Hanna&title=Shingrix%3A+The+New+Adjuvanted+Recombinant+Herpes+Zoster+Vaccine&doi=10.1177%2F1060028018758431"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Shingrix: The New Adjuvanted Recombinant Herpes Zoster Vaccine</span></div><div class="casAuthors">James, Stephanie F.; Chahine, Elias B.; Sucher, Allana J.; Hanna, Cassandra</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Pharmacotherapy</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">673-680</span>CODEN:
                <span class="NLM_cas:coden">APHRER</span>;
        ISSN:<span class="NLM_cas:issn">1542-6270</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">Objectives: To review the immunogenicity, efficacy, and safety of the herpes zoster subunit vaccine (HZ/su) for use in adult patients for the prevention of shingles.  Data Sources: A literature search through PubMed was conducted (June 2008 to Oct. 2017) using the terms shingles vaccine and varicella zoster virus.  Refs. from retrieved articles and the prescribing information were also reviewed for any addnl. material.  Study Selection/Data Extn.: The literature search was limited to human studies published in English.  Randomized controlled, multicenter trials were reviewed and included to evaluate the safety and efficacy of HZ/su.  Literature on the epidemiol. and pathol. of herpes zoster virus infections and recommendations from the Advisory Committee on Immunization Practices (ACIP) were also reviewed.  Data Synthesis: HZ/su is a new adjuvanted recombinant vaccine approved by the Food and Drug Administration for the prevention of herpes zoster in adults 50 years of age and older.  HZ/su significantly reduced the risk of developing herpes zoster by more than 90% as compared with placebo and displayed a comparable adverse effect profile.  The most common local adverse events were injection site pain, redness, and swelling, and the most common systemic adverse events were myalgia, fatigue, and headache.  The ACIP recommends the routine use of HZ/su as the preferred vaccine for the prevention of herpes zoster in immunocompetent adults 50 years of age and older.  Conclusions: Based on published immunogenicity, efficacy, and safety data, as well as the recent recommendations by the ACIP, HZ/su should be included on both hospital and community pharmacy formularies and recommended to all immunocompetent patients older than 50 years to prevent herpes zoster.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVl2Mpn_0xk7Vg90H21EOLACvtfcHk0lh3nynV5VV9CQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtVyjsLrP&md5=91df49dd0441656ccf20a656fa2163d9</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1177%2F1060028018758431&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1060028018758431%26sid%3Dliteratum%253Aachs%26aulast%3DJames%26aufirst%3DS.%2BF.%26aulast%3DChahine%26aufirst%3DE.%2BB.%26aulast%3DSucher%26aufirst%3DA.%2BJ.%26aulast%3DHanna%26aufirst%3DC.%26atitle%3DShingrix%253A%2520The%2520New%2520Adjuvanted%2520Recombinant%2520Herpes%2520Zoster%2520Vaccine%26jtitle%3DAnn.%2520Pharmacother.%26date%3D2018%26volume%3D52%26spage%3D673%26epage%3D680%26doi%3D10.1177%2F1060028018758431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kensil, C. R.</span></span> <span> </span><span class="NLM_article-title">Saponins as vaccine adjuvants</span>. <i>Crit. Rev. Ther. Drug Carrier Syst.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">55</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=8853958" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=1%3ACAS%3A528%3ADyaK28XlsV2qt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1996&pages=1-55&author=C.+R.+Kensil&title=Saponins+as+vaccine+adjuvants"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Saponins as vaccine adjuvants</span></div><div class="casAuthors">Kensil, Charlotte Read</div><div class="citationInfo"><span class="NLM_cas:title">Critical Reviews in Therapeutic Drug Carrier Systems</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">1&2</span>),
    <span class="NLM_cas:pages">1-55</span>CODEN:
                <span class="NLM_cas:coden">CRTSEO</span>;
        ISSN:<span class="NLM_cas:issn">0743-4863</span>.
    
            (<span class="NLM_cas:orgname">Begell House</span>)
        </div><div class="casAbstract">A review with 178 refs.  Naturally occurring triterpene glycosides (saponins) from Quillaja saponaria have considerable adjuvant activity.  Adjuvant functions include stimulation of high levels of antibody to T-dependent and T-independent antigens, induction of mouse IgG1, IgG2b, and IgG2a isotypes, and induction of cytotoxic T lymphocyte responses.  This article reviews responses due to specific saponins or saponin prepns., the effect of formulation, structure/function studies, and use in different preclin. and clin. vaccine applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWkslKgTe3RrVg90H21EOLACvtfcHk0lh3nynV5VV9CQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XlsV2qt7g%253D&md5=06732e4c95d059fb550418380e5cd530</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKensil%26aufirst%3DC.%2BR.%26atitle%3DSaponins%2520as%2520vaccine%2520adjuvants%26jtitle%3DCrit.%2520Rev.%2520Ther.%2520Drug%2520Carrier%2520Syst.%26date%3D1996%26volume%3D13%26spage%3D1%26epage%3D55" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kensil, C. R.</span>; <span class="NLM_string-name">Liu, G.</span>; <span class="NLM_string-name">Anderson, C.</span>; <span class="NLM_string-name">Storey, J.</span></span> <span> </span><span class="NLM_article-title">Effects of QS-21 on Innate and Adaptive Immune Responses</span>. In  <i>Vaccine Adjuvants: Immunological and Clinical Principles</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hackett, C. J.</span>, <span class="NLM_string-name">Harn, D. A. J.</span></span>, Eds.; <span class="NLM_publisher-name">Humana Press Inc</span>: <span class="NLM_publisher-loc">Totowa, NJ</span>, <span class="NLM_year">2005</span>; pp  <span class="NLM_fpage">221</span>– <span class="NLM_lpage">234</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&pages=221-234&author=C.+R.+Kensil&author=G.+Liu&author=C.+Anderson&author=J.+Storeyauthor=C.+J.+Hackett&author=D.+A.+J.+Harn&title=Vaccine+Adjuvants%3A+Immunological+and+Clinical+Principles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DKensil%26aufirst%3DC.%2BR.%26atitle%3DEffects%2520of%2520QS-21%2520on%2520Innate%2520and%2520Adaptive%2520Immune%2520Responses%26btitle%3DVaccine%2520Adjuvants%253A%2520Immunological%2520and%2520Clinical%2520Principles%26aulast%3DHackett%26aufirst%3DC.%2BJ.%26pub%3DHumana%2520Press%2520Inc%26date%3D2005%26spage%3D221%26epage%3D234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kensil, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lennick, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marciani, D.</span></span> <span> </span><span class="NLM_article-title">Separation and characterization of saponins with adjuvant activity from Quillaja saponaria Molina cortex</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>146</i></span>,  <span class="NLM_fpage">431</span>– <span class="NLM_lpage">437</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=1987271" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=1%3ACAS%3A528%3ADyaK3MXit1Sqt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=146&publication_year=1991&pages=431-437&author=C.+R.+Kensilauthor=U.+Patelauthor=M.+Lennickauthor=D.+Marciani&title=Separation+and+characterization+of+saponins+with+adjuvant+activity+from+Quillaja+saponaria+Molina+cortex"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Separation and characterization of saponins with adjuvant activity from Quillaja saponaria Molina cortex</span></div><div class="casAuthors">Kensil, Charlotte R.; Patel, Usha; Lennick, Michael; Marciani, Dante</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">146</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">431-7</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    </div><div class="casAbstract">Saponins were purified from Q. saponaria Molina bark by silica and reverse-phase chromatog.  The resulting purified saponins were tested for adjuvant activity in mice.  Several distinct saponins, designated QS-7, QS-17, QS-18, and QS-21, were demonstrated to boost antibody levels 100-fold or more when used in mouse immunizations with the Ag BSA and beef liver cytochrome b5.  These purified saponins increased titers in all major IgG subclasses.  To det. optimal dose in mice for adjuvant response, QS-7 and QS-21 were tested in a dose-response study in intradermal immunization with BSA in mice; for both of these purified saponins, adjuvant response (detd. by stimulation of ELISA titers to BSA) neared max. at doses of 5 μg and was shown to plateau up to the highest dose tested, 80 μg.  These purified saponins vary considerably in their toxicity, as assessed by lethality in mice (the main component, QS-18, being the most toxic).  Saponins QS-7 and QS-21 showed no or very low toxicity in mice, resp.  None of these saponins stimulated prodn. of reaginic antibodies.  The monosaccharide compn. of these saponins showed similar but distinct compns. with all four contg. fucose, xylose, galactose, and glucuronic acid.  Predominant differences were obsd. in the quantities of rhamnose, arabinose, and glucose.  Monomer mol. wt. (detd. by size exclusion HPLC) were detd. to range from 1800 to 2200.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrl3t6nXiv1D7Vg90H21EOLACvtfcHk0lgb-_hQMulpXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXit1Sqt78%253D&md5=da3c2d6d078a0f85e0913d62be46897d</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKensil%26aufirst%3DC.%2BR.%26aulast%3DPatel%26aufirst%3DU.%26aulast%3DLennick%26aufirst%3DM.%26aulast%3DMarciani%26aufirst%3DD.%26atitle%3DSeparation%2520and%2520characterization%2520of%2520saponins%2520with%2520adjuvant%2520activity%2520from%2520Quillaja%2520saponaria%2520Molina%2520cortex%26jtitle%3DJ.%2520Immunol.%26date%3D1991%26volume%3D146%26spage%3D431%26epage%3D437" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ragupathi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardner, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Livingston, P. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gin, D. Y.</span></span> <span> </span><span class="NLM_article-title">Natural and synthetic saponin adjuvant QS-21 for vaccines against cancer</span>. <i>Expert Rev. Vaccines</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">463</span>– <span class="NLM_lpage">470</span>, <span class="refDoi"> DOI: 10.1586/erv.11.18</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=10.1586%2Ferv.11.18" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=21506644" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkvF2itb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=463-470&author=G.+Ragupathiauthor=J.+R.+Gardnerauthor=P.+O.+Livingstonauthor=D.+Y.+Gin&title=Natural+and+synthetic+saponin+adjuvant+QS-21+for+vaccines+against+cancer&doi=10.1586%2Ferv.11.18"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Natural and synthetic saponin adjuvant QS-21 for vaccines against cancer</span></div><div class="casAuthors">Ragupathi, Govind; Gardner, Jeffrey R.; Livingston, Philip O.; Gin, David Y.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Vaccines</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">463-470</span>CODEN:
                <span class="NLM_cas:coden">ERVXAX</span>;
        ISSN:<span class="NLM_cas:issn">1476-0584</span>.
    
            (<span class="NLM_cas:orgname">Expert Reviews Ltd.</span>)
        </div><div class="casAbstract">A review.  One of the most widely used and potent immunol. adjuvants is a mixt. of sol. triterpene glycosides purified from the soap bark tree (Quillaja saponaria).  Despite challenges in prodn., quality control, stability and toxicity, the QS-21 fraction from this ext. has exhibited exceptional adjuvant properties for a range of antigens.  It possesses an ability to augment clin. significant antibody and T-cell responses to vaccine antigens against a variety of infectious diseases, degenerative disorders and cancers.  The recent synthesis of active mols. of QS-21 has provided a robust method to produce this leading vaccine adjuvant in high purity as well as to produce novel synthetic QS-21 congeners designed to induce increased immune responsiveness and decreased toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOeMw38V5PxbVg90H21EOLACvtfcHk0lgb-_hQMulpXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkvF2itb8%253D&md5=43f901c70c5e4a8b6a913544ac8a673b</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1586%2Ferv.11.18&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252Ferv.11.18%26sid%3Dliteratum%253Aachs%26aulast%3DRagupathi%26aufirst%3DG.%26aulast%3DGardner%26aufirst%3DJ.%2BR.%26aulast%3DLivingston%26aufirst%3DP.%2BO.%26aulast%3DGin%26aufirst%3DD.%2BY.%26atitle%3DNatural%2520and%2520synthetic%2520saponin%2520adjuvant%2520QS-21%2520for%2520vaccines%2520against%2520cancer%26jtitle%3DExpert%2520Rev.%2520Vaccines%26date%3D2011%26volume%3D10%26spage%3D463%26epage%3D470%26doi%3D10.1586%2Ferv.11.18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kamstrup, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">San Martin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doberti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grande, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalsgaard, K.</span></span> <span> </span><span class="NLM_article-title">Preparation and characterisation of Quillaja saponin with less heterogeneity than Quil-A</span>. <i>Vaccine</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">2244</span>– <span class="NLM_lpage">2249</span>, <span class="refDoi"> DOI: 10.1016/S0264-410X(99)00560-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=10.1016%2FS0264-410X%2899%2900560-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=10717344" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjsFGhu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2000&pages=2244-2249&author=S.+Kamstrupauthor=R.+San+Martinauthor=A.+Dobertiauthor=H.+Grandeauthor=K.+Dalsgaard&title=Preparation+and+characterisation+of+Quillaja+saponin+with+less+heterogeneity+than+Quil-A&doi=10.1016%2FS0264-410X%2899%2900560-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Preparation and characterisation of quillaja saponin with less heterogeneity than Quil-A</span></div><div class="casAuthors">Kamstrup, Soren; San Martin, Ricardo; Doberti, Alfredo; Grande, Hans; Dalsgaard, Kristian</div><div class="citationInfo"><span class="NLM_cas:title">Vaccine</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">2244-2249</span>CODEN:
                <span class="NLM_cas:coden">VACCDE</span>;
        ISSN:<span class="NLM_cas:issn">0264-410X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Immunization against pathogens remains one of the most effective ways of preventing or reducing losses due to infectious diseases in animal husbandry.  When inactivated vaccines are used, adjuvants are most often required to obtain satisfactory immune responses.  One such type of adjuvant is saponin derived from the bark of Quillaja saponaria Molina, a tree of the rose family.  A few different com. sources exist, but due to the structural complexity and heterogeneity of these saponin prepns., it has been difficult to establish exactly which components are responsible for the adjuvant activity.  By carefully selecting the bark source, we have succeeded in prepg. a much less heterogeneous prepn. of quillaja saponin.  In this report we describe the prepn., in terms of structural complexity, hemolytic activity, adjuvant activity, and its ability to form ISCOM matrix.  This new prepn. could have implications for use per se, or as starting material for more effective prepn. of pure substances.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTPF0Zbg-5bLVg90H21EOLACvtfcHk0lgb-_hQMulpXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjsFGhu7c%253D&md5=f74d761c5aa76caa00f6a518e4e43dce</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2FS0264-410X%2899%2900560-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0264-410X%252899%252900560-5%26sid%3Dliteratum%253Aachs%26aulast%3DKamstrup%26aufirst%3DS.%26aulast%3DSan%2BMartin%26aufirst%3DR.%26aulast%3DDoberti%26aufirst%3DA.%26aulast%3DGrande%26aufirst%3DH.%26aulast%3DDalsgaard%26aufirst%3DK.%26atitle%3DPreparation%2520and%2520characterisation%2520of%2520Quillaja%2520saponin%2520with%2520less%2520heterogeneity%2520than%2520Quil-A%26jtitle%3DVaccine%26date%3D2000%26volume%3D18%26spage%3D2244%26epage%3D2249%26doi%3D10.1016%2FS0264-410X%2899%2900560-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martin, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Briones, R.</span></span> <span> </span><span class="NLM_article-title">Industrial uses and sustainable supply of <i>Quillaja Saponaria</i> (Rosaceae) Saponins</span>. <i>Econ. Bot.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">302</span>– <span class="NLM_lpage">311</span>, <span class="refDoi"> DOI: 10.1007/BF02866642</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=10.1007%2FBF02866642" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1999&pages=302-311&author=R.+S.+Martinauthor=R.+Briones&title=Industrial+uses+and+sustainable+supply+of+Quillaja+Saponaria+%28Rosaceae%29+Saponins&doi=10.1007%2FBF02866642"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1007%2FBF02866642&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF02866642%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DR.%2BS.%26aulast%3DBriones%26aufirst%3DR.%26atitle%3DIndustrial%2520uses%2520and%2520sustainable%2520supply%2520of%2520Quillaja%2520Saponaria%2520%2528Rosaceae%2529%2520Saponins%26jtitle%3DEcon.%2520Bot.%26date%3D1999%26volume%3D53%26spage%3D302%26epage%3D311%26doi%3D10.1007%2FBF02866642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scaltreto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kensil, C. R.</span></span> <span> </span><span class="NLM_article-title">QS-21 structure/function studies: effect of acylation on adjuvant activity</span>. <i>Vaccine</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">2808</span>– <span class="NLM_lpage">2815</span>, <span class="refDoi"> DOI: 10.1016/S0264-410X(02)00209-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=10.1016%2FS0264-410X%2802%2900209-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=12034108" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=1%3ACAS%3A528%3ADC%252BD38XktVCrurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2002&pages=2808-2815&author=G.+Liuauthor=C.+Andersonauthor=H.+Scaltretoauthor=J.+Barbonauthor=C.+R.+Kensil&title=QS-21+structure%2Ffunction+studies%3A+effect+of+acylation+on+adjuvant+activity&doi=10.1016%2FS0264-410X%2802%2900209-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">QS-21 structure/function studies: effect of acylation on adjuvant activity</span></div><div class="casAuthors">Liu, Gui; Anderson, Christine; Scaltreto, Heidi; Barbon, Jeffrey; Kensil, Charlotte R.</div><div class="citationInfo"><span class="NLM_cas:title">Vaccine</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">21-22</span>),
    <span class="NLM_cas:pages">2808-2815</span>CODEN:
                <span class="NLM_cas:coden">VACCDE</span>;
        ISSN:<span class="NLM_cas:issn">0264-410X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">QS-21 is a natural saponin adjuvant derived from the tree Quillaja saponaria Molina.  Previous studies over a limited dose range suggested the acylation is crit. to adjuvant activity.  In this study, the authors prepd. DS-1 (deacylated QS-21) and RDS-1 (reacylated DS-1 with dodecylamine at a different site than QS-21) to det. the effect on a dose-response curve over a wider range in mice.  DS-1 and RDS-1 induced IgG1 responses at higher doses compared to that induced by QS-21.  DS-1 was inactive for inducing IgG2a or CTL responses at any doses.  RDS-1 showed moderate IgG2a response at 240 μg, but did not show CTL response at any dose evaluated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoygzLdmmKH7Vg90H21EOLACvtfcHk0lgszzBpT5oSEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XktVCrurk%253D&md5=d33bf4281d08ba836e211e77ddc55436</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2FS0264-410X%2802%2900209-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0264-410X%252802%252900209-8%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DAnderson%26aufirst%3DC.%26aulast%3DScaltreto%26aufirst%3DH.%26aulast%3DBarbon%26aufirst%3DJ.%26aulast%3DKensil%26aufirst%3DC.%2BR.%26atitle%3DQS-21%2520structure%252Ffunction%2520studies%253A%2520effect%2520of%2520acylation%2520on%2520adjuvant%2520activity%26jtitle%3DVaccine%26date%3D2002%26volume%3D20%26spage%3D2808%26epage%3D2815%26doi%3D10.1016%2FS0264-410X%2802%2900209-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pillion, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amsden, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kensil, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Recchia, J.</span></span> <span> </span><span class="NLM_article-title">Structure-function relationship among Quillaja saponins serving as excipients for nasal and ocular delivery of insulin</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>85</i></span>,  <span class="NLM_fpage">518</span>– <span class="NLM_lpage">524</span>, <span class="refDoi"> DOI: 10.1021/js9504651</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=10.1021%2Fjs9504651" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=8742944" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=1%3ACAS%3A528%3ADyaK28XitFCqtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=1996&pages=518-524&author=D.+J.+Pillionauthor=J.+A.+Amsdenauthor=C.+R.+Kensilauthor=J.+Recchia&title=Structure-function+relationship+among+Quillaja+saponins+serving+as+excipients+for+nasal+and+ocular+delivery+of+insulin&doi=10.1021%2Fjs9504651"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Function Relationship among Quillaja Saponins Serving as Excipients for Nasal and Ocular Delivery of Insulin</span></div><div class="casAuthors">Pillion, Dennis J.; Amsden, Jennifer A.; Kensil, Charlotte R.; Recchia, Joanne</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">518-24</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The purpose of this investigation was to explore the structure-function relationship among naturally occurring Quillaja saponins and derivs. for their ability to stimulate insulin delivery from nosedrops and eyedrops and to test the hypothesis that stimulation of peptide drug delivery was correlated with surfactant strength.  Native saponins, including QS-21, were purified from an aq. ext. of Quillaja saponaria bark by adsorption chromatog. and HPLC.  Native saponins were then deacylated by mild alk. hydrolysis to form DS-1 and DS-2, derivs. that are smaller and more hydrophilic than their parent compds.  DS-1 was further treated either to reduce an aldehyde residue to form DS-1(R) or to remove the fucose-contg. oligosaccharide to form QH-957.  Rats receiving eyedrops or nosedrops formulated with insulin, but without any Quillaja saponins, showed no hypoglycemic response.  Rats receiving eyedrops or nosedrops formulated with insulin plus saponins showed a dose-dependent hypoglycemic response, with the following rank order: QS-21 > DS-1 > DS-1(R) > DS-2 > QH-957.  Surfactant strength was detd. by measurement of the crit. micellar concn. (cmc) and hemolysis of sheep erythrocytes.  The cmc was lowest for the parent saponins QS-21 and QS-18, and increased for the deacylated saponin derivs. DS-1, DS-2, and QH-957; hemolysis of sheep erythrocytes was obsd. at low concns. (∼0.006 mM) of the parent saponins, QS-21 and QS-18, at intermediate concns. (0.06-0.08 mM) of DS-1 and DS-2, and at higher concns. of DS-1(R) (0.45 mM) and QH-957 (1.5 mM).  Hence, efficacy as an absorption-enhancing agent was greatest in those saponins with the lowest hemolytic titers and cmc values.  However, this relationship was not a strict one, because DS-1, which differs from DS-2 only in the absence of one glucose residue, was significantly more potent than DS-2 in stimulating the absorption of insulin.  DS-1 and DS-2 share a similar cmc and hemolytic titer, so this difference in efficacy must be due to some specificity beyond simple surfactant strength.  Furthermore, DS-1 does not trigger an immune response when administered to animals, whereas QS-21 is a strong immune system activator.  Therefore, DS-1 has emerged as an interesting candidate for inclusion in an eyedrop or nosedrop formulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKYcWkSEcWFrVg90H21EOLACvtfcHk0lgszzBpT5oSEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XitFCqtrw%253D&md5=52265aea98787f99577f8daaa861fff6</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjs9504651&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjs9504651%26sid%3Dliteratum%253Aachs%26aulast%3DPillion%26aufirst%3DD.%2BJ.%26aulast%3DAmsden%26aufirst%3DJ.%2BA.%26aulast%3DKensil%26aufirst%3DC.%2BR.%26aulast%3DRecchia%26aufirst%3DJ.%26atitle%3DStructure-function%2520relationship%2520among%2520Quillaja%2520saponins%2520serving%2520as%2520excipients%2520for%2520nasal%2520and%2520ocular%2520delivery%2520of%2520insulin%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D1996%26volume%3D85%26spage%3D518%26epage%3D524%26doi%3D10.1021%2Fjs9504651" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thogaripally, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michalek, S. M.</span></span> <span> </span><span class="NLM_article-title">Synthesis of QS-21-based immunoadjuvants</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>78</i></span>,  <span class="NLM_fpage">11525</span>– <span class="NLM_lpage">11534</span>, <span class="refDoi"> DOI: 10.1021/jo402118j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo402118j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1KktLfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2013&pages=11525-11534&author=P.+Wangauthor=Q.+Daiauthor=P.+Thogaripallyauthor=P.+Zhangauthor=S.+M.+Michalek&title=Synthesis+of+QS-21-based+immunoadjuvants&doi=10.1021%2Fjo402118j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of QS-21-Based Immunoadjuvants</span></div><div class="casAuthors">Wang, Pengfei; Dai, Qipu; Thogaripally, Punith; Zhang, Ping; Michalek, Suzanne M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">11525-11534</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Three structurally defined QS-21-based immune adjuvant candidates have been synthesized.  Application of the two-stage activation glycosylation approach utilizing allyl glycoside building blocks improved the synthetic accessibility of the new adjuvants.  The efficient synthesis and establishment of the stand-alone adjuvanticity of the examd. synthetic adjuvants open the door to the pursuit of a new series of structurally defined QS-saponin-based synthetic adjuvants.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhT8N6m2NGbrVg90H21EOLACvtfcHk0lhS_Cn4-H4M5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1KktLfK&md5=5cd2c8ff419d9f35141f33cc8ed9a5a5</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjo402118j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo402118j%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DP.%26aulast%3DDai%26aufirst%3DQ.%26aulast%3DThogaripally%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DP.%26aulast%3DMichalek%26aufirst%3DS.%2BM.%26atitle%3DSynthesis%2520of%2520QS-21-based%2520immunoadjuvants%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2013%26volume%3D78%26spage%3D11525%26epage%3D11534%26doi%3D10.1021%2Fjo402118j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devalankar, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michalek, S. M.</span></span> <span> </span><span class="NLM_article-title">Synthesis and evaluation of QS-21-based immunoadjuvants with a terminal-functionalized side chain incorporated in the west wing trisaccharide</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>81</i></span>,  <span class="NLM_fpage">9560</span>– <span class="NLM_lpage">9566</span>, <span class="refDoi"> DOI: 10.1021/acs.joc.6b00922</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.joc.6b00922" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1ems7zL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2016&pages=9560-9566&author=P.+Wangauthor=D.+A.+Devalankarauthor=Q.+Daiauthor=P.+Zhangauthor=S.+M.+Michalek&title=Synthesis+and+evaluation+of+QS-21-based+immunoadjuvants+with+a+terminal-functionalized+side+chain+incorporated+in+the+west+wing+trisaccharide&doi=10.1021%2Facs.joc.6b00922"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Evaluation of QS-21-Based Immunoadjuvants with a Terminal-Functionalized Side Chain Incorporated in the West Wing Trisaccharide</span></div><div class="casAuthors">Wang, Pengfei; Devalankar, Dattatray A.; Dai, Qipu; Zhang, Ping; Michalek, Suzanne M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">9560-9566</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Three QS-21-based vaccine adjuvant candidates with a terminal-functionalized side chain incorporated in the west wing trisaccharide have been synthesized.  The terminal polar functional group serve to increase the soly. of these analogs in water.  Two of the synthetic analogs have been shown to have adjuvant activity comparable to that of GPI-0100.  The stand-alone adjuvant activity of the new synthetic analogs again confirmed that it is a feasible way to develop new saponin-based vaccine adjuvants through derivatizing at the west wing branched trisaccharide domain.  Inclusion of an addnl. polar functional group such as a carboxyl group (as in 3x) or a monosaccharide (as in 4x and 5x), is sufficient to increase the water-soly. of the corresponding synthetic analogs to a level comparable to that of GPI-0100 and suitable for immunol. studies and clin. application.  The structure of the incorporated side chain has a significant impact on the adjuvant activity in terms of the magnitude and nature of the host's responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7LJQzF2JT67Vg90H21EOLACvtfcHk0lhS_Cn4-H4M5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1ems7zL&md5=b8189013dff721ff7ff6f32ff37256ee</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Facs.joc.6b00922&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.joc.6b00922%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DP.%26aulast%3DDevalankar%26aufirst%3DD.%2BA.%26aulast%3DDai%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DP.%26aulast%3DMichalek%26aufirst%3DS.%2BM.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520QS-21-based%2520immunoadjuvants%2520with%2520a%2520terminal-functionalized%2520side%2520chain%2520incorporated%2520in%2520the%2520west%2520wing%2520trisaccharide%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2016%26volume%3D81%26spage%3D9560%26epage%3D9566%26doi%3D10.1021%2Facs.joc.6b00922" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Škalamera, Đ.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sui, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michalek, S. M.</span></span> <span> </span><span class="NLM_article-title">Synthesis and evaluation of a QS-17/18-based vaccine adjuvant</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">1669</span>– <span class="NLM_lpage">1676</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01997</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01997" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=1%3ACAS%3A528%3ADC%252BC1MXht1CqsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=1669-1676&author=P.+Wangauthor=%C4%90.+%C5%A0kalameraauthor=X.+Suiauthor=P.+Zhangauthor=S.+M.+Michalek&title=Synthesis+and+evaluation+of+a+QS-17%2F18-based+vaccine+adjuvant&doi=10.1021%2Facs.jmedchem.8b01997"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and evaluation of a QS-17/18-based vaccine adjuvant</span></div><div class="casAuthors">Wang, Pengfei; Skalamera, Djani; Sui, Xianwei; Zhang, Ping; Michalek, Suzanne M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1669-1676</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We have synthesized a QS-17/18 analog (7) and evaluated its adjuvant activity in the formulation with rHagB antigen.  Compd. 7 and QS-21 analogs 5 and 6 are presumably the major components of GPI-0100, a widely used complex mixt. of semisynthetic derivs. of Quillaja saponaria (QS) Molina saponins.  The QS-17/18 analog 7 shows an adjuvant activity profile similar to that of GPI-0100, potentiating mixed Th-1/Th-2 immune responses, which is different from those of QS-21 analogs 5 and 6 that probably only induce a Th2-like immunity.  The combination of QS-17/18 and QS-21 analogs does not show a synergistic effect.  These results suggest that QS-17/18 analog 7 might be the active component of GPI-0100 responsible for its immunostimulant property.  Therefore, compd. 7 can not only be a structurally defined alternative to GPI-0100 but also provide a valuable clue for rational design of new QS-based vaccine adjuvants with better adjuvant properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrp-y-QiSiy7bVg90H21EOLACvtfcHk0lhrtm0DjuxQeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXht1CqsLw%253D&md5=a14271d4290e791a90d0010148184c46</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01997&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01997%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DP.%26aulast%3D%25C5%25A0kalamera%26aufirst%3D%25C4%2590.%26aulast%3DSui%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DP.%26aulast%3DMichalek%26aufirst%3DS.%2BM.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520a%2520QS-17%252F18-based%2520vaccine%2520adjuvant%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D1669%26epage%3D1676%26doi%3D10.1021%2Facs.jmedchem.8b01997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Škalamera, Đ.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sui, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michalek, S. M.</span></span> <span> </span><span class="NLM_article-title">Synthesis and evaluation of QS-7-based vaccine adjuvants</span>. <i>ACS Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">974</span>– <span class="NLM_lpage">981</span>, <span class="refDoi"> DOI: 10.1021/acsinfecdis.9b00039</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsinfecdis.9b00039" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=1%3ACAS%3A528%3ADC%252BC1MXlvFWhsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2019&pages=974-981&author=P.+Wangauthor=%C4%90.+%C5%A0kalameraauthor=X.+Suiauthor=P.+Zhangauthor=S.+M.+Michalek&title=Synthesis+and+evaluation+of+QS-7-based+vaccine+adjuvants&doi=10.1021%2Facsinfecdis.9b00039"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Evaluation of QS-7-Based Vaccine Adjuvants</span></div><div class="casAuthors">Wang, Pengfei; Skalamera, Djani; Sui, Xianwei; Zhang, Ping; Michalek, Suzanne M.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Infectious Diseases</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">974-981</span>CODEN:
                <span class="NLM_cas:coden">AIDCBC</span>;
        ISSN:<span class="NLM_cas:issn">2373-8227</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We have designed and synthesized two analogs (5 and 6) of QS-7, a natural saponin compd. isolated from Quillaja saponaria (QS) Molina tree bark.  The only structural difference between compd. 5 and 6 is that 5 is acetylated at the 3- and 4-O positions of the quillaic acid C28 fucosyl unit while 6 is not.  However, the two analogs show significantly different immunostimulant profiles.  Compd. 5 may potentiate a mixed Th1/Th2 (Th, T helper cells) immune response against the specific antigens while compd. 6 may only induce a Th2-biased immunity.  These results suggest that the 3- and/or 4-O acetyl groups of the fucosyl unit may play an important role in tuning the adjuvanticity of the QS-7 analogs, and compd. 5 can serve as a structurally defined synthetic adjuvant when a mixed Th1/Th2 immune responses is desired.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6r-bFz3RLYrVg90H21EOLACvtfcHk0lhrtm0DjuxQeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXlvFWhsL4%253D&md5=d9e5cdc0eed8d91718d2f142e1012d98</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Facsinfecdis.9b00039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsinfecdis.9b00039%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DP.%26aulast%3D%25C5%25A0kalamera%26aufirst%3D%25C4%2590.%26aulast%3DSui%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DP.%26aulast%3DMichalek%26aufirst%3DS.%2BM.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520QS-7-based%2520vaccine%2520adjuvants%26jtitle%3DACS%2520Infect.%2520Dis.%26date%3D2019%26volume%3D5%26spage%3D974%26epage%3D981%26doi%3D10.1021%2Facsinfecdis.9b00039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marciani, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Press, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reynolds, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pathak, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pathak, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gundy, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farmer, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koratich, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">May, R. D.</span></span> <span> </span><span class="NLM_article-title">Development of semisynthetic triterpenoid saponin derivatives with immune stimulating activity</span>. <i>Vaccine</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">3141</span>– <span class="NLM_lpage">3151</span>, <span class="refDoi"> DOI: 10.1016/S0264-410X(00)00118-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=10.1016%2FS0264-410X%2800%2900118-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=10856794" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlslGjtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2000&pages=3141-3151&author=D.+Marcianiauthor=J.+B.+Pressauthor=R.+C.+Reynoldsauthor=A.+K.+Pathakauthor=V.+Pathakauthor=L.+E.+Gundyauthor=J.+T.+Farmerauthor=M.+S.+Koratichauthor=R.+D.+May&title=Development+of+semisynthetic+triterpenoid+saponin+derivatives+with+immune+stimulating+activity&doi=10.1016%2FS0264-410X%2800%2900118-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Development of semisynthetic triterpenoid saponin derivatives with immune stimulating activity</span></div><div class="casAuthors">Marciani, D. J.; Press, J. B.; Reynolds, R. C.; Pathak, A. K.; Pathak, V.; Gundy, L. E.; Farmer, J. T.; Koratich, M. S.; May, R. D.</div><div class="citationInfo"><span class="NLM_cas:title">Vaccine</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">3141-3151</span>CODEN:
                <span class="NLM_cas:coden">VACCDE</span>;
        ISSN:<span class="NLM_cas:issn">0264-410X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Aldehyde-contg. triterpene saponins have adjuvant properties, but only those from Quillaja saponaria Molina stimulate the prodn. of cytotoxic T lymphocytes (CTL) against exogenous antigens.  Quillaja saponins have two normonoterpene ester moieties, linked linearly to their fucosyl residue, that play a crit. role in the stimulation of CTL.  These ester moieties are also responsible for these saponins' instability and toxicity.  Based on the structure-activity relationships for the different groups of Q. saponaria saponins, new semi-synthetic analogs were developed that have the adjuvanticity of quillaja saponins, yet with less toxicity and greater stability in aq. solns.  The quillaja saponin analogs were prepd. by replacing their hydrolytically unstable ester groups with another lipophilic chain linked by a stable amide bond on these saponins' glucuronic acid residue.  One of these analogs, GPI-0100, is a dodecylamide saponin deriv. that stimulates an antibody isotype profile that corresponds to a Th1 type immune response, as well as CTL prodn. against exogenous antigens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmbWVA2dMPGLVg90H21EOLACvtfcHk0liEopL-ycS1yQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlslGjtr0%253D&md5=b7e953dc68ace13d6983da9950bdd913</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2FS0264-410X%2800%2900118-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0264-410X%252800%252900118-3%26sid%3Dliteratum%253Aachs%26aulast%3DMarciani%26aufirst%3DD.%26aulast%3DPress%26aufirst%3DJ.%2BB.%26aulast%3DReynolds%26aufirst%3DR.%2BC.%26aulast%3DPathak%26aufirst%3DA.%2BK.%26aulast%3DPathak%26aufirst%3DV.%26aulast%3DGundy%26aufirst%3DL.%2BE.%26aulast%3DFarmer%26aufirst%3DJ.%2BT.%26aulast%3DKoratich%26aufirst%3DM.%2BS.%26aulast%3DMay%26aufirst%3DR.%2BD.%26atitle%3DDevelopment%2520of%2520semisynthetic%2520triterpenoid%2520saponin%2520derivatives%2520with%2520immune%2520stimulating%2520activity%26jtitle%3DVaccine%26date%3D2000%26volume%3D18%26spage%3D3141%26epage%3D3151%26doi%3D10.1016%2FS0264-410X%2800%2900118-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marciani, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reynolds, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pathak, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finley-Woodman, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">May, R. D.</span></span> <span> </span><span class="NLM_article-title">Fractionation, structural studies, and immunological characterization of the semi-synthetic Quillaja saponins derivative GPI-0100</span>. <i>Vaccine</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">3961</span>– <span class="NLM_lpage">3971</span>, <span class="refDoi"> DOI: 10.1016/S0264-410X(03)00298-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=10.1016%2FS0264-410X%2803%2900298-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=12922132" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmt1Gku7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2003&pages=3961-3971&author=D.+J.+Marcianiauthor=R.+C.+Reynoldsauthor=A.+K.+Pathakauthor=K.+Finley-Woodmanauthor=R.+D.+May&title=Fractionation%2C+structural+studies%2C+and+immunological+characterization+of+the+semi-synthetic+Quillaja+saponins+derivative+GPI-0100&doi=10.1016%2FS0264-410X%2803%2900298-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Fractionation, structural studies, and immunological characterization of the semi-synthetic Quillaja saponins derivative GPI-0100</span></div><div class="casAuthors">Marciani, Dante J.; Reynolds, Robert C.; Pathak, Ashish K.; Finley-Woodman, Kyra; May, Richard D.</div><div class="citationInfo"><span class="NLM_cas:title">Vaccine</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">25-26</span>),
    <span class="NLM_cas:pages">3961-3971</span>CODEN:
                <span class="NLM_cas:coden">VACCDE</span>;
        ISSN:<span class="NLM_cas:issn">0264-410X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Unfractionated GPI-0100 (UFGPI-0100) contg. semi-synthetic derivs. of deacylated Quillaja saponins (DS saponins) modified at the glucuronic acid residue was resolved by reverse phase low-pressure liq. chromatog. (RP-LPLC) into two fractions, RP18-1 and RP18-2, with different compns. and adjuvanticity.  The fraction RP18-1 contained DS saponin adducts of N-dicyclohexylurea, and stimulated Th2 immunity with prodn. of IgG1, while the RP18-2 fraction contained the dodecylamide derivs. of DS saponins and stimulated Th1 immunity with prodn. of IgG2a, IFN-γ, IL-2, and CTL.  The strong immune stimulatory properties of RP18-2, relative to RP18-1, and the formation of RP18-1/RP18-2 mixed micelles may account for the effective stimulation of Th1 immunity by UFGPI-0100.  UFGPI-0100 was free of acylated quillaja saponin components, including the more stable QS-7.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYGroTQ5yVA7Vg90H21EOLACvtfcHk0liEopL-ycS1yQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmt1Gku7s%253D&md5=aad68bb05facdd21feff5d5b4970b133</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2FS0264-410X%2803%2900298-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0264-410X%252803%252900298-6%26sid%3Dliteratum%253Aachs%26aulast%3DMarciani%26aufirst%3DD.%2BJ.%26aulast%3DReynolds%26aufirst%3DR.%2BC.%26aulast%3DPathak%26aufirst%3DA.%2BK.%26aulast%3DFinley-Woodman%26aufirst%3DK.%26aulast%3DMay%26aufirst%3DR.%2BD.%26atitle%3DFractionation%252C%2520structural%2520studies%252C%2520and%2520immunological%2520characterization%2520of%2520the%2520semi-synthetic%2520Quillaja%2520saponins%2520derivative%2520GPI-0100%26jtitle%3DVaccine%26date%3D2003%26volume%3D21%26spage%3D3961%26epage%3D3971%26doi%3D10.1016%2FS0264-410X%2803%2900298-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Q.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marciani, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clements, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michalek, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katz, J.</span></span> <span> </span><span class="NLM_article-title">Effectiveness of the quillaja saponin semi-synthetic analog GPI-0100 in potentiating mucosal and systemic responses to recombinant HagB from Porphyromonas gingivalis</span>. <i>Vaccine</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">4459</span>– <span class="NLM_lpage">4471</span>, <span class="refDoi"> DOI: 10.1016/S0264-410X(03)00438-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=10.1016%2FS0264-410X%2803%2900438-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=14505929" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnvFSiurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2003&pages=4459-4471&author=P.+Zhangauthor=Q.-B.+Yangauthor=D.+J.+Marcianiauthor=M.+Martinauthor=J.+D.+Clementsauthor=S.+M.+Michalekauthor=J.+Katz&title=Effectiveness+of+the+quillaja+saponin+semi-synthetic+analog+GPI-0100+in+potentiating+mucosal+and+systemic+responses+to+recombinant+HagB+from+Porphyromonas+gingivalis&doi=10.1016%2FS0264-410X%2803%2900438-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Effectiveness of the quillaja saponin semi-synthetic analog GPI-0100 in potentiating mucosal and systemic responses to recombinant HagB from Porphyromonas gingivalis</span></div><div class="casAuthors">Zhang, Ping; Yang, Qiu-Bo; Marciani, Dante J.; Martin, Michael; Clements, John D.; Michalek, Suzanne M.; Katz, Jannet</div><div class="citationInfo"><span class="NLM_cas:title">Vaccine</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">27-30</span>),
    <span class="NLM_cas:pages">4459-4471</span>CODEN:
                <span class="NLM_cas:coden">VACCDE</span>;
        ISSN:<span class="NLM_cas:issn">0264-410X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">The gram-neg., anaerobic bacterium Porphyromonas gingivalis, has been implicated in the etiol. of adult periodontal disease.  Among the potential virulence factors of this bacterium, the non-fimbrial adhesin hemagglutinin B (HagB) appears to be involved in the initial adherence of the bacteria to host tissue and the induction of anti-HagB antibody responses affords some protection from exptl. alveolar bone loss.  In the present study, we have investigated the ability of the quillaja saponin deriv. GPI-0100 to act as an immunostimulant of responses to HagB following s.c. or intranasal (i.n.) immunization of mice.  We have also compared the immunopotentiating ability of GPI-0100 with that of five other adjuvants.  Evidence is provided that GPI-0100 was more effective than monophosphoryl lipid A and alum in inducing serum anti-HagB responses following s.c. immunization.  A comparison of the responses induced following i.n. immunization with HagB and adjuvant revealed that the heat-labile toxin of Escherichia coli (LT) and the non-enzymic mutant LT (E112K), followed by GPI-0100 potentiated higher serum and mucosal anti-HagB antibody responses, which in most cases were higher than those seen with the other adjuvants tested (i.e. monophosphoryl lipid A, alum and the B subunit of cholera toxin).  Furthermore, a difference was seen in the nature of the serum IgG anti-HagB response based on the adjuvant used and route of immunization.  These results demonstrate the effectiveness of GPI-0100 as both a systemic and mucosal adjuvant and support its potential use in the development of vaccines against periodontal, as well as other pathogens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoH15_EMh9Su7Vg90H21EOLACvtfcHk0lh8VNK1pSCzhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnvFSiurg%253D&md5=0b819682d65db32890cec6f09f743b0e</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2FS0264-410X%2803%2900438-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0264-410X%252803%252900438-9%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DP.%26aulast%3DYang%26aufirst%3DQ.-B.%26aulast%3DMarciani%26aufirst%3DD.%2BJ.%26aulast%3DMartin%26aufirst%3DM.%26aulast%3DClements%26aufirst%3DJ.%2BD.%26aulast%3DMichalek%26aufirst%3DS.%2BM.%26aulast%3DKatz%26aufirst%3DJ.%26atitle%3DEffectiveness%2520of%2520the%2520quillaja%2520saponin%2520semi-synthetic%2520analog%2520GPI-0100%2520in%2520potentiating%2520mucosal%2520and%2520systemic%2520responses%2520to%2520recombinant%2520HagB%2520from%2520Porphyromonas%2520gingivalis%26jtitle%3DVaccine%26date%3D2003%26volume%3D21%26spage%3D4459%26epage%3D4471%26doi%3D10.1016%2FS0264-410X%2803%2900438-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Iwamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okabe, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamauchi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rokutani, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hara, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mihashi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higuchi, R.</span></span> <span> </span><span class="NLM_article-title">Studies on the constituents of Momordica cochinchinensis SPRENG. I. Isolation and characterization of the seed saponins, momordica saponins I and II</span>. <i>Chem. Pharm. Bull.</i> <span class="NLM_year" style="font-weight: bold;">1985</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">464</span>– <span class="NLM_lpage">478</span>, <span class="refDoi"> DOI: 10.1248/cpb.33.464</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=10.1248%2Fcpb.33.464" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=1%3ACAS%3A528%3ADyaL2MXitFygsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1985&pages=464-478&author=M.+Iwamotoauthor=H.+Okabeauthor=T.+Yamauchiauthor=M.+Tanakaauthor=Y.+Rokutaniauthor=S.+Haraauthor=K.+Mihashiauthor=R.+Higuchi&title=Studies+on+the+constituents+of+Momordica+cochinchinensis+SPRENG.+I.+Isolation+and+characterization+of+the+seed+saponins%2C+momordica+saponins+I+and+II&doi=10.1248%2Fcpb.33.464"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Studies on the constituents of Momordica cochinchinensis Spreng.  I.  Isolation and characterization of the seed saponins, momordica saponins I and II</span></div><div class="casAuthors">Iwamoto, Masayo; Okabe, Hikaru; Yamauchi, Tatsuo; Tanaka, Masako; Rokutani, Yoshie; Hara, Shuji; Mihashi, Kunihide; Higuchi, Ryuichi</div><div class="citationInfo"><span class="NLM_cas:title">Chemical & Pharmaceutical Bulletin</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">464-78</span>CODEN:
                <span class="NLM_cas:coden">CPBTAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-2363</span>.
    </div><div class="casAbstract">The structures of momordica saponins I and II, the seed saponins of M. cochinchinensis were elucidated on the basis of spectral and chem. evidence as the 3-O-β-D-galactopyranosyl(1→2)-[α-L-rhamnopyranosyl(1→3)]-β-D-glucuronopyranosido-28-O-β-D-xylopyranosyl(1→3)-β-D-glucopyranosyl(1→3)-[β-D-xylopyranosyl(1→4)]-α-L-rhamnopyranosyl(1→2)-β-D-fucopyranosides of gypsogenin and quillaic acid, resp.  The saponins I and II are contained in the seed kernels in a carboxylate form.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobHMuJ-Kl_YrVg90H21EOLACvtfcHk0lh8VNK1pSCzhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXitFygsbg%253D&md5=0bd5548482e378e8d03e28e2612510d2</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1248%2Fcpb.33.464&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fcpb.33.464%26sid%3Dliteratum%253Aachs%26aulast%3DIwamoto%26aufirst%3DM.%26aulast%3DOkabe%26aufirst%3DH.%26aulast%3DYamauchi%26aufirst%3DT.%26aulast%3DTanaka%26aufirst%3DM.%26aulast%3DRokutani%26aufirst%3DY.%26aulast%3DHara%26aufirst%3DS.%26aulast%3DMihashi%26aufirst%3DK.%26aulast%3DHiguchi%26aufirst%3DR.%26atitle%3DStudies%2520on%2520the%2520constituents%2520of%2520Momordica%2520cochinchinensis%2520SPRENG.%2520I.%2520Isolation%2520and%2520characterization%2520of%2520the%2520seed%2520saponins%252C%2520momordica%2520saponins%2520I%2520and%2520II%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D1985%26volume%3D33%26spage%3D464%26epage%3D478%26doi%3D10.1248%2Fcpb.33.464" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oda, K.</span></span> <span> </span><span class="NLM_article-title">Relationship between adjuvant activity and amphipathic structure of soyasaponins</span>. <i>Vaccine</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">2145</span>– <span class="NLM_lpage">2151</span>, <span class="refDoi"> DOI: 10.1016/S0264-410X(02)00739-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=10.1016%2FS0264-410X%2802%2900739-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=12706705" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjtFWlsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2003&pages=2145-2151&author=K.+Oda&title=Relationship+between+adjuvant+activity+and+amphipathic+structure+of+soyasaponins&doi=10.1016%2FS0264-410X%2802%2900739-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Relationship between adjuvant activity and amphipathic structure of soyasaponins</span></div><div class="casAuthors">Oda, Kenji; Matsuda, Hisashi; Murakami, Toshiyuki; Katayama, Shigeji; Ohgitani, Toshiaki; Yoshikawa, Masayuki</div><div class="citationInfo"><span class="NLM_cas:title">Vaccine</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">17-18</span>),
    <span class="NLM_cas:pages">2145-2151</span>CODEN:
                <span class="NLM_cas:coden">VACCDE</span>;
        ISSN:<span class="NLM_cas:issn">0264-410X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A correlation between adjuvant activity and amphipathic structure of saponin was first demonstrated on an exptl. basis using structurally consecutive analogs.  To clarify the physicochem. factors regulating the adjuvanticity of saponin, the authors compared the profile of the antibody response against chicken ovalbumin (OVA) in mice and hydrophile-lipophile balance (HLB) of 8 purified soyasaponins.  Soyasaponins bearing sugar chain(s) showed adjuvanticity stimulating anti-OVA total IgG and IgG1 antibody responses, while their corresponding aglycons soyasapogenols A and B, did not.  Among bisdesmosidic soyasaponins, soyasaponin A1 (HLB: 26.9) with a long sugar side chain induced stronger total-IgG and IgG1 antibody responses than soyasaponin A2 (HLB: 21.4).  For monodesmosidic soyasaponins, the ranking in terms of antibody response was soyasaponin I [which has the highest HLB value (13.6) among the monodesmosidic soyasaponins] > soyasaponin II (HLB: 12.2) > soyasaponin III (HLB: 10.0).  The adjuvant activity increased with the HLB value.  The length, the no., and the compn. of sugar side chains affecting the HLB value would give the overall conformation of each saponin mol., and the amphipathic structure may define the fundamental adjuvanticity of saponins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotsHMF_IzKlbVg90H21EOLACvtfcHk0lh8VNK1pSCzhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjtFWlsrg%253D&md5=f48c43dfdad5cc579597dc44a6b70f1d</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2FS0264-410X%2802%2900739-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0264-410X%252802%252900739-9%26sid%3Dliteratum%253Aachs%26aulast%3DOda%26aufirst%3DK.%26atitle%3DRelationship%2520between%2520adjuvant%2520activity%2520and%2520amphipathic%2520structure%2520of%2520soyasaponins%26jtitle%3DVaccine%26date%3D2003%26volume%3D21%26spage%3D2145%26epage%3D2151%26doi%3D10.1016%2FS0264-410X%2802%2900739-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tang, W.</span>; <span class="NLM_string-name">Eisenbrand, G.</span></span> <i>Handbook of Chinese Medicinal Plants</i>; <span class="NLM_publisher-name">Wiley-VCH</span>: <span class="NLM_publisher-loc">Weinheim, Germany</span>, <span class="NLM_year">2011</span>; Vol.  <span class="NLM_volume">2</span>, p  <span class="NLM_fpage">768</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&pages=768&author=W.+Tang&author=G.+Eisenbrand&title=Handbook+of+Chinese+Medicinal+Plants"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DW.%26btitle%3DHandbook%2520of%2520Chinese%2520Medicinal%2520Plants%26pub%3DWiley-VCH%26date%3D2011%26volume%3D2%26spage%3D768" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajput, Z. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, S.</span></span> <span> </span><span class="NLM_article-title">Enhancement of serological immune responses to foot-and-mouth disease vaccine by a supplement made of extract of cochinchina momordica seeds</span>. <i>Clinical and Vaccine Immunology: CVI</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">1634</span>– <span class="NLM_lpage">1639</span>, <span class="refDoi"> DOI: 10.1128/CVI.00339-07</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=10.1128%2FCVI.00339-07" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=17942610" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=1%3ACAS%3A280%3ADC%252BD2sjhvVCqtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2007&pages=1634-1639&author=C.+Xiaoauthor=Z.+I.+Rajputauthor=D.+Liuauthor=S.+Hu&title=Enhancement+of+serological+immune+responses+to+foot-and-mouth+disease+vaccine+by+a+supplement+made+of+extract+of+cochinchina+momordica+seeds&doi=10.1128%2FCVI.00339-07"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Enhancement of serological immune responses to foot-and-mouth disease vaccine by a supplement made of extract of cochinchina momordica seeds</span></div><div class="casAuthors">Xiao Chenwen; Rajput Zahid Iqbal; Liu Diwen; Hu Songhua</div><div class="citationInfo"><span class="NLM_cas:title">Clinical and vaccine immunology : CVI</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1634-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Foot-and-mouth disease (FMD) is a highly contagious disease affecting cloven-hoofed animals.  Vaccination against FMD is a routine practice in many countries where the disease is endemic.  This study was designed first to investigate the extract of the seeds of Momordica cochinchinensis (Lour.) Spreng. (ECMS) for its adjuvant effect on vaccination of inactivated FMDV antigens in a guinea pig model and then to evaluate the supplement of ECMS in oil-emulsified FMD vaccines for its immunopotentiation in pigs.  The results indicated that ECMS and oil emulsion act synergistically as adjuvants to promote the production of FMDV- and VP1-specific immunoglobulin G (IgG) and subclasses in guinea pigs.  A supplement of ECMS in a commercial FMD vaccine significantly enhanced FMDV-specific indirect hemagglutination assay titers as well as VP1-specific IgG and subclasses in pigs.  Therefore, ECMS could be an alternative approach to improving swine FMD vaccination when the vaccine is poor to induce an effective immune response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQxatmtwSKaDUkUaC_kzhvyfW6udTcc2eZLrrKJ9NljY7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2sjhvVCqtg%253D%253D&md5=770eb0f576d3b36febc8ff5567bf584f</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1128%2FCVI.00339-07&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FCVI.00339-07%26sid%3Dliteratum%253Aachs%26aulast%3DXiao%26aufirst%3DC.%26aulast%3DRajput%26aufirst%3DZ.%2BI.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DHu%26aufirst%3DS.%26atitle%3DEnhancement%2520of%2520serological%2520immune%2520responses%2520to%2520foot-and-mouth%2520disease%2520vaccine%2520by%2520a%2520supplement%2520made%2520of%2520extract%2520of%2520cochinchina%2520momordica%2520seeds%26jtitle%3DClinical%2520and%2520Vaccine%2520Immunology%253A%2520CVI%26date%3D2007%26volume%3D14%26spage%3D1634%26epage%3D1639%26doi%3D10.1128%2FCVI.00339-07" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, S. H.</span></span> <span> </span><span class="NLM_article-title">Effect of four adjuvants on immune response to F4 fimbriae in chickens</span>. <i>Vet. Immunol. Immunopathol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>121</i></span>,  <span class="NLM_fpage">107</span>– <span class="NLM_lpage">112</span>, <span class="refDoi"> DOI: 10.1016/j.vetimm.2007.09.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=10.1016%2Fj.vetimm.2007.09.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=18036671" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVeltbnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2008&pages=107-112&author=J.+H.+Sunauthor=Z.+Q.+Jiangauthor=S.+H.+Hu&title=Effect+of+four+adjuvants+on+immune+response+to+F4+fimbriae+in+chickens&doi=10.1016%2Fj.vetimm.2007.09.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of four adjuvants on immune response to F4 fimbriae in chickens</span></div><div class="casAuthors">Sun, Jian-hua; Jiang, Zhong-qi; Hu, Song-hua</div><div class="citationInfo"><span class="NLM_cas:title">Veterinary Immunology and Immunopathology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">121</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">107-112</span>CODEN:
                <span class="NLM_cas:coden">VIIMDS</span>;
        ISSN:<span class="NLM_cas:issn">0165-2427</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">IgG antibody response in chickens immunized with F4 fimbriae extd. from local enterotoxigenic Escherichia coli (ETEC) strain was studied during a 98-day immunization period for comparing the efficacy of four adjuvants: Freund' adjuvant, Quil A (QA), propolis and ext. from Cochinchina momordica seed (ECMS).  For this purpose, chickens were immunized with F4 fimbriae alone or combined with one of the above adjuvants on days 1 and 21.  IgG antibody levels in serum and egg yolk (by ELISA) were measured on days 0, 7, 14, 21, 28, 35, 42, 49, 56, 70, 84 and 98.  The egg prodn. of each group was also detd. during days 1-7 and the following four weeks.  The results showed that QA could enhance antibody titer, as good or almost as good as Freund's adjuvant, whereas the titers of ECMS and propolis groups were relatively lower, with the overall order: Freund's adjuvant > QA > ECMS > propolis both in serum and egg yolk.  However, the significant decrease of egg prodn. was merely obsd. in the Freund's adjuvant group.  It is concluded that the four adjuvants tested can stimulate immune response to F4 fimbriae in chickens, with Freund's adjuvant giving the best results, followed by QA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2bNO-YpE-frVg90H21EOLACvtfcHk0ljhaDj27rMO6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVeltbnN&md5=38950fcd75f91ec1f90e56ba533e6f09</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.vetimm.2007.09.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.vetimm.2007.09.021%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DJ.%2BH.%26aulast%3DJiang%26aufirst%3DZ.%2BQ.%26aulast%3DHu%26aufirst%3DS.%2BH.%26atitle%3DEffect%2520of%2520four%2520adjuvants%2520on%2520immune%2520response%2520to%2520F4%2520fimbriae%2520in%2520chickens%26jtitle%3DVet.%2520Immunol.%2520Immunopathol.%26date%3D2008%26volume%3D121%26spage%3D107%26epage%3D112%26doi%3D10.1016%2Fj.vetimm.2007.09.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pu, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaid, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boini, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Towsley, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doecke, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitchell, D.</span></span> <span> </span><span class="NLM_article-title">A practical method for functionalized peptide or amide bond formation in aqueous-ethanol media with EDC as Activator</span>. <i>Org. Process Res. Dev.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">310</span>– <span class="NLM_lpage">314</span>, <span class="refDoi"> DOI: 10.1021/op800240d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/op800240d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVKksr%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2009&pages=310-314&author=Y.+J.+Puauthor=R.+K.+Vaidauthor=S.+K.+Boiniauthor=R.+W.+Towsleyauthor=C.+W.+Doeckeauthor=D.+Mitchell&title=A+practical+method+for+functionalized+peptide+or+amide+bond+formation+in+aqueous-ethanol+media+with+EDC+as+Activator&doi=10.1021%2Fop800240d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">A practical method for functionalized peptide or amide bond formation in aqueous-ethanol media with EDC as activator</span></div><div class="casAuthors">Pu, Yangwei John; Vaid, Radhe K.; Boini, Sathish K.; Towsley, Robert W.; Doecke, Christopher W.; Mitchell, David</div><div class="citationInfo"><span class="NLM_cas:title">Organic Process Research & Development</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">310-314</span>CODEN:
                <span class="NLM_cas:coden">OPRDFK</span>;
        ISSN:<span class="NLM_cas:issn">1083-6160</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Selective formation of amides or peptides with ethanol as solvent using a convenient one-pot procedure in which acid activating agent N-(3-dimethylaminopropyl)-N-ethylcarbodiimide hydrochloride (EDC) is simply added to a mixt. of the carboxylic acid, amine, catalytic HOBt (1-hydroxy benzotriazole), and NMM (N-methylmorpholine) as base has been developed.  Sensitive functionalities such as hydroxyl groups are well tolerated under the reaction conditions.  In addn., isolation of products is usually by simple filtration from the reaction media.  The scope and generality of this methodol. was investigated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJg1wh3HuhFrVg90H21EOLACvtfcHk0ljECtpv8OpcWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVKksr%252FJ&md5=a0a7085c5054220988a5ff3a7df35c92</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fop800240d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fop800240d%26sid%3Dliteratum%253Aachs%26aulast%3DPu%26aufirst%3DY.%2BJ.%26aulast%3DVaid%26aufirst%3DR.%2BK.%26aulast%3DBoini%26aufirst%3DS.%2BK.%26aulast%3DTowsley%26aufirst%3DR.%2BW.%26aulast%3DDoecke%26aufirst%3DC.%2BW.%26aulast%3DMitchell%26aufirst%3DD.%26atitle%3DA%2520practical%2520method%2520for%2520functionalized%2520peptide%2520or%2520amide%2520bond%2520formation%2520in%2520aqueous-ethanol%2520media%2520with%2520EDC%2520as%2520Activator%26jtitle%3DOrg.%2520Process%2520Res.%2520Dev.%26date%3D2009%26volume%3D13%26spage%3D310%26epage%3D314%26doi%3D10.1021%2Fop800240d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Q.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michalek, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katz, J.</span></span> <span> </span><span class="NLM_article-title">Role of B7 costimulatory molecules in immune responses and T-helper cell differentiation to recombinant HagB from Prophyromonas gingivalis</span>. <i>Infect. Immun.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>72</i></span>,  <span class="NLM_fpage">637</span>– <span class="NLM_lpage">644</span>, <span class="refDoi"> DOI: 10.1128/IAI.72.2.637-644.2004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=10.1128%2FIAI.72.2.637-644.2004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=14742503" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtFGmsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2004&pages=637-644&author=P.+Zhangauthor=M.+Martinauthor=Q.-B.+Yangauthor=S.+M.+Michalekauthor=J.+Katz&title=Role+of+B7+costimulatory+molecules+in+immune+responses+and+T-helper+cell+differentiation+to+recombinant+HagB+from+Prophyromonas+gingivalis&doi=10.1128%2FIAI.72.2.637-644.2004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Role of B7 costimulatory molecules in immune responses and T-helper cell differentiation in response to recombinant HagB from Porphyromonas gingivalis</span></div><div class="casAuthors">Zhang, Ping; Martin, Michael; Yang, Qiu-Bo; Michalek, Suzanne M.; Katz, Jannet</div><div class="citationInfo"><span class="NLM_cas:title">Infection and Immunity</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">637-644</span>CODEN:
                <span class="NLM_cas:coden">INFIBR</span>;
        ISSN:<span class="NLM_cas:issn">0019-9567</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">In addn. to antigen-specific signals mediated through the T-cell receptor, T cells also require antigen nonspecific costimulation for activation.  The B7 family of mols. on antigen-presenting cells, which include B7-1 (CD80) and B7-2 (CD86), play important roles in providing costimulatory signals required for development of antigen-specific immune responses.  Hemagglutinin B (HagB) is a nonfimbrial adhesin of the periodontopathic microorganism Porphyromonas gingivalis and is thought to be involved in the attachment of the bacterium to host tissues.  However, the immune mechanisms involved in responses to HagB and their roles in pathogenesis have yet to be elucidated.  Therefore, the purpose of this study was to det. the role of B7 costimulatory mols. on T-helper-cell differentiation for the induction of immune responses to HagB.  Mice deficient in either or both of the costimulatory mols. B7-1 and B7-2 were used to explore their role in immune responses to HagB after s.c. immunization.  B7-1-/- mice had levels of IgG anti-HagB antibody activity in serum similar to those of wild-type mice, whereas lower serum IgG anti-HagB antibody responses were seen in B7-2-/- mice.  Moreover, significantly lower nos. of IgG antibody-secreting cells and lower levels of CD4+-T-cell proliferation were obsd. in B7-2-/- mice compared to wild-type mice.  No serum IgG response to HagB was detected in B7-1/B7-2-/- mice.  Anal. of the subclass of the serum IgG responses and the cytokines induced in response to HagB revealed that B7-2-/- mice had significantly lower IgG1 and higher IgG2a anti-HagB antibody responses compared to wild-type mice.  The B7-2-/- mice also had significantly reduced levels of interleukin-4 (IL-4) and IL-5 and enhanced level of gamma interferon.  Furthermore, assessment of B7-1 and B7-2 expression on B cells and macrophages derived from wild-type BALB/c mice after in vitro stimulation with HagB revealed a predominant upregulation in the expression of the B7-2 costimulatory mol. on B cells and macrophages.  Essentially no change was seen in the expression of B7-1.  These results suggest a crit. role for B7, esp. B7-2, for the preferential induction of a Th2-like response to HagB.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAnGRInG-VFbVg90H21EOLACvtfcHk0ljECtpv8OpcWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtFGmsL4%253D&md5=675ca3a5b935bef1f3589fe8490c16a6</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1128%2FIAI.72.2.637-644.2004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FIAI.72.2.637-644.2004%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DP.%26aulast%3DMartin%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DQ.-B.%26aulast%3DMichalek%26aufirst%3DS.%2BM.%26aulast%3DKatz%26aufirst%3DJ.%26atitle%3DRole%2520of%2520B7%2520costimulatory%2520molecules%2520in%2520immune%2520responses%2520and%2520T-helper%2520cell%2520differentiation%2520to%2520recombinant%2520HagB%2520from%2520Prophyromonas%2520gingivalis%26jtitle%3DInfect.%2520Immun.%26date%3D2004%26volume%3D72%26spage%3D637%26epage%3D644%26doi%3D10.1128%2FIAI.72.2.637-644.2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michalek, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katz, J.</span></span> <span> </span><span class="NLM_article-title">Role of mitogen-activated protein kinases and NF-κB in the regulation of pro- and anti-inflammatory cytokines by Porphyromonas gingivalis Hemagglutinin B</span>. <i>Infect. Immun.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">3990</span>– <span class="NLM_lpage">3998</span>, <span class="refDoi"> DOI: 10.1128/IAI.73.7.3990-3998.2005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=10.1128%2FIAI.73.7.3990-3998.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=15972486" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=1%3ACAS%3A528%3ADC%252BD28XhsFWgtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2005&pages=3990-3998&author=P.+Zhangauthor=M.+Martinauthor=S.+M.+Michalekauthor=J.+Katz&title=Role+of+mitogen-activated+protein+kinases+and+NF-%CE%BAB+in+the+regulation+of+pro-+and+anti-inflammatory+cytokines+by+Porphyromonas+gingivalis+Hemagglutinin+B&doi=10.1128%2FIAI.73.7.3990-3998.2005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Role of mitogen-activated protein kinases and NF-κB in the regulation of proinflammatory and anti-inflammatory cytokines by Porphyromonas gingivalis hemagglutinin B</span></div><div class="casAuthors">Zhang, Ping; Martin, Michael; Michalek, Suzanne M.; Katz, Jannet</div><div class="citationInfo"><span class="NLM_cas:title">Infection and Immunity</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3990-3998</span>CODEN:
                <span class="NLM_cas:coden">INFIBR</span>;
        ISSN:<span class="NLM_cas:issn">0019-9567</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Hemagglutinin B (HagB) is a nonfimbrial adhesin expressed on the surface of P. gingivalis and has been implicated as a potential virulence factor involved in mediating the attachment of the bacteria to host cells.  However, the mol. mechanisms underlying host responses to HagB and their roles in pathogenesis have yet to be elucidated.  Mitogen-activated protein kinases (MAPKs) are activated following engagement of a variety of cell surface receptors via dual tyrosine and threonine phosphorylation and are thought to be involved in various cellular responses.  The purpose here was to det. the role of intracellular signaling pathways including the MAPKs and NF-κB in regulating the prodn. of proinflammatory and anti-inflammatory cytokines following stimulation of murine macrophages with recombinant HagB (rHagB).  Stimulation of peritoneal macrophages with rHagB resulted in the prodn. of the proinflammatory cytokines interleukin-12p40 (IL-12p40), γ interferon (IFN-γ), and tumor necrosis factor α, as well as the anti-inflammatory cytokine IL-10.  The authors also demonstrated the activation of extracellular signal-related kinase (ERK), c-Jun NH2-terminal protein kinase (JNK), and p38 MAPKs by rHagB-stimulated macrophages.  Furthermore, blocking of the ERK and p38 signaling pathways by using specific inhibitors revealed differential regulatory roles in the rHagB-mediated prodn. of proinflammatory and anti-inflammatory cytokines.  ERK and p38 were important in down-regulation of IL-12p40 and IFN-γ prodn. and up-regulation of IL-10 prodn.  The enhanced levels of IL-12p40 in rHagB-stimulated macrophages by inhibition of ERK or p38 activity were partially attributable to the inhibition of IL-10 prodn.  Moreover, NF-κB was crit. for up-regulation of IL-12p40 and down-regulation of IL-10 prodn. in rHagB-stimulated macrophages.  The authors' results demonstrate here a role for the p38 and ERK pathways and the transcription factor NF-κB in modulating key immunoregulatory cytokines involved in the development of immune responses to P. gingivalis HagB.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbnS7yALcMarVg90H21EOLACvtfcHk0lgi4EBJG4RAfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhsFWgtLg%253D&md5=c106954f522153aff95529e29db4a94b</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1128%2FIAI.73.7.3990-3998.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FIAI.73.7.3990-3998.2005%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DP.%26aulast%3DMartin%26aufirst%3DM.%26aulast%3DMichalek%26aufirst%3DS.%2BM.%26aulast%3DKatz%26aufirst%3DJ.%26atitle%3DRole%2520of%2520mitogen-activated%2520protein%2520kinases%2520and%2520NF-%25CE%25BAB%2520in%2520the%2520regulation%2520of%2520pro-%2520and%2520anti-inflammatory%2520cytokines%2520by%2520Porphyromonas%2520gingivalis%2520Hemagglutinin%2520B%26jtitle%3DInfect.%2520Immun.%26date%3D2005%26volume%3D73%26spage%3D3990%26epage%3D3998%26doi%3D10.1128%2FIAI.73.7.3990-3998.2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Katz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Black, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michalek, S. M.</span></span> <span> </span><span class="NLM_article-title">Host responses to recombinant hemagglutinin B of Porphyromonas gingivalis in an experimental rat model</span>. <i>Infect. Immun.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">4352</span>– <span class="NLM_lpage">4359</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=10.1128%2FIAI.67.9.4352-4359.1999" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=10456874" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=1%3ACAS%3A528%3ADyaK1MXlsFCmtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=1999&pages=4352-4359&author=J.+Katzauthor=K.+P.+Blackauthor=S.+M.+Michalek&title=Host+responses+to+recombinant+hemagglutinin+B+of+Porphyromonas+gingivalis+in+an+experimental+rat+model"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Host responses to recombinant hemagglutinin B of Porphyromonas gingivalis in an experimental rat model</span></div><div class="casAuthors">Katz, Jannet; Black, Kelley P.; Michalek, Suzanne M.</div><div class="citationInfo"><span class="NLM_cas:title">Infection and Immunity</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4352-4359</span>CODEN:
                <span class="NLM_cas:coden">INFIBR</span>;
        ISSN:<span class="NLM_cas:issn">0019-9567</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Porphyromonas gingivalis, a gram-neg., black-pigmented anaerobe, is among the microorganisms implicated in the etiol. of adult periodontal disease.  This bacterium possesses a no. of factors, including hemagglutinins, of potential importance in virulence.  Several hemagglutinin genes have been identified, cloned, and expressed in Escherichia coli.  The purpose of this study was to characterize host responses to purified recombinant hemagglutinin B (rHag B), using the conventional Fischer rat as the exptl. animal model.  The effectiveness of immunization with rHag B on protection against exptl. periodontal bone loss following infection with P. gingivalis was also evaluated.  Groups of rats were immunized by the s.c. route with rHag B in complete Freund's adjuvant, immunized with rHag B and orally infected with P. gingivalis, nonimmunized and noninfected, or orally infected with P. gingivalis only.  Serum and saliva samples were collected throughout the expt. and evaluated for serum IgG and IgM and salivary IgA antibody activity by ELISA.  No salivary IgA anti-Hag B activity was detected in the various groups of rats.  A slight serum IgM response similar to that seen in preimmune samples was obsd.  Serum IgG antibody activity to Hag B was detected only in samples from rats immunized with rHag B.  This response was primarily of the IgG1 and IgG2a subclasses, followed by IgG2b and low levels of IgG2c.  Supernatants from rHag B-stimulated splenic lymphoid cell cultures from immunized rats contained high levels of gamma interferon, followed by interleukin-2 (IL-2), IL-10, and then IL-4.  These results are consistent with the induction of T helper type 1 (Th1)- and Th2-like responses.  Western blot anal. of sera derived from rHag B-immunized rats reacted with trichloroacetic acid (TCA) ppts. of P. gingivalis 33277, 381, A7A1-28, and W50, revealing a 50-kDa band reflective of Hag B.  However, sera derived from rats immunized with P. gingivalis whole cells or from rats infected with P. gingivalis only did not react with rHag B but did react with TCA ppts. of P. gingivalis strains.  Finally, radiog. measurements of periodontal bone loss indicated that rats immunized with rHag B had less bone loss than those infected with P. gingivalis only.  These results demonstrate the effectiveness of purified rHag B in inducing a protective immune response and support the potential usefulness of this component of P. gingivalis in the development of a vaccine against adult periodontitis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4aCqyjBtYObVg90H21EOLACvtfcHk0lgi4EBJG4RAfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXlsFCmtr8%253D&md5=8cdb21398c62a055b682489526201301</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1128%2FIAI.67.9.4352-4359.1999&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FIAI.67.9.4352-4359.1999%26sid%3Dliteratum%253Aachs%26aulast%3DKatz%26aufirst%3DJ.%26aulast%3DBlack%26aufirst%3DK.%2BP.%26aulast%3DMichalek%26aufirst%3DS.%2BM.%26atitle%3DHost%2520responses%2520to%2520recombinant%2520hemagglutinin%2520B%2520of%2520Porphyromonas%2520gingivalis%2520in%2520an%2520experimental%2520rat%2520model%26jtitle%3DInfect.%2520Immun.%26date%3D1999%26volume%3D67%26spage%3D4352%26epage%3D4359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 4 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Zhi-Yong Zeng, Jin-Xi Liao, Zhen-Ni Hu, De-Yong Liu, Qing-Ju Zhang, <span class="NLM_string-name hlFld-ContribAuthor">Jian-Song Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Synthetic Investigation toward QS-21 Analogues. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2020,</strong> <em>22 </em>
                                    (21)
                                     , 8613-8617. <a href="https://doi.org/10.1021/acs.orglett.0c03185" title="DOI URL">https://doi.org/10.1021/acs.orglett.0c03185</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.0c03185&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.0c03185%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DSynthetic%252BInvestigation%252Btoward%252BQS-21%252BAnalogues%26aulast%3DZeng%26aufirst%3DZhi-Yong%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D24092020%26date%3D19102020%26volume%3D22%26issue%3D21%26spage%3D8613%26epage%3D8617" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Pengfei Wang, Xiong Ding, Hyunjung Kim, Suzanne M. Michalek, <span class="NLM_string-name hlFld-ContribAuthor">Ping Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Structural Effect on Adjuvanticity of Saponins. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (6)
                                     , 3290-3297. <a href="https://doi.org/10.1021/acs.jmedchem.9b02063" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b02063</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b02063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b02063%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructural%252BEffect%252Bon%252BAdjuvanticity%252Bof%252BSaponins%26aulast%3DWang%26aufirst%3DPengfei%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D11122019%26date%3D26022020%26volume%3D63%26issue%3D6%26spage%3D3290%26epage%3D3297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pengfei  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Natural and Synthetic Saponins as Vaccine Adjuvants. </span><span class="cited-content_cbyCitation_journal-name">Vaccines</span><span> <strong>2021,</strong> <em>9 </em>
                                    (3)
                                     , 222. <a href="https://doi.org/10.3390/vaccines9030222" title="DOI URL">https://doi.org/10.3390/vaccines9030222</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/vaccines9030222&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fvaccines9030222%26sid%3Dliteratum%253Aachs%26jtitle%3DVaccines%26atitle%3DNatural%252Band%252BSynthetic%252BSaponins%252Bas%252BVaccine%252BAdjuvants%26aulast%3DWang%26aufirst%3DPengfei%26date%3D2021%26date%3D2021%26volume%3D9%26issue%3D3%26spage%3D222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yu-Pu  Juang</span>, <span class="hlFld-ContribAuthor ">Pi-Hui  Liang</span>. </span><span class="cited-content_cbyCitation_article-title">Biological and Pharmacological Effects of Synthetic Saponins. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (21)
                                     , 4974. <a href="https://doi.org/10.3390/molecules25214974" title="DOI URL">https://doi.org/10.3390/molecules25214974</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25214974&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25214974%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DBiological%252Band%252BPharmacological%252BEffects%252Bof%252BSynthetic%252BSaponins%26aulast%3DJuang%26aufirst%3DYu-Pu%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D21%26spage%3D4974" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01511/20191108/images/medium/jm9b01511_0008.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01511/20191108/images/large/jm9b01511_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01511&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01511/20191108/images/medium/jm9b01511_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01511/20191108/images/large/jm9b01511_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structure of QS-21.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01511/20191108/images/large/jm9b01511_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01511&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01511/20191108/images/medium/jm9b01511_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01511/20191108/images/large/jm9b01511_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Synthesized QS analogs with different adjuvant activities.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01511/20191108/images/large/jm9b01511_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01511&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01511/20191108/images/medium/jm9b01511_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01511/20191108/images/large/jm9b01511_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Structural similarity between MS and deacylated QS-17/18.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01511/20191108/images/large/jm9b01511_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01511&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01511/20191108/images/medium/jm9b01511_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01511/20191108/images/large/jm9b01511_0007.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Derivatizing <i>Momordica</i> Saponins</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01511/20191108/images/large/jm9b01511_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01511&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01511/20191108/images/medium/jm9b01511_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01511/20191108/images/large/jm9b01511_0004.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Serum IgG anti-OVA response in mice immunized by the sc route with OVA alone or with GPI-0100 or saponins <b>3</b>–<b>6</b>. Mice were immunized on days 0, 14, and 28. Serum samples were collected prior to each immunization and at 6 weeks after the initial immunization. Values are expressed as the mean ± SEM: *<i>P</i> < 0.05, **<i>P</i> < 0.01, and ***<i>P</i> < 0.001 compared with mice immunized with OVA alone.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01511/20191108/images/large/jm9b01511_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01511&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01511/20191108/images/medium/jm9b01511_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01511/20191108/images/large/jm9b01511_0005.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Serum IgG1 (A) and IgG2a (B) anti-OVA response in mice immunized by the sc route with OVA alone or with GPI-0100 or saponins <b>3</b>–<b>6</b>. Mice were immunized on days 0, 14, and 28. Serum samples were collected prior to each immunization and at 6 weeks following the initial immunization. Values are expressed as the mean ± SEM: *<i>P</i> < 0.05, **<i>P</i> < 0.01, and ***<i>P</i> < 0.001 compared with mice immunized with OVA alone.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01511/20191108/images/large/jm9b01511_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01511&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01511/20191108/images/medium/jm9b01511_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01511/20191108/images/large/jm9b01511_0006.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Serum IgG (A), IgG1 (B), and IgG2a (C) anti-rHagB response in mice immunized by the sc route with rHagB alone or with GPI-0100 or saponins <b>3</b>–<b>6</b>. Mice were immunized on days 0, 14, and 28. Serum samples were collected prior to each immunization and at 6 weeks after the initial immunization. Values are expressed as the mean ± SEM: *<i>P</i> < 0.05, **<i>P</i> < 0.01, and ***<i>P</i> < 0.001 compared with mice immunized with rHagB alone.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01511/20191108/images/large/jm9b01511_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01511&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i18">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24866" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24866" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 42 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brunner, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen-Jarolim, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pali-Scholl, I.</span></span> <span> </span><span class="NLM_article-title">The ABC of clinical and experimental adjuvants-A brief overview</span>. <i>Immunol. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>128</i></span>,  <span class="NLM_fpage">29</span>– <span class="NLM_lpage">35</span>, <span class="refDoi"> DOI: 10.1016/j.imlet.2009.10.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=10.1016%2Fj.imlet.2009.10.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=19895847" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlegtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2010&pages=29-35&author=R.+Brunnerauthor=E.+Jensen-Jarolimauthor=I.+Pali-Scholl&title=The+ABC+of+clinical+and+experimental+adjuvants-A+brief+overview&doi=10.1016%2Fj.imlet.2009.10.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The ABC of clinical and experimental adjuvants-A brief overview</span></div><div class="casAuthors">Brunner, Richard; Jensen-Jarolim, Erika; Pali-Schoell, Isabella</div><div class="citationInfo"><span class="NLM_cas:title">Immunology Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">128</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">29-35</span>CODEN:
                <span class="NLM_cas:coden">IMLED6</span>;
        ISSN:<span class="NLM_cas:issn">0165-2478</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Adjuvants are compds. that can increase and/or modulate the intrinsic immunogenicity of an antigen and elicit strong and long lasting immune responses.  During the last 80 years many adjuvants have been used in exptl. settings, but due to various shortcomings of most of them only aluminum compds. made it into regular clin. usage.  However, during the last years promising candidates have arisen that may finally adjunct or displace aluminum substances as main adjuvant.  This review summarizes information on adjuvants currently used in clin. as well as in exptl. settings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJiiZR6dRoyrVg90H21EOLACvtfcHk0ljMFb0uaBwttQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlegtr4%253D&md5=f3d75eefb3072d975ba71daf3b4bfb39</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.imlet.2009.10.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.imlet.2009.10.005%26sid%3Dliteratum%253Aachs%26aulast%3DBrunner%26aufirst%3DR.%26aulast%3DJensen-Jarolim%26aufirst%3DE.%26aulast%3DPali-Scholl%26aufirst%3DI.%26atitle%3DThe%2520ABC%2520of%2520clinical%2520and%2520experimental%2520adjuvants-A%2520brief%2520overview%26jtitle%3DImmunol.%2520Lett.%26date%3D2010%26volume%3D128%26spage%3D29%26epage%3D35%26doi%3D10.1016%2Fj.imlet.2009.10.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kensil, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mo, A. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Truneh, A.</span></span> <span> </span><span class="NLM_article-title">Current vaccine adjuvants: an overview of a diverse class</span>. <i>Front. Biosci., Landmark Ed.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">2972</span>– <span class="NLM_lpage">2988</span>, <span class="refDoi"> DOI: 10.2741/1452</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=10.2741%2F1452" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=15353330" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=1%3ACAS%3A528%3ADC%252BD2cXls1enu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=2972-2988&author=C.+R.+Kensilauthor=A.+X.+Moauthor=A.+Truneh&title=Current+vaccine+adjuvants%3A+an+overview+of+a+diverse+class&doi=10.2741%2F1452"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Current vaccine adjuvants: an overview of a diverse class</span></div><div class="casAuthors">Kensil, Charlotte Read; Mo, Annie Xiaoyan; Truneh, Alemseged</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Bioscience</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">Suppl.</span>),
    <span class="NLM_cas:pages">2972-2988</span>CODEN:
                <span class="NLM_cas:coden">FRBIF6</span>;
        ISSN:<span class="NLM_cas:issn">1093-4715</span>.
    
            (<span class="NLM_cas:orgname">Frontiers in Bioscience</span>)
        </div><div class="casAbstract">A review.  Numerous compds. are under evaluation as immunol. adjuvants for improvement of vaccine performance.  This review will briefly summarize some of the many diverse substances that are currently being utilized as vaccine adjuvants in preclin. and clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9URKBt0onobVg90H21EOLACvtfcHk0ljMFb0uaBwttQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXls1enu70%253D&md5=72b7a9d5250812a02c6ae8121c729995</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.2741%2F1452&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2741%252F1452%26sid%3Dliteratum%253Aachs%26aulast%3DKensil%26aufirst%3DC.%2BR.%26aulast%3DMo%26aufirst%3DA.%2BX.%26aulast%3DTruneh%26aufirst%3DA.%26atitle%3DCurrent%2520vaccine%2520adjuvants%253A%2520an%2520overview%2520of%2520a%2520diverse%2520class%26jtitle%3DFront.%2520Biosci.%252C%2520Landmark%2520Ed.%26date%3D2004%26volume%3D9%26spage%3D2972%26epage%3D2988%26doi%3D10.2741%2F1452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leroux-Roels, G.</span></span> <span> </span><span class="NLM_article-title">Unmet needs in modern vaccinology: Adjuvants to improve the immune response</span>. <i>Vaccine</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>28</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">C25</span>– <span class="NLM_lpage">36</span>, <span class="refDoi"> DOI: 10.1016/j.vaccine.2010.07.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=10.1016%2Fj.vaccine.2010.07.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=20713254" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2010&pages=C25-36&issue=3&author=G.+Leroux-Roels&title=Unmet+needs+in+modern+vaccinology%3A+Adjuvants+to+improve+the+immune+response&doi=10.1016%2Fj.vaccine.2010.07.021"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.vaccine.2010.07.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.vaccine.2010.07.021%26sid%3Dliteratum%253Aachs%26aulast%3DLeroux-Roels%26aufirst%3DG.%26atitle%3DUnmet%2520needs%2520in%2520modern%2520vaccinology%253A%2520Adjuvants%2520to%2520improve%2520the%2520immune%2520response%26jtitle%3DVaccine%26date%3D2010%26volume%3D28%26issue%3D3%26spage%3DC25%26epage%3D36%26doi%3D10.1016%2Fj.vaccine.2010.07.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sharp, F. A.</span>; <span class="NLM_string-name">Lavelle, E. C.</span></span> <span> </span><span class="NLM_article-title">Discovery of Vaccine Adjuvants</span>. In  <i>Development of Therapeutic Agents Handbook</i>, <span class="NLM_edition">1</span>st ed.; <span class="NLM_contrib-group"><span class="NLM_string-name">Gad, S. C.</span></span>, Ed.; <span class="NLM_publisher-name">John Wiley & Sons, Inc,</span>: <span class="NLM_publisher-loc">Hoboken, NJ</span>, <span class="NLM_year">2012</span>; pp  <span class="NLM_fpage">533</span>– <span class="NLM_lpage">546</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&pages=533-546&author=F.+A.+Sharp&author=E.+C.+Lavelleauthor=S.+C.+Gad&title=Development+of+Therapeutic+Agents+Handbook"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DSharp%26aufirst%3DF.%2BA.%26atitle%3DDiscovery%2520of%2520Vaccine%2520Adjuvants%26btitle%3DDevelopment%2520of%2520Therapeutic%2520Agents%2520Handbook%26aulast%3DGad%26aufirst%3DS.%2BC.%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26date%3D2012%26spage%3D533%26epage%3D546" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, M.</span></span> <span> </span><span class="NLM_article-title">Selection of adjuvants for enhanced vaccine potency</span>. <i>World J. Vaccines</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>01</i></span>,  <span class="NLM_fpage">33</span>– <span class="NLM_lpage">78</span>, <span class="refDoi"> DOI: 10.4236/wjv.2011.12007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=10.4236%2Fwjv.2011.12007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVOksLrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=01&publication_year=2011&pages=33-78&author=W.+Wangauthor=M.+Singh&title=Selection+of+adjuvants+for+enhanced+vaccine+potency&doi=10.4236%2Fwjv.2011.12007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Selection of adjuvants for enhanced vaccine potency</span></div><div class="casAuthors">Wang, Wei; Singh, Manmohan</div><div class="citationInfo"><span class="NLM_cas:title">World Journal of Vaccines</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">33-78</span>CODEN:
                <span class="NLM_cas:coden">WJVOAC</span>;
        ISSN:<span class="NLM_cas:issn">2160-5815</span>.
    
            (<span class="NLM_cas:orgname">Scientific Research Publishing, Inc.</span>)
        </div><div class="casAbstract">A review.  The advent of mass vaccination has saved millions of human lives and revolutionized the quality of life.  Vaccination is currently one of the most cost effective ways of managing healthcare costs in both emerging and developed countries.  Despite the long vaccine history and success, design and development of efficacious and safe vaccines has been traditionally semi-empirical.  This is mainly due to our limited understanding of vaccination mechanism and its influencing factors.  The most important factor is arguably the type and concn. of vaccine adjuvants.  Until recently, however, only one type of adjuvant-aluminum salts, had been widely used within licensed human vaccines in the US, even though a variety of novel adjuvants have been evaluated in the past few decades.  This review summarizes the key adjuvants that have been evaluated in recent years with an intention to facilitate more efficient development of vaccine products to combat human diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXdaLL9Pj7dbVg90H21EOLACvtfcHk0ljMFb0uaBwttQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVOksLrM&md5=1b95c366abd0723e5f2bef7725d369c6</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.4236%2Fwjv.2011.12007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4236%252Fwjv.2011.12007%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DW.%26aulast%3DSingh%26aufirst%3DM.%26atitle%3DSelection%2520of%2520adjuvants%2520for%2520enhanced%2520vaccine%2520potency%26jtitle%3DWorld%2520J.%2520Vaccines%26date%3D2011%26volume%3D01%26spage%3D33%26epage%3D78%26doi%3D10.4236%2Fwjv.2011.12007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weeratna, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCluskie, M. J.</span></span> <span> </span><span class="NLM_article-title">Recent Advances in Vaccine Adjuvants</span>. In  <i>Emerging Trends in Antibacterial Discovery: Answering the Call to Arms</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, A. A.</span>, <span class="NLM_string-name">Miller, P. F.</span></span>, Eds.; <span class="NLM_publisher-name">Caister Academic Press</span>: <span class="NLM_publisher-loc">Great Britain</span>, <span class="NLM_year">2011</span>; pp  <span class="NLM_fpage">303</span>– <span class="NLM_lpage">322</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&pages=303-322&author=R.+D.+Weeratnaauthor=M.+J.+McCluskieauthor=A.+A.+Miller&author=P.+F.+Miller&title=Emerging+Trends+in+Antibacterial+Discovery%3A+Answering+the+Call+to+Arms"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DWeeratna%26aufirst%3DR.%2BD.%26aulast%3DMcCluskie%26aufirst%3DM.%2BJ.%26atitle%3DRecent%2520Advances%2520in%2520Vaccine%2520Adjuvants%26btitle%3DEmerging%2520Trends%2520in%2520Antibacterial%2520Discovery%253A%2520Answering%2520the%2520Call%2520to%2520Arms%26aulast%3DMiller%26aufirst%3DA.%2BA.%26pub%3DCaister%2520Academic%2520Press%26date%3D2011%26spage%3D303%26epage%3D322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coffman, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sher, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seder, R. A.</span></span> <span> </span><span class="NLM_article-title">Vaccine adjuvants: putting innate immunity to work</span>. <i>Immunity</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">492</span>– <span class="NLM_lpage">503</span>, <span class="refDoi"> DOI: 10.1016/j.immuni.2010.10.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=10.1016%2Fj.immuni.2010.10.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=21029960" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlGmtLvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2010&pages=492-503&author=R.+L.+Coffmanauthor=A.+Sherauthor=R.+A.+Seder&title=Vaccine+adjuvants%3A+putting+innate+immunity+to+work&doi=10.1016%2Fj.immuni.2010.10.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Vaccine Adjuvants: Putting Innate Immunity to Work</span></div><div class="casAuthors">Coffman, Robert L.; Sher, Alan; Seder, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Immunity</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">492-503</span>CODEN:
                <span class="NLM_cas:coden">IUNIEH</span>;
        ISSN:<span class="NLM_cas:issn">1074-7613</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Adjuvants enhance immunity to vaccines and exptl. antigens by a variety of mechanisms.  In the past decade, many receptors and signaling pathways in the innate immune system have been defined and these innate responses strongly influence the adaptive immune response.  The focus of this review is to delineate the innate mechanisms by which adjuvants mediate their effects.  We highlight how adjuvants can be used to influence the magnitude and alter the quality of the adaptive response in order to provide max. protection against specific pathogens.  Despite the impressive success of currently approved adjuvants for generating immunity to viral and bacterial infections, there remains a need for improved adjuvants that enhance protective antibody responses, esp. in populations that respond poorly to current vaccines.  However, the larger challenge is to develop vaccines that generate strong T cell immunity with purified or recombinant vaccine antigens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOyLxJMtsIx7Vg90H21EOLACvtfcHk0lgibLYPxy7Tgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlGmtLvF&md5=26e53f025adef76f6446093b935c52b3</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.immuni.2010.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.immuni.2010.10.002%26sid%3Dliteratum%253Aachs%26aulast%3DCoffman%26aufirst%3DR.%2BL.%26aulast%3DSher%26aufirst%3DA.%26aulast%3DSeder%26aufirst%3DR.%2BA.%26atitle%3DVaccine%2520adjuvants%253A%2520putting%2520innate%2520immunity%2520to%2520work%26jtitle%3DImmunity%26date%3D2010%26volume%3D33%26spage%3D492%26epage%3D503%26doi%3D10.1016%2Fj.immuni.2010.10.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Banday, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeelani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hruby, V. J.</span></span> <span> </span><span class="NLM_article-title">Cancer vaccine adjuvants - Recent clinical progress and future perspectives</span>. <i>Immunopharmacol. Immunotoxicol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">11</span>, <span class="refDoi"> DOI: 10.3109/08923973.2014.971963</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=10.3109%2F08923973.2014.971963" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=25318595" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFaltLjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2015&pages=1-11&author=A.+H.+Bandayauthor=S.+Jeelaniauthor=V.+J.+Hruby&title=Cancer+vaccine+adjuvants+-+Recent+clinical+progress+and+future+perspectives&doi=10.3109%2F08923973.2014.971963"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer vaccine adjuvants - recent clinical progress and future perspectives</span></div><div class="casAuthors">Banday, Abid H.; Jeelani, Salika; Hruby, Victor J.</div><div class="citationInfo"><span class="NLM_cas:title">Immunopharmacology and Immunotoxicology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-11</span>CODEN:
                <span class="NLM_cas:coden">IITOEF</span>;
        ISSN:<span class="NLM_cas:issn">0892-3973</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Despite recent breakthroughs in the prognosis, prevention and treatment, cancer still remains the leading cause of death and affects millions of people worldwide.  With the US FDA approval of various preventive cancer vaccines such as Gardasil (Merck), Cervarix (Glaxosmithkline) and the therapeutic vaccine Sipulencel-T (Provenge), cancer vaccine development is gaining huge ground.  Approval of these vaccines has encouraged the concept of cancer treatment through cellular immunotherapy.  The FDA approval of the above vaccines has provided support for renewed interest and attention which the development of new therapeutic cancer vaccines deserves.  However, most of the new generation vaccines including that for cancer are poorly immunogenic sub-unit vaccines and thus essentially need adjuvants in their formulations to compensate for the immune suppression.  Adjuvants are the essential components of a potent vaccine which increases the efficacy by enhancing the antigen-specific immune response.  However, the design of a successful adjuvant is not easy because of the complexity and the difficulty in designing adjuvants that are safe, potent and economically viable.  The present communication takes a short review of the advancements in adjuvant technol., current clin. scenario of new adjuvants and application of their molecularly defined formulations to new generation cancer vaccines which are currently under development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-wsYLBnvOGLVg90H21EOLACvtfcHk0lgibLYPxy7Tgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFaltLjK&md5=582f37c3159747eaa9bc068fbc258d30</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.3109%2F08923973.2014.971963&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F08923973.2014.971963%26sid%3Dliteratum%253Aachs%26aulast%3DBanday%26aufirst%3DA.%2BH.%26aulast%3DJeelani%26aufirst%3DS.%26aulast%3DHruby%26aufirst%3DV.%2BJ.%26atitle%3DCancer%2520vaccine%2520adjuvants%2520-%2520Recent%2520clinical%2520progress%2520and%2520future%2520perspectives%26jtitle%3DImmunopharmacol.%2520Immunotoxicol.%26date%3D2015%26volume%3D37%26spage%3D1%26epage%3D11%26doi%3D10.3109%2F08923973.2014.971963" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bastola, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noh, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keum, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bashyal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seo, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.</span></span> <span> </span><span class="NLM_article-title">Vaccine adjuvants: smart components to boost the immune system</span>. <i>Arch. Pharmacal Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">1238</span>– <span class="NLM_lpage">1248</span>, <span class="refDoi"> DOI: 10.1007/s12272-017-0969-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=10.1007%2Fs12272-017-0969-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=29027637" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1KgsrnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2017&pages=1238-1248&author=R.+Bastolaauthor=G.+Nohauthor=T.+Keumauthor=S.+Bashyalauthor=J.+E.+Seoauthor=J.+Choiauthor=Y.+Ohauthor=Y.+Choauthor=S.+Lee&title=Vaccine+adjuvants%3A+smart+components+to+boost+the+immune+system&doi=10.1007%2Fs12272-017-0969-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Vaccine adjuvants: smart components to boost the immune system</span></div><div class="casAuthors">Bastola, Rakesh; Noh, Gyubin; Keum, Taekwang; Bashyal, Santosh; Seo, Jo-Eun; Choi, Jaewoong; Oh, Yeonsu; Cho, YoungSik; Lee, Sangkil</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Pharmacal Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1238-1248</span>CODEN:
                <span class="NLM_cas:coden">APHRDQ</span>;
        ISSN:<span class="NLM_cas:issn">0253-6269</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Korea</span>)
        </div><div class="casAbstract">A review.  Vaccination is an effective approach to prevent the consequences of infectious diseases.  Vaccines strengthen immunity and make individuals resistant to infections with pathogens.  Although conventional vaccines are highly immunogenic, they are assocd. with some safety issues.  Subunit vaccines are safe, but they require adjuvants to stimulate the immune system because of their weaker immunogenicity.  Adjuvants are entities incorporated into vaccines to increase the immunogenic responses of antigens.  They play a crucial role in increasing the potency and efficacy of vaccines.  Different adjuvants have different modes of action; therefore, a better understanding of their immunol. could provide guidance for the development of novel adjuvants.  Numerous studies have been conducted using different types of adjuvants to characterize their potency and safety; however, in practice, only few are used in human or animal vaccines.  This review aims to introduce the different modes of action of adjuvants and give insight into the types of adjuvants that possess the greatest potential for adjuvanticity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZCN1ub0Y1rLVg90H21EOLACvtfcHk0lg_B8H1DKGSXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1KgsrnO&md5=8c32b5d1bcecc1b81cc0094a516bb3cc</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1007%2Fs12272-017-0969-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12272-017-0969-z%26sid%3Dliteratum%253Aachs%26aulast%3DBastola%26aufirst%3DR.%26aulast%3DNoh%26aufirst%3DG.%26aulast%3DKeum%26aufirst%3DT.%26aulast%3DBashyal%26aufirst%3DS.%26aulast%3DSeo%26aufirst%3DJ.%2BE.%26aulast%3DChoi%26aufirst%3DJ.%26aulast%3DOh%26aufirst%3DY.%26aulast%3DCho%26aufirst%3DY.%26aulast%3DLee%26aufirst%3DS.%26atitle%3DVaccine%2520adjuvants%253A%2520smart%2520components%2520to%2520boost%2520the%2520immune%2520system%26jtitle%3DArch.%2520Pharmacal%2520Res.%26date%3D2017%26volume%3D40%26spage%3D1238%26epage%3D1248%26doi%3D10.1007%2Fs12272-017-0969-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di
Pasquale, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Preiss, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tavares Da Silva, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcon, N.</span></span> <span> </span><span class="NLM_article-title">Vaccine Adjuvants: From 1920 to 2015 and Beyond</span>. <i>Vaccines (Basel, Switz.)</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">320</span>– <span class="NLM_lpage">343</span>, <span class="refDoi"> DOI: 10.3390/vaccines3020320</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=10.3390%2Fvaccines3020320" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=26343190" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=1%3ACAS%3A528%3ADC%252BC1cXlsFanu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2015&pages=320-343&author=A.+Di%0APasqualeauthor=S.+Preissauthor=F.+Tavares+Da+Silvaauthor=N.+Garcon&title=Vaccine+Adjuvants%3A+From+1920+to+2015+and+Beyond&doi=10.3390%2Fvaccines3020320"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Vaccine adjuvants: from 1920 to 2015 and beyond</span></div><div class="casAuthors">Di Pasquale, Alberta; Preiss, Scott; Tavares Da Silva, Fernanda; Garcon, Nathalie</div><div class="citationInfo"><span class="NLM_cas:title">Vaccines (Basel, Switzerland)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">320-343</span>CODEN:
                <span class="NLM_cas:coden">VBSABP</span>;
        ISSN:<span class="NLM_cas:issn">2076-393X</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">The concept of stimulating the body's immune response is the basis underlying vaccination.  Vaccines act by initiating the innate immune response and activating antigen presenting cells (APCs), thereby inducing a protective adaptive immune response to a pathogen antigen.  Adjuvants are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities, and have been used in human vaccines for more than 90 years.  While early adjuvants (aluminum, oil-in-water emulsions) were used empirically, rapidly increasing knowledge on how the immune system interacts with pathogens means that there is increased understanding of the role of adjuvants and how the formulation of modern vaccines can be better tailored towards the desired clin. benefit.  Continuing safety evaluation of licensed vaccines contg. adjuvants/adjuvant systems suggests that their individual benefit-risk profile remains favorable.  Adjuvants contribute to the initiation of the innate immune response induced by antigens; exemplified by inflammatory responses at the injection site, with mostly localized and short-lived effects.  Activated effectors (such as APCs) then move to draining lymph nodes where they direct the type, magnitude and quality of the adaptive immune response.  Thus, the right match of antigens and adjuvants can potentiate downstream adaptive immune responses, enabling the development of new efficacious vaccines.  Many infectious diseases of worldwide significance are not currently preventable by vaccination.  Adjuvants are the most advanced new technol. in the search for new vaccines against challenging pathogens and for vulnerable populations that respond poorly to traditional vaccines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFyT3gxZhwCbVg90H21EOLACvtfcHk0lg_B8H1DKGSXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXlsFanu78%253D&md5=c3fb1dccaf51d71fbac38a3204efae0c</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.3390%2Fvaccines3020320&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fvaccines3020320%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BPasquale%26aufirst%3DA.%26aulast%3DPreiss%26aufirst%3DS.%26aulast%3DTavares%2BDa%2BSilva%26aufirst%3DF.%26aulast%3DGarcon%26aufirst%3DN.%26atitle%3DVaccine%2520Adjuvants%253A%2520From%25201920%2520to%25202015%2520and%2520Beyond%26jtitle%3DVaccines%2520%2528Basel%252C%2520Switz.%2529%26date%3D2015%26volume%3D3%26spage%3D320%26epage%3D343%26doi%3D10.3390%2Fvaccines3020320" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Temizoz, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuroda, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishii, K. J.</span></span> <span> </span><span class="NLM_article-title">Vaccine adjuvants as potential cancer immunotherapeutics</span>. <i>Int. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">329</span>– <span class="NLM_lpage">338</span>, <span class="refDoi"> DOI: 10.1093/intimm/dxw015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=10.1093%2Fintimm%2Fdxw015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=27006304" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFOru7fE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2016&pages=329-338&author=B.+Temizozauthor=E.+Kurodaauthor=K.+J.+Ishii&title=Vaccine+adjuvants+as+potential+cancer+immunotherapeutics&doi=10.1093%2Fintimm%2Fdxw015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Vaccine adjuvants as potential cancer immunotherapeutics</span></div><div class="casAuthors">Temizoz, Burcu; Kuroda, Etsushi; Ishii, Ken J.</div><div class="citationInfo"><span class="NLM_cas:title">International Immunology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">329-338</span>CODEN:
                <span class="NLM_cas:coden">INIMEN</span>;
        ISSN:<span class="NLM_cas:issn">0953-8178</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Accumulated evidence obtained from various clin. trials and animal studies suggested that cancer vaccines need better adjuvants than those that are currently licensed, which include the most commonly used alum and incomplete Freund's adjuvant, because of either a lack of potent anti-tumor immunity or the induction of undesired immunity.  Several clin. trials using immunostimulatory adjuvants, particularly agonistic as well as non-agonistic ligands for TLRs, C-type lectin receptors, retinoic acid-inducible gene I-like receptors and stimulator of interferon genes, have revealed their therapeutic potential not only as vaccine adjuvants but also as anti-tumor agents.  Recently, combinations of such immunostimulatory or immunomodulatory adjuvants have shown superior efficacy over their singular use, suggesting that seeking optimal combinations of the currently available or well-characterized adjuvants may provide a better chance for the development of novel adjuvants for cancer immunotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpP5mJ4BDhOUrVg90H21EOLACvtfcHk0lg_B8H1DKGSXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFOru7fE&md5=92aa03134406c55673017cb24da45eb4</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1093%2Fintimm%2Fdxw015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fintimm%252Fdxw015%26sid%3Dliteratum%253Aachs%26aulast%3DTemizoz%26aufirst%3DB.%26aulast%3DKuroda%26aufirst%3DE.%26aulast%3DIshii%26aufirst%3DK.%2BJ.%26atitle%3DVaccine%2520adjuvants%2520as%2520potential%2520cancer%2520immunotherapeutics%26jtitle%3DInt.%2520Immunol.%26date%3D2016%26volume%3D28%26spage%3D329%26epage%3D338%26doi%3D10.1093%2Fintimm%2Fdxw015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">O’Hagan, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedland, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanon, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Didierlaurent, A. M.</span></span> <span> </span><span class="NLM_article-title">Towards an evidence based approach for the development of adjuvanted vaccines</span>. <i>Curr. Opin. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">93</span>– <span class="NLM_lpage">102</span>, <span class="refDoi"> DOI: 10.1016/j.coi.2017.07.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=10.1016%2Fj.coi.2017.07.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=28755542" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1WhsbvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2017&pages=93-102&author=D.+T.+O%E2%80%99Haganauthor=L.+R.+Friedlandauthor=E.+Hanonauthor=A.+M.+Didierlaurent&title=Towards+an+evidence+based+approach+for+the+development+of+adjuvanted+vaccines&doi=10.1016%2Fj.coi.2017.07.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Towards an evidence based approach for the development of adjuvanted vaccines</span></div><div class="casAuthors">O'Hagan, Derek T.; Friedland, Leonard R.; Hanon, Emmanuel; Didierlaurent, Arnaud M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Immunology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">93-102</span>CODEN:
                <span class="NLM_cas:coden">COPIEL</span>;
        ISSN:<span class="NLM_cas:issn">0952-7915</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">In the last two decades, several vaccines formulated with a new generation of adjuvants have been licensed or approved to target diseases such as influenza, hepatitis B, cervical cancer, and malaria.  These new generation adjuvants appear to work by delivering a localized activation signal to the innate immune system, which in turn promotes antigen-specific adaptive immunity.  Advances in understanding of the innate immune system together with high-throughput discovery of synthetic immune potentiators are now expanding the portfolio of new generation adjuvants available for evaluation.  Meanwhile, omics and systems biol. are providing mol. benchmarks or signatures to assess vaccine safety and effectiveness.  This accumulating knowledge and experience raises the prospect that the future selection of the right antigen/adjuvant combination can be more evidence based and can speed up the clin. development program for new adjuvanted vaccines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcySAov5jYBrVg90H21EOLACvtfcHk0lg_B8H1DKGSXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1WhsbvM&md5=6a764a037df0e03e71e6a5fe68fc323d</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.coi.2017.07.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coi.2017.07.010%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Hagan%26aufirst%3DD.%2BT.%26aulast%3DFriedland%26aufirst%3DL.%2BR.%26aulast%3DHanon%26aufirst%3DE.%26aulast%3DDidierlaurent%26aufirst%3DA.%2BM.%26atitle%3DTowards%2520an%2520evidence%2520based%2520approach%2520for%2520the%2520development%2520of%2520adjuvanted%2520vaccines%26jtitle%3DCurr.%2520Opin.%2520Immunol.%26date%3D2017%26volume%3D47%26spage%3D93%26epage%3D102%26doi%3D10.1016%2Fj.coi.2017.07.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Garçon, N.</span>; <span class="NLM_string-name">Leroux-Roels, G.</span>; <span class="NLM_string-name">Cheng, W.-F.</span></span> <span> </span><span class="NLM_article-title">Vaccine Adjuvants</span>. In  <i>Understanding Modern Vaccines Perspectives in Vaccinology</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garçon, N.</span>, <span class="NLM_string-name">Stern, P. L.</span>, <span class="NLM_string-name">Cunningham, A. L.</span></span>, Eds.; <span class="NLM_publisher-name">Elsevier</span>: <span class="NLM_publisher-loc">Amsterdam</span>, <span class="NLM_year">2011</span>; Vol.  <span class="NLM_volume">1</span>; pp  <span class="NLM_fpage">89</span>– <span class="NLM_lpage">113</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&pages=89-113&author=N.+Gar%C3%A7on&author=G.+Leroux-Roels&author=W.-F.+Chengauthor=N.+Gar%C3%A7on&author=P.+L.+Stern&author=A.+L.+Cunningham&title=Understanding+Modern+Vaccines+Perspectives+in+Vaccinology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DGar%25C3%25A7on%26aufirst%3DN.%26atitle%3DVaccine%2520Adjuvants%26btitle%3DUnderstanding%2520Modern%2520Vaccines%2520Perspectives%2520in%2520Vaccinology%26aulast%3DGar%25C3%25A7on%26aufirst%3DN.%26pub%3DElsevier%26date%3D2011%26volume%3D1%26spage%3D89%26epage%3D113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harandi, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medaglini, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shattock, R. J.</span></span> <span> </span><span class="NLM_article-title">Working Group convened by EUROPRISE. Vaccine adjuvants: a priority for vaccine research</span>. <i>Vaccine</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">2363</span>– <span class="NLM_lpage">2366</span>, <span class="refDoi"> DOI: 10.1016/j.vaccine.2009.12.084</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=10.1016%2Fj.vaccine.2009.12.084" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=20064476" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=1%3ACAS%3A280%3ADC%252BC3c7nsF2muw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2010&pages=2363-2366&author=A.+M.+Harandiauthor=D.+Medagliniauthor=R.+J.+Shattock&title=Working+Group+convened+by+EUROPRISE.+Vaccine+adjuvants%3A+a+priority+for+vaccine+research&doi=10.1016%2Fj.vaccine.2009.12.084"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Vaccine adjuvants: a priority for vaccine research</span></div><div class="casAuthors">Harandi Ali M; Medaglini Donata; Shattock Robin J</div><div class="citationInfo"><span class="NLM_cas:title">Vaccine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2363-6</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The workshop on vaccine adjuvants was held in July of 2009 at the European Commission in Brussels, with the goal of identifying key scientific priorities as they pertain to the development of effective vaccines against life-threatening diseases especially those associated with poverty, including HIV/AIDS, malaria and tuberculosis as well as neglected infectious diseases.  On the basis of new advances in adjuvant research and related technology as well as potential challenges and roadblocks, six priorities were identified to accelerate development of improved or novel vaccine adjuvants for human use.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSivWj553HudAyMywPm6HgQfW6udTcc2eafM9jLqKIUdbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3c7nsF2muw%253D%253D&md5=e4cd9efcd73d1051ce8ab76e3ff08dc5</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.vaccine.2009.12.084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.vaccine.2009.12.084%26sid%3Dliteratum%253Aachs%26aulast%3DHarandi%26aufirst%3DA.%2BM.%26aulast%3DMedaglini%26aufirst%3DD.%26aulast%3DShattock%26aufirst%3DR.%2BJ.%26atitle%3DWorking%2520Group%2520convened%2520by%2520EUROPRISE.%2520Vaccine%2520adjuvants%253A%2520a%2520priority%2520for%2520vaccine%2520research%26jtitle%3DVaccine%26date%3D2010%26volume%3D28%26spage%3D2363%26epage%3D2366%26doi%3D10.1016%2Fj.vaccine.2009.12.084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bowen, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Svrivastava, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batra, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barsoumian, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shirwan, H.</span></span> <span> </span><span class="NLM_article-title">Current challenges for cancer vaccine adjuvant development</span>. <i>Expert Rev. Vaccines</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">207</span>– <span class="NLM_lpage">215</span>, <span class="refDoi"> DOI: 10.1080/14760584.2018.1434000</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=10.1080%2F14760584.2018.1434000" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=29372660" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVKgtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2018&pages=207-215&author=W.+S.+Bowenauthor=A.+K.+Svrivastavaauthor=L.+Batraauthor=H.+Barsoumianauthor=H.+Shirwan&title=Current+challenges+for+cancer+vaccine+adjuvant+development&doi=10.1080%2F14760584.2018.1434000"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Current challenges for cancer vaccine adjuvant development</span></div><div class="casAuthors">Bowen, William S.; Svrivastava, Abhishek K.; Batra, Lalit; Barsoumian, Hampartsoum; Shirwan, Haval</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Vaccines</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">207-215</span>CODEN:
                <span class="NLM_cas:coden">ERVXAX</span>;
        ISSN:<span class="NLM_cas:issn">1476-0584</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">: Although much progress has been made in the last decade(s) toward development of effective cancer vaccines, there are still important obstacles to therapeutic successes.  New generations of cancer vaccines will benefit from a combination adjuvant approach that targets multiple branches of the immune response.: Herein we describe how combinatorial adjuvant strategies can help overcome important obstacles to cancer vaccine development, including antigen immunogenicity and tumor immune suppression.  Tumor antigens may be both tolerogenic and may utilize active mechanisms to suppress host immunity, including downregulation of MHC mols. to evade recognition and upregulation of immune inhibitory receptors, to subvert an effective immune response.  The current cancer vaccine literature was surveyed to identify advancements in the understanding of the biol. mechanisms underlying poor antigen immunogenicity and tumor immune evasion, as well as adjuvant strategies designed to overcome them.: Poor immunogenicity of tumor antigens and tumor immune evasion mechanisms make the design of cancer vaccines challenging.  Growing understanding of the tumor microenvironment and assocd. immune responses indicate the importance of augmenting not only the effector response, but also overcoming the endogenous regulatory response and tumor evasion mechanisms.  Therefore, new vaccines will benefit from multi-adjuvanted approaches that simultaneously stimulate immunity while preventing inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruqNXpJ6DAkbVg90H21EOLACvtfcHk0lilFZNyX0q13A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVKgtrs%253D&md5=3910ef73b0edeb5570c8b516870b5f00</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1080%2F14760584.2018.1434000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F14760584.2018.1434000%26sid%3Dliteratum%253Aachs%26aulast%3DBowen%26aufirst%3DW.%2BS.%26aulast%3DSvrivastava%26aufirst%3DA.%2BK.%26aulast%3DBatra%26aufirst%3DL.%26aulast%3DBarsoumian%26aufirst%3DH.%26aulast%3DShirwan%26aufirst%3DH.%26atitle%3DCurrent%2520challenges%2520for%2520cancer%2520vaccine%2520adjuvant%2520development%26jtitle%3DExpert%2520Rev.%2520Vaccines%26date%3D2018%26volume%3D17%26spage%3D207%26epage%3D215%26doi%3D10.1080%2F14760584.2018.1434000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brito, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Hagan, D. T.</span></span> <span> </span><span class="NLM_article-title">Designing and building the next generation of improved vaccine adjuvants</span>. <i>J. Controlled Release</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>190</i></span>,  <span class="NLM_fpage">563</span>– <span class="NLM_lpage">579</span>, <span class="refDoi"> DOI: 10.1016/j.jconrel.2014.06.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=10.1016%2Fj.jconrel.2014.06.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=24998942" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFOjt7%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=190&publication_year=2014&pages=563-579&author=L.+A.+Britoauthor=D.+T.+O%E2%80%99Hagan&title=Designing+and+building+the+next+generation+of+improved+vaccine+adjuvants&doi=10.1016%2Fj.jconrel.2014.06.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Designing and building the next generation of improved vaccine adjuvants</span></div><div class="casAuthors">Brito, Luis A.; O'Hagan, Derek T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Controlled Release</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">190</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">563-579</span>CODEN:
                <span class="NLM_cas:coden">JCREEC</span>;
        ISSN:<span class="NLM_cas:issn">0168-3659</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Vaccine adjuvants interact with the immune system, to increase the potency of vaccine antigens.  Many of the adjuvants currently available were developed with little understanding of how they worked.  Highly pure recombinant antigens are typically very poorly immunogenic due to a lack of exogenous immune activating components such as nucleic acids, lipids, and cell membrane components.  In this review we discuss the role of adjuvants and their role as 'delivery systems' or 'immune potentiators'.  We also highlight the need for appropriate delivery of immune potentiators with several 'delivery system' adjuvants such as alum, emulsions, liposomes, and polymeric particles.  The challenges faced by vaccinologists to create the next generation of vaccines can be solved in-part by developing a greater understanding of the impact of delivery, and an appreciation of the key role of pharmaceutical sciences.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2YXLm6MLzCLVg90H21EOLACvtfcHk0lilFZNyX0q13A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFOjt7%252FE&md5=01052901ac692e712f9418540fceb593</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.jconrel.2014.06.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jconrel.2014.06.027%26sid%3Dliteratum%253Aachs%26aulast%3DBrito%26aufirst%3DL.%2BA.%26aulast%3DO%25E2%2580%2599Hagan%26aufirst%3DD.%2BT.%26atitle%3DDesigning%2520and%2520building%2520the%2520next%2520generation%2520of%2520improved%2520vaccine%2520adjuvants%26jtitle%3DJ.%2520Controlled%2520Release%26date%3D2014%26volume%3D190%26spage%3D563%26epage%3D579%26doi%3D10.1016%2Fj.jconrel.2014.06.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Didierlaurent, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laupeze, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Pasquale, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hergli, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collignon, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcon, N.</span></span> <span> </span><span class="NLM_article-title">Adjuvant system AS01: helping to overcome the challenges of modern vaccines</span>. <i>Expert Rev. Vaccines</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">55</span>– <span class="NLM_lpage">63</span>, <span class="refDoi"> DOI: 10.1080/14760584.2016.1213632</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=10.1080%2F14760584.2016.1213632" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=27448771" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1ygurfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&pages=55-63&author=A.+M.+Didierlaurentauthor=B.+Laupezeauthor=A.+Di+Pasqualeauthor=N.+Hergliauthor=C.+Collignonauthor=N.+Garcon&title=Adjuvant+system+AS01%3A+helping+to+overcome+the+challenges+of+modern+vaccines&doi=10.1080%2F14760584.2016.1213632"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Adjuvant system AS01: helping to overcome the challenges of modern vaccines</span></div><div class="casAuthors">Didierlaurent, Arnaud M.; Laupeze, Beatrice; Di Pasquale, Alberta; Hergli, Nadia; Collignon, Catherine; Garcon, Nathalie</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Vaccines</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">55-63</span>CODEN:
                <span class="NLM_cas:coden">ERVXAX</span>;
        ISSN:<span class="NLM_cas:issn">1476-0584</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">: Adjuvants are used to improve vaccine immunogenicity and efficacy by enhancing antigen presentation to antigen-specific immune cells with the aim to confer long-term protection against targeted pathogens.  Adjuvants have been used in vaccines for more than 90 years.  Combinations of immunostimulatory mols., such as in the Adjuvant System AS01, have opened the way to the development of new or improved vaccines.: AS01 is a liposome-based vaccine adjuvant system contg. two immunostimulants: 3-O-desacyl-4'-monophosphoryl lipid A (MPL) and the saponin QS-21.  Here we describe studies investigating the mode of action of AS01, and consider the role of AS01 in enhancing specific immune responses to the antigen for selected candidate vaccines targeting malaria and herpes zoster.  The effects of AS01 are rapid and transient, being localized to the injected muscle and draining lymph node.  AS01 is efficient at promoting CD4+ T cell-mediated immune responses and is an appropriate candidate adjuvant for inclusion in vaccines targeting viruses or intracellular pathogens.: AS01 activity to enhance adaptive responses depends on synergistic activities of QS-21 and MPL.  AS01 adjuvantation shows good prospects for use in new vaccines targeted to populations with challenging immune statuses and against diseases caused by complex pathogens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrypUW00VPSPbVg90H21EOLACvtfcHk0ljC_bsgw9AeJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1ygurfF&md5=715022fe094be1b814d6b79ff2171bd6</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1080%2F14760584.2016.1213632&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F14760584.2016.1213632%26sid%3Dliteratum%253Aachs%26aulast%3DDidierlaurent%26aufirst%3DA.%2BM.%26aulast%3DLaupeze%26aufirst%3DB.%26aulast%3DDi%2BPasquale%26aufirst%3DA.%26aulast%3DHergli%26aufirst%3DN.%26aulast%3DCollignon%26aufirst%3DC.%26aulast%3DGarcon%26aufirst%3DN.%26atitle%3DAdjuvant%2520system%2520AS01%253A%2520helping%2520to%2520overcome%2520the%2520challenges%2520of%2520modern%2520vaccines%26jtitle%3DExpert%2520Rev.%2520Vaccines%26date%3D2017%26volume%3D16%26spage%3D55%26epage%3D63%26doi%3D10.1080%2F14760584.2016.1213632" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">James, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chahine, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sucher, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanna, C.</span></span> <span> </span><span class="NLM_article-title">Shingrix: The New Adjuvanted Recombinant Herpes Zoster Vaccine</span>. <i>Ann. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">673</span>– <span class="NLM_lpage">680</span>, <span class="refDoi"> DOI: 10.1177/1060028018758431</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=10.1177%2F1060028018758431" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=29457489" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtVyjsLrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2018&pages=673-680&author=S.+F.+Jamesauthor=E.+B.+Chahineauthor=A.+J.+Sucherauthor=C.+Hanna&title=Shingrix%3A+The+New+Adjuvanted+Recombinant+Herpes+Zoster+Vaccine&doi=10.1177%2F1060028018758431"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Shingrix: The New Adjuvanted Recombinant Herpes Zoster Vaccine</span></div><div class="casAuthors">James, Stephanie F.; Chahine, Elias B.; Sucher, Allana J.; Hanna, Cassandra</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Pharmacotherapy</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">673-680</span>CODEN:
                <span class="NLM_cas:coden">APHRER</span>;
        ISSN:<span class="NLM_cas:issn">1542-6270</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">Objectives: To review the immunogenicity, efficacy, and safety of the herpes zoster subunit vaccine (HZ/su) for use in adult patients for the prevention of shingles.  Data Sources: A literature search through PubMed was conducted (June 2008 to Oct. 2017) using the terms shingles vaccine and varicella zoster virus.  Refs. from retrieved articles and the prescribing information were also reviewed for any addnl. material.  Study Selection/Data Extn.: The literature search was limited to human studies published in English.  Randomized controlled, multicenter trials were reviewed and included to evaluate the safety and efficacy of HZ/su.  Literature on the epidemiol. and pathol. of herpes zoster virus infections and recommendations from the Advisory Committee on Immunization Practices (ACIP) were also reviewed.  Data Synthesis: HZ/su is a new adjuvanted recombinant vaccine approved by the Food and Drug Administration for the prevention of herpes zoster in adults 50 years of age and older.  HZ/su significantly reduced the risk of developing herpes zoster by more than 90% as compared with placebo and displayed a comparable adverse effect profile.  The most common local adverse events were injection site pain, redness, and swelling, and the most common systemic adverse events were myalgia, fatigue, and headache.  The ACIP recommends the routine use of HZ/su as the preferred vaccine for the prevention of herpes zoster in immunocompetent adults 50 years of age and older.  Conclusions: Based on published immunogenicity, efficacy, and safety data, as well as the recent recommendations by the ACIP, HZ/su should be included on both hospital and community pharmacy formularies and recommended to all immunocompetent patients older than 50 years to prevent herpes zoster.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVl2Mpn_0xk7Vg90H21EOLACvtfcHk0ljC_bsgw9AeJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtVyjsLrP&md5=91df49dd0441656ccf20a656fa2163d9</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1177%2F1060028018758431&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1060028018758431%26sid%3Dliteratum%253Aachs%26aulast%3DJames%26aufirst%3DS.%2BF.%26aulast%3DChahine%26aufirst%3DE.%2BB.%26aulast%3DSucher%26aufirst%3DA.%2BJ.%26aulast%3DHanna%26aufirst%3DC.%26atitle%3DShingrix%253A%2520The%2520New%2520Adjuvanted%2520Recombinant%2520Herpes%2520Zoster%2520Vaccine%26jtitle%3DAnn.%2520Pharmacother.%26date%3D2018%26volume%3D52%26spage%3D673%26epage%3D680%26doi%3D10.1177%2F1060028018758431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kensil, C. R.</span></span> <span> </span><span class="NLM_article-title">Saponins as vaccine adjuvants</span>. <i>Crit. Rev. Ther. Drug Carrier Syst.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">55</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=8853958" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=1%3ACAS%3A528%3ADyaK28XlsV2qt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1996&pages=1-55&author=C.+R.+Kensil&title=Saponins+as+vaccine+adjuvants"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Saponins as vaccine adjuvants</span></div><div class="casAuthors">Kensil, Charlotte Read</div><div class="citationInfo"><span class="NLM_cas:title">Critical Reviews in Therapeutic Drug Carrier Systems</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">1&2</span>),
    <span class="NLM_cas:pages">1-55</span>CODEN:
                <span class="NLM_cas:coden">CRTSEO</span>;
        ISSN:<span class="NLM_cas:issn">0743-4863</span>.
    
            (<span class="NLM_cas:orgname">Begell House</span>)
        </div><div class="casAbstract">A review with 178 refs.  Naturally occurring triterpene glycosides (saponins) from Quillaja saponaria have considerable adjuvant activity.  Adjuvant functions include stimulation of high levels of antibody to T-dependent and T-independent antigens, induction of mouse IgG1, IgG2b, and IgG2a isotypes, and induction of cytotoxic T lymphocyte responses.  This article reviews responses due to specific saponins or saponin prepns., the effect of formulation, structure/function studies, and use in different preclin. and clin. vaccine applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWkslKgTe3RrVg90H21EOLACvtfcHk0ljC_bsgw9AeJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XlsV2qt7g%253D&md5=06732e4c95d059fb550418380e5cd530</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKensil%26aufirst%3DC.%2BR.%26atitle%3DSaponins%2520as%2520vaccine%2520adjuvants%26jtitle%3DCrit.%2520Rev.%2520Ther.%2520Drug%2520Carrier%2520Syst.%26date%3D1996%26volume%3D13%26spage%3D1%26epage%3D55" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kensil, C. R.</span>; <span class="NLM_string-name">Liu, G.</span>; <span class="NLM_string-name">Anderson, C.</span>; <span class="NLM_string-name">Storey, J.</span></span> <span> </span><span class="NLM_article-title">Effects of QS-21 on Innate and Adaptive Immune Responses</span>. In  <i>Vaccine Adjuvants: Immunological and Clinical Principles</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hackett, C. J.</span>, <span class="NLM_string-name">Harn, D. A. J.</span></span>, Eds.; <span class="NLM_publisher-name">Humana Press Inc</span>: <span class="NLM_publisher-loc">Totowa, NJ</span>, <span class="NLM_year">2005</span>; pp  <span class="NLM_fpage">221</span>– <span class="NLM_lpage">234</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&pages=221-234&author=C.+R.+Kensil&author=G.+Liu&author=C.+Anderson&author=J.+Storeyauthor=C.+J.+Hackett&author=D.+A.+J.+Harn&title=Vaccine+Adjuvants%3A+Immunological+and+Clinical+Principles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DKensil%26aufirst%3DC.%2BR.%26atitle%3DEffects%2520of%2520QS-21%2520on%2520Innate%2520and%2520Adaptive%2520Immune%2520Responses%26btitle%3DVaccine%2520Adjuvants%253A%2520Immunological%2520and%2520Clinical%2520Principles%26aulast%3DHackett%26aufirst%3DC.%2BJ.%26pub%3DHumana%2520Press%2520Inc%26date%3D2005%26spage%3D221%26epage%3D234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kensil, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lennick, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marciani, D.</span></span> <span> </span><span class="NLM_article-title">Separation and characterization of saponins with adjuvant activity from Quillaja saponaria Molina cortex</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>146</i></span>,  <span class="NLM_fpage">431</span>– <span class="NLM_lpage">437</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=1987271" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=1%3ACAS%3A528%3ADyaK3MXit1Sqt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=146&publication_year=1991&pages=431-437&author=C.+R.+Kensilauthor=U.+Patelauthor=M.+Lennickauthor=D.+Marciani&title=Separation+and+characterization+of+saponins+with+adjuvant+activity+from+Quillaja+saponaria+Molina+cortex"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Separation and characterization of saponins with adjuvant activity from Quillaja saponaria Molina cortex</span></div><div class="casAuthors">Kensil, Charlotte R.; Patel, Usha; Lennick, Michael; Marciani, Dante</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">146</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">431-7</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    </div><div class="casAbstract">Saponins were purified from Q. saponaria Molina bark by silica and reverse-phase chromatog.  The resulting purified saponins were tested for adjuvant activity in mice.  Several distinct saponins, designated QS-7, QS-17, QS-18, and QS-21, were demonstrated to boost antibody levels 100-fold or more when used in mouse immunizations with the Ag BSA and beef liver cytochrome b5.  These purified saponins increased titers in all major IgG subclasses.  To det. optimal dose in mice for adjuvant response, QS-7 and QS-21 were tested in a dose-response study in intradermal immunization with BSA in mice; for both of these purified saponins, adjuvant response (detd. by stimulation of ELISA titers to BSA) neared max. at doses of 5 μg and was shown to plateau up to the highest dose tested, 80 μg.  These purified saponins vary considerably in their toxicity, as assessed by lethality in mice (the main component, QS-18, being the most toxic).  Saponins QS-7 and QS-21 showed no or very low toxicity in mice, resp.  None of these saponins stimulated prodn. of reaginic antibodies.  The monosaccharide compn. of these saponins showed similar but distinct compns. with all four contg. fucose, xylose, galactose, and glucuronic acid.  Predominant differences were obsd. in the quantities of rhamnose, arabinose, and glucose.  Monomer mol. wt. (detd. by size exclusion HPLC) were detd. to range from 1800 to 2200.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrl3t6nXiv1D7Vg90H21EOLACvtfcHk0lhl2iu1zvEaWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXit1Sqt78%253D&md5=da3c2d6d078a0f85e0913d62be46897d</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKensil%26aufirst%3DC.%2BR.%26aulast%3DPatel%26aufirst%3DU.%26aulast%3DLennick%26aufirst%3DM.%26aulast%3DMarciani%26aufirst%3DD.%26atitle%3DSeparation%2520and%2520characterization%2520of%2520saponins%2520with%2520adjuvant%2520activity%2520from%2520Quillaja%2520saponaria%2520Molina%2520cortex%26jtitle%3DJ.%2520Immunol.%26date%3D1991%26volume%3D146%26spage%3D431%26epage%3D437" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ragupathi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardner, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Livingston, P. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gin, D. Y.</span></span> <span> </span><span class="NLM_article-title">Natural and synthetic saponin adjuvant QS-21 for vaccines against cancer</span>. <i>Expert Rev. Vaccines</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">463</span>– <span class="NLM_lpage">470</span>, <span class="refDoi"> DOI: 10.1586/erv.11.18</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=10.1586%2Ferv.11.18" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=21506644" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkvF2itb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=463-470&author=G.+Ragupathiauthor=J.+R.+Gardnerauthor=P.+O.+Livingstonauthor=D.+Y.+Gin&title=Natural+and+synthetic+saponin+adjuvant+QS-21+for+vaccines+against+cancer&doi=10.1586%2Ferv.11.18"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Natural and synthetic saponin adjuvant QS-21 for vaccines against cancer</span></div><div class="casAuthors">Ragupathi, Govind; Gardner, Jeffrey R.; Livingston, Philip O.; Gin, David Y.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Vaccines</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">463-470</span>CODEN:
                <span class="NLM_cas:coden">ERVXAX</span>;
        ISSN:<span class="NLM_cas:issn">1476-0584</span>.
    
            (<span class="NLM_cas:orgname">Expert Reviews Ltd.</span>)
        </div><div class="casAbstract">A review.  One of the most widely used and potent immunol. adjuvants is a mixt. of sol. triterpene glycosides purified from the soap bark tree (Quillaja saponaria).  Despite challenges in prodn., quality control, stability and toxicity, the QS-21 fraction from this ext. has exhibited exceptional adjuvant properties for a range of antigens.  It possesses an ability to augment clin. significant antibody and T-cell responses to vaccine antigens against a variety of infectious diseases, degenerative disorders and cancers.  The recent synthesis of active mols. of QS-21 has provided a robust method to produce this leading vaccine adjuvant in high purity as well as to produce novel synthetic QS-21 congeners designed to induce increased immune responsiveness and decreased toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOeMw38V5PxbVg90H21EOLACvtfcHk0lhl2iu1zvEaWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkvF2itb8%253D&md5=43f901c70c5e4a8b6a913544ac8a673b</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1586%2Ferv.11.18&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252Ferv.11.18%26sid%3Dliteratum%253Aachs%26aulast%3DRagupathi%26aufirst%3DG.%26aulast%3DGardner%26aufirst%3DJ.%2BR.%26aulast%3DLivingston%26aufirst%3DP.%2BO.%26aulast%3DGin%26aufirst%3DD.%2BY.%26atitle%3DNatural%2520and%2520synthetic%2520saponin%2520adjuvant%2520QS-21%2520for%2520vaccines%2520against%2520cancer%26jtitle%3DExpert%2520Rev.%2520Vaccines%26date%3D2011%26volume%3D10%26spage%3D463%26epage%3D470%26doi%3D10.1586%2Ferv.11.18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kamstrup, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">San Martin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doberti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grande, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalsgaard, K.</span></span> <span> </span><span class="NLM_article-title">Preparation and characterisation of Quillaja saponin with less heterogeneity than Quil-A</span>. <i>Vaccine</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">2244</span>– <span class="NLM_lpage">2249</span>, <span class="refDoi"> DOI: 10.1016/S0264-410X(99)00560-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=10.1016%2FS0264-410X%2899%2900560-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=10717344" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjsFGhu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2000&pages=2244-2249&author=S.+Kamstrupauthor=R.+San+Martinauthor=A.+Dobertiauthor=H.+Grandeauthor=K.+Dalsgaard&title=Preparation+and+characterisation+of+Quillaja+saponin+with+less+heterogeneity+than+Quil-A&doi=10.1016%2FS0264-410X%2899%2900560-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Preparation and characterisation of quillaja saponin with less heterogeneity than Quil-A</span></div><div class="casAuthors">Kamstrup, Soren; San Martin, Ricardo; Doberti, Alfredo; Grande, Hans; Dalsgaard, Kristian</div><div class="citationInfo"><span class="NLM_cas:title">Vaccine</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">2244-2249</span>CODEN:
                <span class="NLM_cas:coden">VACCDE</span>;
        ISSN:<span class="NLM_cas:issn">0264-410X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Immunization against pathogens remains one of the most effective ways of preventing or reducing losses due to infectious diseases in animal husbandry.  When inactivated vaccines are used, adjuvants are most often required to obtain satisfactory immune responses.  One such type of adjuvant is saponin derived from the bark of Quillaja saponaria Molina, a tree of the rose family.  A few different com. sources exist, but due to the structural complexity and heterogeneity of these saponin prepns., it has been difficult to establish exactly which components are responsible for the adjuvant activity.  By carefully selecting the bark source, we have succeeded in prepg. a much less heterogeneous prepn. of quillaja saponin.  In this report we describe the prepn., in terms of structural complexity, hemolytic activity, adjuvant activity, and its ability to form ISCOM matrix.  This new prepn. could have implications for use per se, or as starting material for more effective prepn. of pure substances.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTPF0Zbg-5bLVg90H21EOLACvtfcHk0lhl2iu1zvEaWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjsFGhu7c%253D&md5=f74d761c5aa76caa00f6a518e4e43dce</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2FS0264-410X%2899%2900560-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0264-410X%252899%252900560-5%26sid%3Dliteratum%253Aachs%26aulast%3DKamstrup%26aufirst%3DS.%26aulast%3DSan%2BMartin%26aufirst%3DR.%26aulast%3DDoberti%26aufirst%3DA.%26aulast%3DGrande%26aufirst%3DH.%26aulast%3DDalsgaard%26aufirst%3DK.%26atitle%3DPreparation%2520and%2520characterisation%2520of%2520Quillaja%2520saponin%2520with%2520less%2520heterogeneity%2520than%2520Quil-A%26jtitle%3DVaccine%26date%3D2000%26volume%3D18%26spage%3D2244%26epage%3D2249%26doi%3D10.1016%2FS0264-410X%2899%2900560-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martin, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Briones, R.</span></span> <span> </span><span class="NLM_article-title">Industrial uses and sustainable supply of <i>Quillaja Saponaria</i> (Rosaceae) Saponins</span>. <i>Econ. Bot.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">302</span>– <span class="NLM_lpage">311</span>, <span class="refDoi"> DOI: 10.1007/BF02866642</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=10.1007%2FBF02866642" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1999&pages=302-311&author=R.+S.+Martinauthor=R.+Briones&title=Industrial+uses+and+sustainable+supply+of+Quillaja+Saponaria+%28Rosaceae%29+Saponins&doi=10.1007%2FBF02866642"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1007%2FBF02866642&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF02866642%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DR.%2BS.%26aulast%3DBriones%26aufirst%3DR.%26atitle%3DIndustrial%2520uses%2520and%2520sustainable%2520supply%2520of%2520Quillaja%2520Saponaria%2520%2528Rosaceae%2529%2520Saponins%26jtitle%3DEcon.%2520Bot.%26date%3D1999%26volume%3D53%26spage%3D302%26epage%3D311%26doi%3D10.1007%2FBF02866642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scaltreto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kensil, C. R.</span></span> <span> </span><span class="NLM_article-title">QS-21 structure/function studies: effect of acylation on adjuvant activity</span>. <i>Vaccine</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">2808</span>– <span class="NLM_lpage">2815</span>, <span class="refDoi"> DOI: 10.1016/S0264-410X(02)00209-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=10.1016%2FS0264-410X%2802%2900209-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=12034108" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=1%3ACAS%3A528%3ADC%252BD38XktVCrurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2002&pages=2808-2815&author=G.+Liuauthor=C.+Andersonauthor=H.+Scaltretoauthor=J.+Barbonauthor=C.+R.+Kensil&title=QS-21+structure%2Ffunction+studies%3A+effect+of+acylation+on+adjuvant+activity&doi=10.1016%2FS0264-410X%2802%2900209-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">QS-21 structure/function studies: effect of acylation on adjuvant activity</span></div><div class="casAuthors">Liu, Gui; Anderson, Christine; Scaltreto, Heidi; Barbon, Jeffrey; Kensil, Charlotte R.</div><div class="citationInfo"><span class="NLM_cas:title">Vaccine</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">21-22</span>),
    <span class="NLM_cas:pages">2808-2815</span>CODEN:
                <span class="NLM_cas:coden">VACCDE</span>;
        ISSN:<span class="NLM_cas:issn">0264-410X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">QS-21 is a natural saponin adjuvant derived from the tree Quillaja saponaria Molina.  Previous studies over a limited dose range suggested the acylation is crit. to adjuvant activity.  In this study, the authors prepd. DS-1 (deacylated QS-21) and RDS-1 (reacylated DS-1 with dodecylamine at a different site than QS-21) to det. the effect on a dose-response curve over a wider range in mice.  DS-1 and RDS-1 induced IgG1 responses at higher doses compared to that induced by QS-21.  DS-1 was inactive for inducing IgG2a or CTL responses at any doses.  RDS-1 showed moderate IgG2a response at 240 μg, but did not show CTL response at any dose evaluated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoygzLdmmKH7Vg90H21EOLACvtfcHk0lh9xfhweXuybg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XktVCrurk%253D&md5=d33bf4281d08ba836e211e77ddc55436</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2FS0264-410X%2802%2900209-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0264-410X%252802%252900209-8%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DAnderson%26aufirst%3DC.%26aulast%3DScaltreto%26aufirst%3DH.%26aulast%3DBarbon%26aufirst%3DJ.%26aulast%3DKensil%26aufirst%3DC.%2BR.%26atitle%3DQS-21%2520structure%252Ffunction%2520studies%253A%2520effect%2520of%2520acylation%2520on%2520adjuvant%2520activity%26jtitle%3DVaccine%26date%3D2002%26volume%3D20%26spage%3D2808%26epage%3D2815%26doi%3D10.1016%2FS0264-410X%2802%2900209-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pillion, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amsden, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kensil, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Recchia, J.</span></span> <span> </span><span class="NLM_article-title">Structure-function relationship among Quillaja saponins serving as excipients for nasal and ocular delivery of insulin</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>85</i></span>,  <span class="NLM_fpage">518</span>– <span class="NLM_lpage">524</span>, <span class="refDoi"> DOI: 10.1021/js9504651</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=10.1021%2Fjs9504651" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=8742944" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=1%3ACAS%3A528%3ADyaK28XitFCqtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=1996&pages=518-524&author=D.+J.+Pillionauthor=J.+A.+Amsdenauthor=C.+R.+Kensilauthor=J.+Recchia&title=Structure-function+relationship+among+Quillaja+saponins+serving+as+excipients+for+nasal+and+ocular+delivery+of+insulin&doi=10.1021%2Fjs9504651"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Function Relationship among Quillaja Saponins Serving as Excipients for Nasal and Ocular Delivery of Insulin</span></div><div class="casAuthors">Pillion, Dennis J.; Amsden, Jennifer A.; Kensil, Charlotte R.; Recchia, Joanne</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">518-24</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The purpose of this investigation was to explore the structure-function relationship among naturally occurring Quillaja saponins and derivs. for their ability to stimulate insulin delivery from nosedrops and eyedrops and to test the hypothesis that stimulation of peptide drug delivery was correlated with surfactant strength.  Native saponins, including QS-21, were purified from an aq. ext. of Quillaja saponaria bark by adsorption chromatog. and HPLC.  Native saponins were then deacylated by mild alk. hydrolysis to form DS-1 and DS-2, derivs. that are smaller and more hydrophilic than their parent compds.  DS-1 was further treated either to reduce an aldehyde residue to form DS-1(R) or to remove the fucose-contg. oligosaccharide to form QH-957.  Rats receiving eyedrops or nosedrops formulated with insulin, but without any Quillaja saponins, showed no hypoglycemic response.  Rats receiving eyedrops or nosedrops formulated with insulin plus saponins showed a dose-dependent hypoglycemic response, with the following rank order: QS-21 > DS-1 > DS-1(R) > DS-2 > QH-957.  Surfactant strength was detd. by measurement of the crit. micellar concn. (cmc) and hemolysis of sheep erythrocytes.  The cmc was lowest for the parent saponins QS-21 and QS-18, and increased for the deacylated saponin derivs. DS-1, DS-2, and QH-957; hemolysis of sheep erythrocytes was obsd. at low concns. (∼0.006 mM) of the parent saponins, QS-21 and QS-18, at intermediate concns. (0.06-0.08 mM) of DS-1 and DS-2, and at higher concns. of DS-1(R) (0.45 mM) and QH-957 (1.5 mM).  Hence, efficacy as an absorption-enhancing agent was greatest in those saponins with the lowest hemolytic titers and cmc values.  However, this relationship was not a strict one, because DS-1, which differs from DS-2 only in the absence of one glucose residue, was significantly more potent than DS-2 in stimulating the absorption of insulin.  DS-1 and DS-2 share a similar cmc and hemolytic titer, so this difference in efficacy must be due to some specificity beyond simple surfactant strength.  Furthermore, DS-1 does not trigger an immune response when administered to animals, whereas QS-21 is a strong immune system activator.  Therefore, DS-1 has emerged as an interesting candidate for inclusion in an eyedrop or nosedrop formulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKYcWkSEcWFrVg90H21EOLACvtfcHk0lh9xfhweXuybg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XitFCqtrw%253D&md5=52265aea98787f99577f8daaa861fff6</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjs9504651&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjs9504651%26sid%3Dliteratum%253Aachs%26aulast%3DPillion%26aufirst%3DD.%2BJ.%26aulast%3DAmsden%26aufirst%3DJ.%2BA.%26aulast%3DKensil%26aufirst%3DC.%2BR.%26aulast%3DRecchia%26aufirst%3DJ.%26atitle%3DStructure-function%2520relationship%2520among%2520Quillaja%2520saponins%2520serving%2520as%2520excipients%2520for%2520nasal%2520and%2520ocular%2520delivery%2520of%2520insulin%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D1996%26volume%3D85%26spage%3D518%26epage%3D524%26doi%3D10.1021%2Fjs9504651" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thogaripally, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michalek, S. M.</span></span> <span> </span><span class="NLM_article-title">Synthesis of QS-21-based immunoadjuvants</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>78</i></span>,  <span class="NLM_fpage">11525</span>– <span class="NLM_lpage">11534</span>, <span class="refDoi"> DOI: 10.1021/jo402118j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo402118j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1KktLfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2013&pages=11525-11534&author=P.+Wangauthor=Q.+Daiauthor=P.+Thogaripallyauthor=P.+Zhangauthor=S.+M.+Michalek&title=Synthesis+of+QS-21-based+immunoadjuvants&doi=10.1021%2Fjo402118j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of QS-21-Based Immunoadjuvants</span></div><div class="casAuthors">Wang, Pengfei; Dai, Qipu; Thogaripally, Punith; Zhang, Ping; Michalek, Suzanne M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">11525-11534</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Three structurally defined QS-21-based immune adjuvant candidates have been synthesized.  Application of the two-stage activation glycosylation approach utilizing allyl glycoside building blocks improved the synthetic accessibility of the new adjuvants.  The efficient synthesis and establishment of the stand-alone adjuvanticity of the examd. synthetic adjuvants open the door to the pursuit of a new series of structurally defined QS-saponin-based synthetic adjuvants.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhT8N6m2NGbrVg90H21EOLACvtfcHk0lh9xfhweXuybg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1KktLfK&md5=5cd2c8ff419d9f35141f33cc8ed9a5a5</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjo402118j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo402118j%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DP.%26aulast%3DDai%26aufirst%3DQ.%26aulast%3DThogaripally%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DP.%26aulast%3DMichalek%26aufirst%3DS.%2BM.%26atitle%3DSynthesis%2520of%2520QS-21-based%2520immunoadjuvants%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2013%26volume%3D78%26spage%3D11525%26epage%3D11534%26doi%3D10.1021%2Fjo402118j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devalankar, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michalek, S. M.</span></span> <span> </span><span class="NLM_article-title">Synthesis and evaluation of QS-21-based immunoadjuvants with a terminal-functionalized side chain incorporated in the west wing trisaccharide</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>81</i></span>,  <span class="NLM_fpage">9560</span>– <span class="NLM_lpage">9566</span>, <span class="refDoi"> DOI: 10.1021/acs.joc.6b00922</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.joc.6b00922" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1ems7zL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2016&pages=9560-9566&author=P.+Wangauthor=D.+A.+Devalankarauthor=Q.+Daiauthor=P.+Zhangauthor=S.+M.+Michalek&title=Synthesis+and+evaluation+of+QS-21-based+immunoadjuvants+with+a+terminal-functionalized+side+chain+incorporated+in+the+west+wing+trisaccharide&doi=10.1021%2Facs.joc.6b00922"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Evaluation of QS-21-Based Immunoadjuvants with a Terminal-Functionalized Side Chain Incorporated in the West Wing Trisaccharide</span></div><div class="casAuthors">Wang, Pengfei; Devalankar, Dattatray A.; Dai, Qipu; Zhang, Ping; Michalek, Suzanne M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">9560-9566</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Three QS-21-based vaccine adjuvant candidates with a terminal-functionalized side chain incorporated in the west wing trisaccharide have been synthesized.  The terminal polar functional group serve to increase the soly. of these analogs in water.  Two of the synthetic analogs have been shown to have adjuvant activity comparable to that of GPI-0100.  The stand-alone adjuvant activity of the new synthetic analogs again confirmed that it is a feasible way to develop new saponin-based vaccine adjuvants through derivatizing at the west wing branched trisaccharide domain.  Inclusion of an addnl. polar functional group such as a carboxyl group (as in 3x) or a monosaccharide (as in 4x and 5x), is sufficient to increase the water-soly. of the corresponding synthetic analogs to a level comparable to that of GPI-0100 and suitable for immunol. studies and clin. application.  The structure of the incorporated side chain has a significant impact on the adjuvant activity in terms of the magnitude and nature of the host's responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7LJQzF2JT67Vg90H21EOLACvtfcHk0ljmqyslCyeRXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1ems7zL&md5=b8189013dff721ff7ff6f32ff37256ee</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Facs.joc.6b00922&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.joc.6b00922%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DP.%26aulast%3DDevalankar%26aufirst%3DD.%2BA.%26aulast%3DDai%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DP.%26aulast%3DMichalek%26aufirst%3DS.%2BM.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520QS-21-based%2520immunoadjuvants%2520with%2520a%2520terminal-functionalized%2520side%2520chain%2520incorporated%2520in%2520the%2520west%2520wing%2520trisaccharide%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2016%26volume%3D81%26spage%3D9560%26epage%3D9566%26doi%3D10.1021%2Facs.joc.6b00922" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Škalamera, Đ.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sui, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michalek, S. M.</span></span> <span> </span><span class="NLM_article-title">Synthesis and evaluation of a QS-17/18-based vaccine adjuvant</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">1669</span>– <span class="NLM_lpage">1676</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01997</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01997" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=1%3ACAS%3A528%3ADC%252BC1MXht1CqsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=1669-1676&author=P.+Wangauthor=%C4%90.+%C5%A0kalameraauthor=X.+Suiauthor=P.+Zhangauthor=S.+M.+Michalek&title=Synthesis+and+evaluation+of+a+QS-17%2F18-based+vaccine+adjuvant&doi=10.1021%2Facs.jmedchem.8b01997"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and evaluation of a QS-17/18-based vaccine adjuvant</span></div><div class="casAuthors">Wang, Pengfei; Skalamera, Djani; Sui, Xianwei; Zhang, Ping; Michalek, Suzanne M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1669-1676</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We have synthesized a QS-17/18 analog (7) and evaluated its adjuvant activity in the formulation with rHagB antigen.  Compd. 7 and QS-21 analogs 5 and 6 are presumably the major components of GPI-0100, a widely used complex mixt. of semisynthetic derivs. of Quillaja saponaria (QS) Molina saponins.  The QS-17/18 analog 7 shows an adjuvant activity profile similar to that of GPI-0100, potentiating mixed Th-1/Th-2 immune responses, which is different from those of QS-21 analogs 5 and 6 that probably only induce a Th2-like immunity.  The combination of QS-17/18 and QS-21 analogs does not show a synergistic effect.  These results suggest that QS-17/18 analog 7 might be the active component of GPI-0100 responsible for its immunostimulant property.  Therefore, compd. 7 can not only be a structurally defined alternative to GPI-0100 but also provide a valuable clue for rational design of new QS-based vaccine adjuvants with better adjuvant properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrp-y-QiSiy7bVg90H21EOLACvtfcHk0ljmqyslCyeRXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXht1CqsLw%253D&md5=a14271d4290e791a90d0010148184c46</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01997&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01997%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DP.%26aulast%3D%25C5%25A0kalamera%26aufirst%3D%25C4%2590.%26aulast%3DSui%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DP.%26aulast%3DMichalek%26aufirst%3DS.%2BM.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520a%2520QS-17%252F18-based%2520vaccine%2520adjuvant%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D1669%26epage%3D1676%26doi%3D10.1021%2Facs.jmedchem.8b01997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Škalamera, Đ.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sui, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michalek, S. M.</span></span> <span> </span><span class="NLM_article-title">Synthesis and evaluation of QS-7-based vaccine adjuvants</span>. <i>ACS Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">974</span>– <span class="NLM_lpage">981</span>, <span class="refDoi"> DOI: 10.1021/acsinfecdis.9b00039</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsinfecdis.9b00039" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=1%3ACAS%3A528%3ADC%252BC1MXlvFWhsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2019&pages=974-981&author=P.+Wangauthor=%C4%90.+%C5%A0kalameraauthor=X.+Suiauthor=P.+Zhangauthor=S.+M.+Michalek&title=Synthesis+and+evaluation+of+QS-7-based+vaccine+adjuvants&doi=10.1021%2Facsinfecdis.9b00039"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Evaluation of QS-7-Based Vaccine Adjuvants</span></div><div class="casAuthors">Wang, Pengfei; Skalamera, Djani; Sui, Xianwei; Zhang, Ping; Michalek, Suzanne M.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Infectious Diseases</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">974-981</span>CODEN:
                <span class="NLM_cas:coden">AIDCBC</span>;
        ISSN:<span class="NLM_cas:issn">2373-8227</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We have designed and synthesized two analogs (5 and 6) of QS-7, a natural saponin compd. isolated from Quillaja saponaria (QS) Molina tree bark.  The only structural difference between compd. 5 and 6 is that 5 is acetylated at the 3- and 4-O positions of the quillaic acid C28 fucosyl unit while 6 is not.  However, the two analogs show significantly different immunostimulant profiles.  Compd. 5 may potentiate a mixed Th1/Th2 (Th, T helper cells) immune response against the specific antigens while compd. 6 may only induce a Th2-biased immunity.  These results suggest that the 3- and/or 4-O acetyl groups of the fucosyl unit may play an important role in tuning the adjuvanticity of the QS-7 analogs, and compd. 5 can serve as a structurally defined synthetic adjuvant when a mixed Th1/Th2 immune responses is desired.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6r-bFz3RLYrVg90H21EOLACvtfcHk0ljmqyslCyeRXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXlvFWhsL4%253D&md5=d9e5cdc0eed8d91718d2f142e1012d98</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Facsinfecdis.9b00039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsinfecdis.9b00039%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DP.%26aulast%3D%25C5%25A0kalamera%26aufirst%3D%25C4%2590.%26aulast%3DSui%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DP.%26aulast%3DMichalek%26aufirst%3DS.%2BM.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520QS-7-based%2520vaccine%2520adjuvants%26jtitle%3DACS%2520Infect.%2520Dis.%26date%3D2019%26volume%3D5%26spage%3D974%26epage%3D981%26doi%3D10.1021%2Facsinfecdis.9b00039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marciani, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Press, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reynolds, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pathak, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pathak, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gundy, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farmer, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koratich, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">May, R. D.</span></span> <span> </span><span class="NLM_article-title">Development of semisynthetic triterpenoid saponin derivatives with immune stimulating activity</span>. <i>Vaccine</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">3141</span>– <span class="NLM_lpage">3151</span>, <span class="refDoi"> DOI: 10.1016/S0264-410X(00)00118-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=10.1016%2FS0264-410X%2800%2900118-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=10856794" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlslGjtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2000&pages=3141-3151&author=D.+Marcianiauthor=J.+B.+Pressauthor=R.+C.+Reynoldsauthor=A.+K.+Pathakauthor=V.+Pathakauthor=L.+E.+Gundyauthor=J.+T.+Farmerauthor=M.+S.+Koratichauthor=R.+D.+May&title=Development+of+semisynthetic+triterpenoid+saponin+derivatives+with+immune+stimulating+activity&doi=10.1016%2FS0264-410X%2800%2900118-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Development of semisynthetic triterpenoid saponin derivatives with immune stimulating activity</span></div><div class="casAuthors">Marciani, D. J.; Press, J. B.; Reynolds, R. C.; Pathak, A. K.; Pathak, V.; Gundy, L. E.; Farmer, J. T.; Koratich, M. S.; May, R. D.</div><div class="citationInfo"><span class="NLM_cas:title">Vaccine</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">3141-3151</span>CODEN:
                <span class="NLM_cas:coden">VACCDE</span>;
        ISSN:<span class="NLM_cas:issn">0264-410X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Aldehyde-contg. triterpene saponins have adjuvant properties, but only those from Quillaja saponaria Molina stimulate the prodn. of cytotoxic T lymphocytes (CTL) against exogenous antigens.  Quillaja saponins have two normonoterpene ester moieties, linked linearly to their fucosyl residue, that play a crit. role in the stimulation of CTL.  These ester moieties are also responsible for these saponins' instability and toxicity.  Based on the structure-activity relationships for the different groups of Q. saponaria saponins, new semi-synthetic analogs were developed that have the adjuvanticity of quillaja saponins, yet with less toxicity and greater stability in aq. solns.  The quillaja saponin analogs were prepd. by replacing their hydrolytically unstable ester groups with another lipophilic chain linked by a stable amide bond on these saponins' glucuronic acid residue.  One of these analogs, GPI-0100, is a dodecylamide saponin deriv. that stimulates an antibody isotype profile that corresponds to a Th1 type immune response, as well as CTL prodn. against exogenous antigens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmbWVA2dMPGLVg90H21EOLACvtfcHk0li5zwrRFe_IYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlslGjtr0%253D&md5=b7e953dc68ace13d6983da9950bdd913</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2FS0264-410X%2800%2900118-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0264-410X%252800%252900118-3%26sid%3Dliteratum%253Aachs%26aulast%3DMarciani%26aufirst%3DD.%26aulast%3DPress%26aufirst%3DJ.%2BB.%26aulast%3DReynolds%26aufirst%3DR.%2BC.%26aulast%3DPathak%26aufirst%3DA.%2BK.%26aulast%3DPathak%26aufirst%3DV.%26aulast%3DGundy%26aufirst%3DL.%2BE.%26aulast%3DFarmer%26aufirst%3DJ.%2BT.%26aulast%3DKoratich%26aufirst%3DM.%2BS.%26aulast%3DMay%26aufirst%3DR.%2BD.%26atitle%3DDevelopment%2520of%2520semisynthetic%2520triterpenoid%2520saponin%2520derivatives%2520with%2520immune%2520stimulating%2520activity%26jtitle%3DVaccine%26date%3D2000%26volume%3D18%26spage%3D3141%26epage%3D3151%26doi%3D10.1016%2FS0264-410X%2800%2900118-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marciani, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reynolds, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pathak, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finley-Woodman, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">May, R. D.</span></span> <span> </span><span class="NLM_article-title">Fractionation, structural studies, and immunological characterization of the semi-synthetic Quillaja saponins derivative GPI-0100</span>. <i>Vaccine</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">3961</span>– <span class="NLM_lpage">3971</span>, <span class="refDoi"> DOI: 10.1016/S0264-410X(03)00298-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=10.1016%2FS0264-410X%2803%2900298-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=12922132" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmt1Gku7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2003&pages=3961-3971&author=D.+J.+Marcianiauthor=R.+C.+Reynoldsauthor=A.+K.+Pathakauthor=K.+Finley-Woodmanauthor=R.+D.+May&title=Fractionation%2C+structural+studies%2C+and+immunological+characterization+of+the+semi-synthetic+Quillaja+saponins+derivative+GPI-0100&doi=10.1016%2FS0264-410X%2803%2900298-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Fractionation, structural studies, and immunological characterization of the semi-synthetic Quillaja saponins derivative GPI-0100</span></div><div class="casAuthors">Marciani, Dante J.; Reynolds, Robert C.; Pathak, Ashish K.; Finley-Woodman, Kyra; May, Richard D.</div><div class="citationInfo"><span class="NLM_cas:title">Vaccine</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">25-26</span>),
    <span class="NLM_cas:pages">3961-3971</span>CODEN:
                <span class="NLM_cas:coden">VACCDE</span>;
        ISSN:<span class="NLM_cas:issn">0264-410X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Unfractionated GPI-0100 (UFGPI-0100) contg. semi-synthetic derivs. of deacylated Quillaja saponins (DS saponins) modified at the glucuronic acid residue was resolved by reverse phase low-pressure liq. chromatog. (RP-LPLC) into two fractions, RP18-1 and RP18-2, with different compns. and adjuvanticity.  The fraction RP18-1 contained DS saponin adducts of N-dicyclohexylurea, and stimulated Th2 immunity with prodn. of IgG1, while the RP18-2 fraction contained the dodecylamide derivs. of DS saponins and stimulated Th1 immunity with prodn. of IgG2a, IFN-γ, IL-2, and CTL.  The strong immune stimulatory properties of RP18-2, relative to RP18-1, and the formation of RP18-1/RP18-2 mixed micelles may account for the effective stimulation of Th1 immunity by UFGPI-0100.  UFGPI-0100 was free of acylated quillaja saponin components, including the more stable QS-7.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYGroTQ5yVA7Vg90H21EOLACvtfcHk0li5zwrRFe_IYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmt1Gku7s%253D&md5=aad68bb05facdd21feff5d5b4970b133</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2FS0264-410X%2803%2900298-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0264-410X%252803%252900298-6%26sid%3Dliteratum%253Aachs%26aulast%3DMarciani%26aufirst%3DD.%2BJ.%26aulast%3DReynolds%26aufirst%3DR.%2BC.%26aulast%3DPathak%26aufirst%3DA.%2BK.%26aulast%3DFinley-Woodman%26aufirst%3DK.%26aulast%3DMay%26aufirst%3DR.%2BD.%26atitle%3DFractionation%252C%2520structural%2520studies%252C%2520and%2520immunological%2520characterization%2520of%2520the%2520semi-synthetic%2520Quillaja%2520saponins%2520derivative%2520GPI-0100%26jtitle%3DVaccine%26date%3D2003%26volume%3D21%26spage%3D3961%26epage%3D3971%26doi%3D10.1016%2FS0264-410X%2803%2900298-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Q.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marciani, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clements, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michalek, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katz, J.</span></span> <span> </span><span class="NLM_article-title">Effectiveness of the quillaja saponin semi-synthetic analog GPI-0100 in potentiating mucosal and systemic responses to recombinant HagB from Porphyromonas gingivalis</span>. <i>Vaccine</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">4459</span>– <span class="NLM_lpage">4471</span>, <span class="refDoi"> DOI: 10.1016/S0264-410X(03)00438-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=10.1016%2FS0264-410X%2803%2900438-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=14505929" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnvFSiurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2003&pages=4459-4471&author=P.+Zhangauthor=Q.-B.+Yangauthor=D.+J.+Marcianiauthor=M.+Martinauthor=J.+D.+Clementsauthor=S.+M.+Michalekauthor=J.+Katz&title=Effectiveness+of+the+quillaja+saponin+semi-synthetic+analog+GPI-0100+in+potentiating+mucosal+and+systemic+responses+to+recombinant+HagB+from+Porphyromonas+gingivalis&doi=10.1016%2FS0264-410X%2803%2900438-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Effectiveness of the quillaja saponin semi-synthetic analog GPI-0100 in potentiating mucosal and systemic responses to recombinant HagB from Porphyromonas gingivalis</span></div><div class="casAuthors">Zhang, Ping; Yang, Qiu-Bo; Marciani, Dante J.; Martin, Michael; Clements, John D.; Michalek, Suzanne M.; Katz, Jannet</div><div class="citationInfo"><span class="NLM_cas:title">Vaccine</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">27-30</span>),
    <span class="NLM_cas:pages">4459-4471</span>CODEN:
                <span class="NLM_cas:coden">VACCDE</span>;
        ISSN:<span class="NLM_cas:issn">0264-410X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">The gram-neg., anaerobic bacterium Porphyromonas gingivalis, has been implicated in the etiol. of adult periodontal disease.  Among the potential virulence factors of this bacterium, the non-fimbrial adhesin hemagglutinin B (HagB) appears to be involved in the initial adherence of the bacteria to host tissue and the induction of anti-HagB antibody responses affords some protection from exptl. alveolar bone loss.  In the present study, we have investigated the ability of the quillaja saponin deriv. GPI-0100 to act as an immunostimulant of responses to HagB following s.c. or intranasal (i.n.) immunization of mice.  We have also compared the immunopotentiating ability of GPI-0100 with that of five other adjuvants.  Evidence is provided that GPI-0100 was more effective than monophosphoryl lipid A and alum in inducing serum anti-HagB responses following s.c. immunization.  A comparison of the responses induced following i.n. immunization with HagB and adjuvant revealed that the heat-labile toxin of Escherichia coli (LT) and the non-enzymic mutant LT (E112K), followed by GPI-0100 potentiated higher serum and mucosal anti-HagB antibody responses, which in most cases were higher than those seen with the other adjuvants tested (i.e. monophosphoryl lipid A, alum and the B subunit of cholera toxin).  Furthermore, a difference was seen in the nature of the serum IgG anti-HagB response based on the adjuvant used and route of immunization.  These results demonstrate the effectiveness of GPI-0100 as both a systemic and mucosal adjuvant and support its potential use in the development of vaccines against periodontal, as well as other pathogens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoH15_EMh9Su7Vg90H21EOLACvtfcHk0li5zwrRFe_IYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnvFSiurg%253D&md5=0b819682d65db32890cec6f09f743b0e</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2FS0264-410X%2803%2900438-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0264-410X%252803%252900438-9%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DP.%26aulast%3DYang%26aufirst%3DQ.-B.%26aulast%3DMarciani%26aufirst%3DD.%2BJ.%26aulast%3DMartin%26aufirst%3DM.%26aulast%3DClements%26aufirst%3DJ.%2BD.%26aulast%3DMichalek%26aufirst%3DS.%2BM.%26aulast%3DKatz%26aufirst%3DJ.%26atitle%3DEffectiveness%2520of%2520the%2520quillaja%2520saponin%2520semi-synthetic%2520analog%2520GPI-0100%2520in%2520potentiating%2520mucosal%2520and%2520systemic%2520responses%2520to%2520recombinant%2520HagB%2520from%2520Porphyromonas%2520gingivalis%26jtitle%3DVaccine%26date%3D2003%26volume%3D21%26spage%3D4459%26epage%3D4471%26doi%3D10.1016%2FS0264-410X%2803%2900438-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Iwamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okabe, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamauchi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rokutani, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hara, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mihashi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higuchi, R.</span></span> <span> </span><span class="NLM_article-title">Studies on the constituents of Momordica cochinchinensis SPRENG. I. Isolation and characterization of the seed saponins, momordica saponins I and II</span>. <i>Chem. Pharm. Bull.</i> <span class="NLM_year" style="font-weight: bold;">1985</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">464</span>– <span class="NLM_lpage">478</span>, <span class="refDoi"> DOI: 10.1248/cpb.33.464</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=10.1248%2Fcpb.33.464" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=1%3ACAS%3A528%3ADyaL2MXitFygsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1985&pages=464-478&author=M.+Iwamotoauthor=H.+Okabeauthor=T.+Yamauchiauthor=M.+Tanakaauthor=Y.+Rokutaniauthor=S.+Haraauthor=K.+Mihashiauthor=R.+Higuchi&title=Studies+on+the+constituents+of+Momordica+cochinchinensis+SPRENG.+I.+Isolation+and+characterization+of+the+seed+saponins%2C+momordica+saponins+I+and+II&doi=10.1248%2Fcpb.33.464"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Studies on the constituents of Momordica cochinchinensis Spreng.  I.  Isolation and characterization of the seed saponins, momordica saponins I and II</span></div><div class="casAuthors">Iwamoto, Masayo; Okabe, Hikaru; Yamauchi, Tatsuo; Tanaka, Masako; Rokutani, Yoshie; Hara, Shuji; Mihashi, Kunihide; Higuchi, Ryuichi</div><div class="citationInfo"><span class="NLM_cas:title">Chemical & Pharmaceutical Bulletin</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">464-78</span>CODEN:
                <span class="NLM_cas:coden">CPBTAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-2363</span>.
    </div><div class="casAbstract">The structures of momordica saponins I and II, the seed saponins of M. cochinchinensis were elucidated on the basis of spectral and chem. evidence as the 3-O-β-D-galactopyranosyl(1→2)-[α-L-rhamnopyranosyl(1→3)]-β-D-glucuronopyranosido-28-O-β-D-xylopyranosyl(1→3)-β-D-glucopyranosyl(1→3)-[β-D-xylopyranosyl(1→4)]-α-L-rhamnopyranosyl(1→2)-β-D-fucopyranosides of gypsogenin and quillaic acid, resp.  The saponins I and II are contained in the seed kernels in a carboxylate form.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobHMuJ-Kl_YrVg90H21EOLACvtfcHk0li5zwrRFe_IYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXitFygsbg%253D&md5=0bd5548482e378e8d03e28e2612510d2</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1248%2Fcpb.33.464&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fcpb.33.464%26sid%3Dliteratum%253Aachs%26aulast%3DIwamoto%26aufirst%3DM.%26aulast%3DOkabe%26aufirst%3DH.%26aulast%3DYamauchi%26aufirst%3DT.%26aulast%3DTanaka%26aufirst%3DM.%26aulast%3DRokutani%26aufirst%3DY.%26aulast%3DHara%26aufirst%3DS.%26aulast%3DMihashi%26aufirst%3DK.%26aulast%3DHiguchi%26aufirst%3DR.%26atitle%3DStudies%2520on%2520the%2520constituents%2520of%2520Momordica%2520cochinchinensis%2520SPRENG.%2520I.%2520Isolation%2520and%2520characterization%2520of%2520the%2520seed%2520saponins%252C%2520momordica%2520saponins%2520I%2520and%2520II%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D1985%26volume%3D33%26spage%3D464%26epage%3D478%26doi%3D10.1248%2Fcpb.33.464" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oda, K.</span></span> <span> </span><span class="NLM_article-title">Relationship between adjuvant activity and amphipathic structure of soyasaponins</span>. <i>Vaccine</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">2145</span>– <span class="NLM_lpage">2151</span>, <span class="refDoi"> DOI: 10.1016/S0264-410X(02)00739-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=10.1016%2FS0264-410X%2802%2900739-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=12706705" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjtFWlsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2003&pages=2145-2151&author=K.+Oda&title=Relationship+between+adjuvant+activity+and+amphipathic+structure+of+soyasaponins&doi=10.1016%2FS0264-410X%2802%2900739-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Relationship between adjuvant activity and amphipathic structure of soyasaponins</span></div><div class="casAuthors">Oda, Kenji; Matsuda, Hisashi; Murakami, Toshiyuki; Katayama, Shigeji; Ohgitani, Toshiaki; Yoshikawa, Masayuki</div><div class="citationInfo"><span class="NLM_cas:title">Vaccine</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">17-18</span>),
    <span class="NLM_cas:pages">2145-2151</span>CODEN:
                <span class="NLM_cas:coden">VACCDE</span>;
        ISSN:<span class="NLM_cas:issn">0264-410X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A correlation between adjuvant activity and amphipathic structure of saponin was first demonstrated on an exptl. basis using structurally consecutive analogs.  To clarify the physicochem. factors regulating the adjuvanticity of saponin, the authors compared the profile of the antibody response against chicken ovalbumin (OVA) in mice and hydrophile-lipophile balance (HLB) of 8 purified soyasaponins.  Soyasaponins bearing sugar chain(s) showed adjuvanticity stimulating anti-OVA total IgG and IgG1 antibody responses, while their corresponding aglycons soyasapogenols A and B, did not.  Among bisdesmosidic soyasaponins, soyasaponin A1 (HLB: 26.9) with a long sugar side chain induced stronger total-IgG and IgG1 antibody responses than soyasaponin A2 (HLB: 21.4).  For monodesmosidic soyasaponins, the ranking in terms of antibody response was soyasaponin I [which has the highest HLB value (13.6) among the monodesmosidic soyasaponins] > soyasaponin II (HLB: 12.2) > soyasaponin III (HLB: 10.0).  The adjuvant activity increased with the HLB value.  The length, the no., and the compn. of sugar side chains affecting the HLB value would give the overall conformation of each saponin mol., and the amphipathic structure may define the fundamental adjuvanticity of saponins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotsHMF_IzKlbVg90H21EOLACvtfcHk0liTLqtqlwAYUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjtFWlsrg%253D&md5=f48c43dfdad5cc579597dc44a6b70f1d</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2FS0264-410X%2802%2900739-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0264-410X%252802%252900739-9%26sid%3Dliteratum%253Aachs%26aulast%3DOda%26aufirst%3DK.%26atitle%3DRelationship%2520between%2520adjuvant%2520activity%2520and%2520amphipathic%2520structure%2520of%2520soyasaponins%26jtitle%3DVaccine%26date%3D2003%26volume%3D21%26spage%3D2145%26epage%3D2151%26doi%3D10.1016%2FS0264-410X%2802%2900739-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tang, W.</span>; <span class="NLM_string-name">Eisenbrand, G.</span></span> <i>Handbook of Chinese Medicinal Plants</i>; <span class="NLM_publisher-name">Wiley-VCH</span>: <span class="NLM_publisher-loc">Weinheim, Germany</span>, <span class="NLM_year">2011</span>; Vol.  <span class="NLM_volume">2</span>, p  <span class="NLM_fpage">768</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&pages=768&author=W.+Tang&author=G.+Eisenbrand&title=Handbook+of+Chinese+Medicinal+Plants"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DW.%26btitle%3DHandbook%2520of%2520Chinese%2520Medicinal%2520Plants%26pub%3DWiley-VCH%26date%3D2011%26volume%3D2%26spage%3D768" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajput, Z. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, S.</span></span> <span> </span><span class="NLM_article-title">Enhancement of serological immune responses to foot-and-mouth disease vaccine by a supplement made of extract of cochinchina momordica seeds</span>. <i>Clinical and Vaccine Immunology: CVI</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">1634</span>– <span class="NLM_lpage">1639</span>, <span class="refDoi"> DOI: 10.1128/CVI.00339-07</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=10.1128%2FCVI.00339-07" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=17942610" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=1%3ACAS%3A280%3ADC%252BD2sjhvVCqtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2007&pages=1634-1639&author=C.+Xiaoauthor=Z.+I.+Rajputauthor=D.+Liuauthor=S.+Hu&title=Enhancement+of+serological+immune+responses+to+foot-and-mouth+disease+vaccine+by+a+supplement+made+of+extract+of+cochinchina+momordica+seeds&doi=10.1128%2FCVI.00339-07"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Enhancement of serological immune responses to foot-and-mouth disease vaccine by a supplement made of extract of cochinchina momordica seeds</span></div><div class="casAuthors">Xiao Chenwen; Rajput Zahid Iqbal; Liu Diwen; Hu Songhua</div><div class="citationInfo"><span class="NLM_cas:title">Clinical and vaccine immunology : CVI</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1634-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Foot-and-mouth disease (FMD) is a highly contagious disease affecting cloven-hoofed animals.  Vaccination against FMD is a routine practice in many countries where the disease is endemic.  This study was designed first to investigate the extract of the seeds of Momordica cochinchinensis (Lour.) Spreng. (ECMS) for its adjuvant effect on vaccination of inactivated FMDV antigens in a guinea pig model and then to evaluate the supplement of ECMS in oil-emulsified FMD vaccines for its immunopotentiation in pigs.  The results indicated that ECMS and oil emulsion act synergistically as adjuvants to promote the production of FMDV- and VP1-specific immunoglobulin G (IgG) and subclasses in guinea pigs.  A supplement of ECMS in a commercial FMD vaccine significantly enhanced FMDV-specific indirect hemagglutination assay titers as well as VP1-specific IgG and subclasses in pigs.  Therefore, ECMS could be an alternative approach to improving swine FMD vaccination when the vaccine is poor to induce an effective immune response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQxatmtwSKaDUkUaC_kzhvyfW6udTcc2ebZRXOhXHKibbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2sjhvVCqtg%253D%253D&md5=770eb0f576d3b36febc8ff5567bf584f</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1128%2FCVI.00339-07&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FCVI.00339-07%26sid%3Dliteratum%253Aachs%26aulast%3DXiao%26aufirst%3DC.%26aulast%3DRajput%26aufirst%3DZ.%2BI.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DHu%26aufirst%3DS.%26atitle%3DEnhancement%2520of%2520serological%2520immune%2520responses%2520to%2520foot-and-mouth%2520disease%2520vaccine%2520by%2520a%2520supplement%2520made%2520of%2520extract%2520of%2520cochinchina%2520momordica%2520seeds%26jtitle%3DClinical%2520and%2520Vaccine%2520Immunology%253A%2520CVI%26date%3D2007%26volume%3D14%26spage%3D1634%26epage%3D1639%26doi%3D10.1128%2FCVI.00339-07" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, S. H.</span></span> <span> </span><span class="NLM_article-title">Effect of four adjuvants on immune response to F4 fimbriae in chickens</span>. <i>Vet. Immunol. Immunopathol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>121</i></span>,  <span class="NLM_fpage">107</span>– <span class="NLM_lpage">112</span>, <span class="refDoi"> DOI: 10.1016/j.vetimm.2007.09.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=10.1016%2Fj.vetimm.2007.09.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=18036671" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVeltbnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2008&pages=107-112&author=J.+H.+Sunauthor=Z.+Q.+Jiangauthor=S.+H.+Hu&title=Effect+of+four+adjuvants+on+immune+response+to+F4+fimbriae+in+chickens&doi=10.1016%2Fj.vetimm.2007.09.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of four adjuvants on immune response to F4 fimbriae in chickens</span></div><div class="casAuthors">Sun, Jian-hua; Jiang, Zhong-qi; Hu, Song-hua</div><div class="citationInfo"><span class="NLM_cas:title">Veterinary Immunology and Immunopathology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">121</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">107-112</span>CODEN:
                <span class="NLM_cas:coden">VIIMDS</span>;
        ISSN:<span class="NLM_cas:issn">0165-2427</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">IgG antibody response in chickens immunized with F4 fimbriae extd. from local enterotoxigenic Escherichia coli (ETEC) strain was studied during a 98-day immunization period for comparing the efficacy of four adjuvants: Freund' adjuvant, Quil A (QA), propolis and ext. from Cochinchina momordica seed (ECMS).  For this purpose, chickens were immunized with F4 fimbriae alone or combined with one of the above adjuvants on days 1 and 21.  IgG antibody levels in serum and egg yolk (by ELISA) were measured on days 0, 7, 14, 21, 28, 35, 42, 49, 56, 70, 84 and 98.  The egg prodn. of each group was also detd. during days 1-7 and the following four weeks.  The results showed that QA could enhance antibody titer, as good or almost as good as Freund's adjuvant, whereas the titers of ECMS and propolis groups were relatively lower, with the overall order: Freund's adjuvant > QA > ECMS > propolis both in serum and egg yolk.  However, the significant decrease of egg prodn. was merely obsd. in the Freund's adjuvant group.  It is concluded that the four adjuvants tested can stimulate immune response to F4 fimbriae in chickens, with Freund's adjuvant giving the best results, followed by QA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2bNO-YpE-frVg90H21EOLACvtfcHk0ljZPWadY3zyGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVeltbnN&md5=38950fcd75f91ec1f90e56ba533e6f09</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.vetimm.2007.09.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.vetimm.2007.09.021%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DJ.%2BH.%26aulast%3DJiang%26aufirst%3DZ.%2BQ.%26aulast%3DHu%26aufirst%3DS.%2BH.%26atitle%3DEffect%2520of%2520four%2520adjuvants%2520on%2520immune%2520response%2520to%2520F4%2520fimbriae%2520in%2520chickens%26jtitle%3DVet.%2520Immunol.%2520Immunopathol.%26date%3D2008%26volume%3D121%26spage%3D107%26epage%3D112%26doi%3D10.1016%2Fj.vetimm.2007.09.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pu, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaid, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boini, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Towsley, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doecke, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitchell, D.</span></span> <span> </span><span class="NLM_article-title">A practical method for functionalized peptide or amide bond formation in aqueous-ethanol media with EDC as Activator</span>. <i>Org. Process Res. Dev.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">310</span>– <span class="NLM_lpage">314</span>, <span class="refDoi"> DOI: 10.1021/op800240d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/op800240d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVKksr%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2009&pages=310-314&author=Y.+J.+Puauthor=R.+K.+Vaidauthor=S.+K.+Boiniauthor=R.+W.+Towsleyauthor=C.+W.+Doeckeauthor=D.+Mitchell&title=A+practical+method+for+functionalized+peptide+or+amide+bond+formation+in+aqueous-ethanol+media+with+EDC+as+Activator&doi=10.1021%2Fop800240d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">A practical method for functionalized peptide or amide bond formation in aqueous-ethanol media with EDC as activator</span></div><div class="casAuthors">Pu, Yangwei John; Vaid, Radhe K.; Boini, Sathish K.; Towsley, Robert W.; Doecke, Christopher W.; Mitchell, David</div><div class="citationInfo"><span class="NLM_cas:title">Organic Process Research & Development</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">310-314</span>CODEN:
                <span class="NLM_cas:coden">OPRDFK</span>;
        ISSN:<span class="NLM_cas:issn">1083-6160</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Selective formation of amides or peptides with ethanol as solvent using a convenient one-pot procedure in which acid activating agent N-(3-dimethylaminopropyl)-N-ethylcarbodiimide hydrochloride (EDC) is simply added to a mixt. of the carboxylic acid, amine, catalytic HOBt (1-hydroxy benzotriazole), and NMM (N-methylmorpholine) as base has been developed.  Sensitive functionalities such as hydroxyl groups are well tolerated under the reaction conditions.  In addn., isolation of products is usually by simple filtration from the reaction media.  The scope and generality of this methodol. was investigated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJg1wh3HuhFrVg90H21EOLACvtfcHk0ljZPWadY3zyGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVKksr%252FJ&md5=a0a7085c5054220988a5ff3a7df35c92</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fop800240d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fop800240d%26sid%3Dliteratum%253Aachs%26aulast%3DPu%26aufirst%3DY.%2BJ.%26aulast%3DVaid%26aufirst%3DR.%2BK.%26aulast%3DBoini%26aufirst%3DS.%2BK.%26aulast%3DTowsley%26aufirst%3DR.%2BW.%26aulast%3DDoecke%26aufirst%3DC.%2BW.%26aulast%3DMitchell%26aufirst%3DD.%26atitle%3DA%2520practical%2520method%2520for%2520functionalized%2520peptide%2520or%2520amide%2520bond%2520formation%2520in%2520aqueous-ethanol%2520media%2520with%2520EDC%2520as%2520Activator%26jtitle%3DOrg.%2520Process%2520Res.%2520Dev.%26date%3D2009%26volume%3D13%26spage%3D310%26epage%3D314%26doi%3D10.1021%2Fop800240d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Q.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michalek, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katz, J.</span></span> <span> </span><span class="NLM_article-title">Role of B7 costimulatory molecules in immune responses and T-helper cell differentiation to recombinant HagB from Prophyromonas gingivalis</span>. <i>Infect. Immun.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>72</i></span>,  <span class="NLM_fpage">637</span>– <span class="NLM_lpage">644</span>, <span class="refDoi"> DOI: 10.1128/IAI.72.2.637-644.2004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=10.1128%2FIAI.72.2.637-644.2004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=14742503" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtFGmsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2004&pages=637-644&author=P.+Zhangauthor=M.+Martinauthor=Q.-B.+Yangauthor=S.+M.+Michalekauthor=J.+Katz&title=Role+of+B7+costimulatory+molecules+in+immune+responses+and+T-helper+cell+differentiation+to+recombinant+HagB+from+Prophyromonas+gingivalis&doi=10.1128%2FIAI.72.2.637-644.2004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Role of B7 costimulatory molecules in immune responses and T-helper cell differentiation in response to recombinant HagB from Porphyromonas gingivalis</span></div><div class="casAuthors">Zhang, Ping; Martin, Michael; Yang, Qiu-Bo; Michalek, Suzanne M.; Katz, Jannet</div><div class="citationInfo"><span class="NLM_cas:title">Infection and Immunity</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">637-644</span>CODEN:
                <span class="NLM_cas:coden">INFIBR</span>;
        ISSN:<span class="NLM_cas:issn">0019-9567</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">In addn. to antigen-specific signals mediated through the T-cell receptor, T cells also require antigen nonspecific costimulation for activation.  The B7 family of mols. on antigen-presenting cells, which include B7-1 (CD80) and B7-2 (CD86), play important roles in providing costimulatory signals required for development of antigen-specific immune responses.  Hemagglutinin B (HagB) is a nonfimbrial adhesin of the periodontopathic microorganism Porphyromonas gingivalis and is thought to be involved in the attachment of the bacterium to host tissues.  However, the immune mechanisms involved in responses to HagB and their roles in pathogenesis have yet to be elucidated.  Therefore, the purpose of this study was to det. the role of B7 costimulatory mols. on T-helper-cell differentiation for the induction of immune responses to HagB.  Mice deficient in either or both of the costimulatory mols. B7-1 and B7-2 were used to explore their role in immune responses to HagB after s.c. immunization.  B7-1-/- mice had levels of IgG anti-HagB antibody activity in serum similar to those of wild-type mice, whereas lower serum IgG anti-HagB antibody responses were seen in B7-2-/- mice.  Moreover, significantly lower nos. of IgG antibody-secreting cells and lower levels of CD4+-T-cell proliferation were obsd. in B7-2-/- mice compared to wild-type mice.  No serum IgG response to HagB was detected in B7-1/B7-2-/- mice.  Anal. of the subclass of the serum IgG responses and the cytokines induced in response to HagB revealed that B7-2-/- mice had significantly lower IgG1 and higher IgG2a anti-HagB antibody responses compared to wild-type mice.  The B7-2-/- mice also had significantly reduced levels of interleukin-4 (IL-4) and IL-5 and enhanced level of gamma interferon.  Furthermore, assessment of B7-1 and B7-2 expression on B cells and macrophages derived from wild-type BALB/c mice after in vitro stimulation with HagB revealed a predominant upregulation in the expression of the B7-2 costimulatory mol. on B cells and macrophages.  Essentially no change was seen in the expression of B7-1.  These results suggest a crit. role for B7, esp. B7-2, for the preferential induction of a Th2-like response to HagB.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAnGRInG-VFbVg90H21EOLACvtfcHk0ljZPWadY3zyGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtFGmsL4%253D&md5=675ca3a5b935bef1f3589fe8490c16a6</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1128%2FIAI.72.2.637-644.2004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FIAI.72.2.637-644.2004%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DP.%26aulast%3DMartin%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DQ.-B.%26aulast%3DMichalek%26aufirst%3DS.%2BM.%26aulast%3DKatz%26aufirst%3DJ.%26atitle%3DRole%2520of%2520B7%2520costimulatory%2520molecules%2520in%2520immune%2520responses%2520and%2520T-helper%2520cell%2520differentiation%2520to%2520recombinant%2520HagB%2520from%2520Prophyromonas%2520gingivalis%26jtitle%3DInfect.%2520Immun.%26date%3D2004%26volume%3D72%26spage%3D637%26epage%3D644%26doi%3D10.1128%2FIAI.72.2.637-644.2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michalek, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katz, J.</span></span> <span> </span><span class="NLM_article-title">Role of mitogen-activated protein kinases and NF-κB in the regulation of pro- and anti-inflammatory cytokines by Porphyromonas gingivalis Hemagglutinin B</span>. <i>Infect. Immun.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">3990</span>– <span class="NLM_lpage">3998</span>, <span class="refDoi"> DOI: 10.1128/IAI.73.7.3990-3998.2005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=10.1128%2FIAI.73.7.3990-3998.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=15972486" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=1%3ACAS%3A528%3ADC%252BD28XhsFWgtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2005&pages=3990-3998&author=P.+Zhangauthor=M.+Martinauthor=S.+M.+Michalekauthor=J.+Katz&title=Role+of+mitogen-activated+protein+kinases+and+NF-%CE%BAB+in+the+regulation+of+pro-+and+anti-inflammatory+cytokines+by+Porphyromonas+gingivalis+Hemagglutinin+B&doi=10.1128%2FIAI.73.7.3990-3998.2005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Role of mitogen-activated protein kinases and NF-κB in the regulation of proinflammatory and anti-inflammatory cytokines by Porphyromonas gingivalis hemagglutinin B</span></div><div class="casAuthors">Zhang, Ping; Martin, Michael; Michalek, Suzanne M.; Katz, Jannet</div><div class="citationInfo"><span class="NLM_cas:title">Infection and Immunity</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3990-3998</span>CODEN:
                <span class="NLM_cas:coden">INFIBR</span>;
        ISSN:<span class="NLM_cas:issn">0019-9567</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Hemagglutinin B (HagB) is a nonfimbrial adhesin expressed on the surface of P. gingivalis and has been implicated as a potential virulence factor involved in mediating the attachment of the bacteria to host cells.  However, the mol. mechanisms underlying host responses to HagB and their roles in pathogenesis have yet to be elucidated.  Mitogen-activated protein kinases (MAPKs) are activated following engagement of a variety of cell surface receptors via dual tyrosine and threonine phosphorylation and are thought to be involved in various cellular responses.  The purpose here was to det. the role of intracellular signaling pathways including the MAPKs and NF-κB in regulating the prodn. of proinflammatory and anti-inflammatory cytokines following stimulation of murine macrophages with recombinant HagB (rHagB).  Stimulation of peritoneal macrophages with rHagB resulted in the prodn. of the proinflammatory cytokines interleukin-12p40 (IL-12p40), γ interferon (IFN-γ), and tumor necrosis factor α, as well as the anti-inflammatory cytokine IL-10.  The authors also demonstrated the activation of extracellular signal-related kinase (ERK), c-Jun NH2-terminal protein kinase (JNK), and p38 MAPKs by rHagB-stimulated macrophages.  Furthermore, blocking of the ERK and p38 signaling pathways by using specific inhibitors revealed differential regulatory roles in the rHagB-mediated prodn. of proinflammatory and anti-inflammatory cytokines.  ERK and p38 were important in down-regulation of IL-12p40 and IFN-γ prodn. and up-regulation of IL-10 prodn.  The enhanced levels of IL-12p40 in rHagB-stimulated macrophages by inhibition of ERK or p38 activity were partially attributable to the inhibition of IL-10 prodn.  Moreover, NF-κB was crit. for up-regulation of IL-12p40 and down-regulation of IL-10 prodn. in rHagB-stimulated macrophages.  The authors' results demonstrate here a role for the p38 and ERK pathways and the transcription factor NF-κB in modulating key immunoregulatory cytokines involved in the development of immune responses to P. gingivalis HagB.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbnS7yALcMarVg90H21EOLACvtfcHk0ljq_LtxOheWfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhsFWgtLg%253D&md5=c106954f522153aff95529e29db4a94b</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1128%2FIAI.73.7.3990-3998.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FIAI.73.7.3990-3998.2005%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DP.%26aulast%3DMartin%26aufirst%3DM.%26aulast%3DMichalek%26aufirst%3DS.%2BM.%26aulast%3DKatz%26aufirst%3DJ.%26atitle%3DRole%2520of%2520mitogen-activated%2520protein%2520kinases%2520and%2520NF-%25CE%25BAB%2520in%2520the%2520regulation%2520of%2520pro-%2520and%2520anti-inflammatory%2520cytokines%2520by%2520Porphyromonas%2520gingivalis%2520Hemagglutinin%2520B%26jtitle%3DInfect.%2520Immun.%26date%3D2005%26volume%3D73%26spage%3D3990%26epage%3D3998%26doi%3D10.1128%2FIAI.73.7.3990-3998.2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Katz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Black, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michalek, S. M.</span></span> <span> </span><span class="NLM_article-title">Host responses to recombinant hemagglutinin B of Porphyromonas gingivalis in an experimental rat model</span>. <i>Infect. Immun.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">4352</span>– <span class="NLM_lpage">4359</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=10.1128%2FIAI.67.9.4352-4359.1999" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=10456874" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;key=1%3ACAS%3A528%3ADyaK1MXlsFCmtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=1999&pages=4352-4359&author=J.+Katzauthor=K.+P.+Blackauthor=S.+M.+Michalek&title=Host+responses+to+recombinant+hemagglutinin+B+of+Porphyromonas+gingivalis+in+an+experimental+rat+model"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Host responses to recombinant hemagglutinin B of Porphyromonas gingivalis in an experimental rat model</span></div><div class="casAuthors">Katz, Jannet; Black, Kelley P.; Michalek, Suzanne M.</div><div class="citationInfo"><span class="NLM_cas:title">Infection and Immunity</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4352-4359</span>CODEN:
                <span class="NLM_cas:coden">INFIBR</span>;
        ISSN:<span class="NLM_cas:issn">0019-9567</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Porphyromonas gingivalis, a gram-neg., black-pigmented anaerobe, is among the microorganisms implicated in the etiol. of adult periodontal disease.  This bacterium possesses a no. of factors, including hemagglutinins, of potential importance in virulence.  Several hemagglutinin genes have been identified, cloned, and expressed in Escherichia coli.  The purpose of this study was to characterize host responses to purified recombinant hemagglutinin B (rHag B), using the conventional Fischer rat as the exptl. animal model.  The effectiveness of immunization with rHag B on protection against exptl. periodontal bone loss following infection with P. gingivalis was also evaluated.  Groups of rats were immunized by the s.c. route with rHag B in complete Freund's adjuvant, immunized with rHag B and orally infected with P. gingivalis, nonimmunized and noninfected, or orally infected with P. gingivalis only.  Serum and saliva samples were collected throughout the expt. and evaluated for serum IgG and IgM and salivary IgA antibody activity by ELISA.  No salivary IgA anti-Hag B activity was detected in the various groups of rats.  A slight serum IgM response similar to that seen in preimmune samples was obsd.  Serum IgG antibody activity to Hag B was detected only in samples from rats immunized with rHag B.  This response was primarily of the IgG1 and IgG2a subclasses, followed by IgG2b and low levels of IgG2c.  Supernatants from rHag B-stimulated splenic lymphoid cell cultures from immunized rats contained high levels of gamma interferon, followed by interleukin-2 (IL-2), IL-10, and then IL-4.  These results are consistent with the induction of T helper type 1 (Th1)- and Th2-like responses.  Western blot anal. of sera derived from rHag B-immunized rats reacted with trichloroacetic acid (TCA) ppts. of P. gingivalis 33277, 381, A7A1-28, and W50, revealing a 50-kDa band reflective of Hag B.  However, sera derived from rats immunized with P. gingivalis whole cells or from rats infected with P. gingivalis only did not react with rHag B but did react with TCA ppts. of P. gingivalis strains.  Finally, radiog. measurements of periodontal bone loss indicated that rats immunized with rHag B had less bone loss than those infected with P. gingivalis only.  These results demonstrate the effectiveness of purified rHag B in inducing a protective immune response and support the potential usefulness of this component of P. gingivalis in the development of a vaccine against adult periodontitis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4aCqyjBtYObVg90H21EOLACvtfcHk0ljq_LtxOheWfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXlsFCmtr8%253D&md5=8cdb21398c62a055b682489526201301</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1128%2FIAI.67.9.4352-4359.1999&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FIAI.67.9.4352-4359.1999%26sid%3Dliteratum%253Aachs%26aulast%3DKatz%26aufirst%3DJ.%26aulast%3DBlack%26aufirst%3DK.%2BP.%26aulast%3DMichalek%26aufirst%3DS.%2BM.%26atitle%3DHost%2520responses%2520to%2520recombinant%2520hemagglutinin%2520B%2520of%2520Porphyromonas%2520gingivalis%2520in%2520an%2520experimental%2520rat%2520model%26jtitle%3DInfect.%2520Immun.%26date%3D1999%26volume%3D67%26spage%3D4352%26epage%3D4359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i15"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01511">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_50630"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.9b01511">10.1021/acs.jmedchem.9b01511</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline"><sup>1</sup>H NMR spectra of the known compounds <b>3</b> and <b>4</b> and <sup>1</sup>H and <sup>13</sup>C NMR spectra of the new compounds <b>5</b> and <b>6</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01511/suppl_file/jm9b01511_si_001.pdf">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01511/suppl_file/jm9b01511_si_001.pdf">jm9b01511_si_001.pdf (0.99 MB)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.9b01511&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.9b01511%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2019.62.issue-21%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.9b01511" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                904KB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679954b30fa33cd0","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
